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Abstract 
 
The nucleosome remodeling factor (NURF) is an evolutionary conserved ATP-
dependent chromatin remodeling factor. It was first isolated from Drosophila as a 
complex with enzymatic activity that once recruited to nucleosome, it slides the 
nucleosome to provide accessibility for transcription factors. Since then, numerous 
works from animal models and cell lines show the role of NURF as a regulator of gene 
expression. NURF interacts with H3K4me3 and sequence specific transcription factors 
that recruit the complex to promoter regions. Whether this is the only mechanism by 
which NURF regulates gene expression is not known. However, other ATP-dependent 
chromatin remodeling complexes are known to regulate gene expression independent 
from transcription initiation. In order to explore the role of NURF in regulating gene 
expression, we utilized two genome wide approaches to map NURF binding and NURF 
dependent changes in chromatin structure using ChIP-Seq and FAIRE-Seq, 
respectively. From these analyses, we discovered that NURF broadly localizes in the 
genome with preferences to gene bodies and 3’ends of genes. Also, we found that 
NURF maintains open chromatin regions at upstream, intron and downstream of genes. 
These novel findings shed light on new roles for NURF complex within genes, in 
addition to its classical role at promoter regions. Furthermore, we discovered the 
function of a previously uncharacterized domain in the NURF specific subunit BPTF. We 
show that the N-terminal the plant homeodomain (PHD) of BPTF directly interacts with 
THOC4, a protein associated with RNA-pol 2. Also, we show using ChIP analyses that 
this interaction recruits BPTF to gene bodies. Next, we investigated functional 
	  
	   xxi	  
consequences for NURF recruitment to gene bodies using Cyclin D1 (Ccnd1) gene as a 
model. These analyses revealed that NURF is required for normal mRNA processing 
and loss of NURF induces intron retention, which results in unstable transcripts. Finally, 
we show that the defect in mRNA processing is not specific to the Ccnd1 gene, as we 
observe similar defects in four other BPTF dependent genes. Together, our work 
uncovered new role of mammalian NURF complex in regulating gene expression 
through mRNA processing. 
	  
	   1	  
CHAPTER ONE 
Introduction 
 
Overview 
In multicellular organisms, all cells share the same genetic material. However 
diverse cell types exist which are functionally and phenotypically distinct. This is 
achieved by modulating the genome to allow cell type specific gene expression. A key 
to this process is regulating the chromatin structure. Mechanisms that regulate the 
chromatin structure include histone modifications, histone variants and Adenosine-
triphosphate (ATP)-dependent chromatin remodeling complexes (Rando and Chang 
2009). In oppose to alterations in DNA sequences, alterations in chromatin structure 
can be reversible. Extensive research on histone modifications clarifies their role in 
normal tissues and their impact on diseases and tumorigenesis (Brookes and Shi 2014). 
Eventually, this led to the development of successful therapeutic drugs, such as the 
histone deacetylase inhibitors suberoylanilide hydroxamic acid (SAHA) to treat certain 
type of human cancers (Esteller 2007). This highlights the importance of exploring roles 
of other chromatin regulators in cell biology and the impact they have on pathological 
states. Important regulators of chromatin structures that also impact gene expression 
are the ATP-dependent chromatin remodeling complexes (Clapier and Cairns 2009). 
These complexes have enzymatic activity that allows remodeling chromatin structure, 
and they are involved in regulating gene expression, DNA repair and DNA replication. 
The Nucleosome Remodeling Factor (NURF) is one of the ATP-dependent 
chromatin remodeling complexes. NURF is essential for embryonic development and 
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cell differentiation, but not survival of normal cells (Landry , Sharov , et al. 2008) 
(Landry, et al. 2011). Recently, a number of reports showed the requirement of the 
NURF specific subunit BPTF in cancer cell growth, and correlation between BPTF 
expression and the poor prognosis in cancer patients (Dar, et al. 2015) (Xiao, Liu and 
Lu, et al. 2015) (Xiao, Liu and Fang, et al. 2015). In addition, down regulation of NURF 
catalytic subunit has adverse effects on cancer cell growth but not normal cells (Ye, et 
al. 2012). This suggests that further characterization of NURF is required to understand 
its role in normal cells as well as cancer cells. Works from Drosophila and mouse model 
as well as human cell lines suggest that NURF functions as a regulator of gene 
expression (Alkhatib and Landry 2011). However, mechanisms by which NURF 
regulates gene expression in vivo are largely unknown. To date, NURF localizes to 
promoter regions through specific recognition to H3K4me3, H4K16ac and interaction 
with sequence specific transcription activators or repressors. However, in Drosophila 
the recognition of H3K4me3 by NURF is not required to regulate a majority of NURF 
dependent genes. In addition, role of chromatin remodeling complexes in gene 
expression is not limited to transcription initiation. Genome wide approaches uncovered 
new insights into roles of chromatin-associated proteins. In this work we proposed three 
aims to better understand how NURF complex function as a regulator of gene 
expression: 
Aim1: Identifying NURF Localization Genome Wide in Mouse Genome  
 
Aim2: Identifying NURF Dependent Changes in Chromatin Structure Using 
FAIRE-Seq 
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Aim3: Characterize a Mechanism of NURF Recruitment to Chromatin and 
Role in Regulation of Gene Expression 
 
 
 
1.1 Chromatin structure  
In eukaryotes, the genetic information is stored in the deoxyribonucleic acid 
(DNA). The human genome contains ~3 billion nucleotides, which as a linear DNA is 
approximately 2 meters length. In order to fit the DNA into the ~10 micrometer (µm) 
nucleus, the nuclear DNA is packaged with RNA and proteins to form chromatin. 
However, this structure prevents the accessibility of DNA binding proteins (DBPs) to the 
underling DNA sequences, which is required to read, replicate or maintain the integrity 
of the genetic information. To overcome this problem, the cells utilize mechanisms that 
modulate the chromatin structure and to promote the accessibility of DBPs. Thus, the 
chromatin functions is an efficient tool to package the genomic material in the nucleus 
and an important regulator of DNA dependent processes such as gene expression, 
DNA replication and DNA damage repair (Clapier and Cairns 2009).  
Fundamental component of the chromatin are histone proteins. The core histone 
proteins are highly conserved, which reflects the conservation of chromatin structure in 
eukaryotes. The basic subunit of this structure is a nucleosome in which 146 base pair 
(bp) of double stranded DNA is wrapped around eight histone proteins (2 dimer  each of 
H2A/H2B and H3/H4) (Luger, et al. 1997). Series of nucleosomes form the beads on 
string, 11 nanometer (nm) nucleosome fiber. Addition of linker histones and inter-
nucleosomal interactions within the fiber fold the chromatin into more condensed, 30 nm 
	  
	   4	  
structure. Further folding of the chromatin into even higher ordered structures exists in 
the nucleus (Li and Reingberg 2011).  
Based on degree, chromatin is organized into domains with less condensed and 
active regions (euchromatin) or more condensed and repressed regions 
(heterochromatin) each contains specific set of chromatin modifications and associated 
proteins (discussed below). Heterochromatin further can be divided into constitutive and 
facultative heterochromatin. Constitutive heterochromatin are usually gene poor regions 
and contain high content of repetitive elements which occupy telomeric, centromeric 
and pericentromeric regions. Therefore, Constitutive heterochromatins are similar in 
different cell types. Facultative heterochromatin regions contain genes that are 
developmentally regulated genes or genes that are inactive at specific cell stage or 
expressed from one allele depends on parent of origin (imprinting). Thus, facultative 
heterochromatin is different between cells types (Trojer and Reinberg 2007).  
Maintaining the integrity of these domains can be mediated through insulator 
elements at the boundaries of these domains. CCCTC-binding factor (CTCF) is a 
protein that binds to these elements and involve in long distance interactions that 
regulate the chromatin topology within the nucleus (Ghirlando, et al. 2012). In addition, 
the cohesin complex, which is a multi-subunit complex that associates with CTCF, is 
also involved in chromatin looping that mediate close localization of two regulatory 
elements that are far from each other in term of genetic distance such as enhancer to 
promoter regions (Dekker 2008) 
The chromatin structure is highly dynamic, and global change in chromatin 
structure occurs during cell differentiation. In embryonic stem cells (ESC) the chromatin 
	  
	   5	  
is less condensed and more accessible comparing to differentiated cells. For example, 
deposition of linker histone and heterochromatin protein 1 (HP1) is more dynamic in 
ESC, and they become more stabilized upon differentiation. Also, an increase in 
incorporation of repressive histone marks is associated with differentiation which lead to 
more heterochromatin formation in differentiated cells (Saladi and Serna 2010).  
 
 
 
1.2 Factors Influence Chromatin Structure 
1.2.1 Histone Modifications 
Histone modifications are post-translational modifications (PTMs) on histone 
proteins mainly at the amino terminal (N-terminal) and to less extent in the carboxy 
terminal (C-terminal) and core residues. The N- terminal tails of H2A, H2B, H3 and H4 
are extended outside the nucleosome core structure and contain 19 to 40 amino acids 
rich with basic residues (Lysine (K) and Arginine (R)). Histone tails can directly influence 
chromatin folding through interactions with other histone proteins. For example, basic 
residues between amino acid 16-20 of H4 tail interact with an acidic region at H2A core 
protein of the neighboring nucleosome and promote internucleosome interaction (Luger, 
et al. 1997) (Zhou, et al. 2007). Another example is the role of the N-terminal tail of the 
H2A in regulating the linker histone H1 incorporation into nucleosome (Jason, et al. 
2005).  
Major PTMs that can modify histone proteins are methylation, acetylation, 
phosphorylation and ubiquitination (Figure 1.1). The main role of PTMs on histone tails 
is to serve as a signal or a platform for chromatin modifying proteins and transcription 
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factors (TFs) that contain specific domains that recognize these PTMs. For example, 
methylation can be recognized by chromodomain, plant homeodomain (PHD) and 
PWWP domain, and acetylation is mainly recognized by bromodomain (Zeng and Zhou 
2002), but, recently, tandem PHD finger also found to bind to acetylated histone (Zeng, 
Zhang, et al. 2010). 
  
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Acetylation occurs on lysine (K) residues. One proposed function of acetylation is 
to modulate high order chromatin structure as it neutralizes the basic charge of the 
Figure 1.1: A diagram showing common PTMs on canonical histone 
tails  
Amino acids sequences for canonical histone tails N-terminal, left and C-
terminal, right from the core protein (center, bold). Each residue colored 
based on the PTM and numbered based on the distance from the core 
protein. Adopted and modified from (Lodish, et al. 2008). 
Figure 1.1 
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lysine. As mentioned above the basic residue in the H4 tail from one nucleosome can 
interact with the H2A in the adjacent nucleosome (Luger, et al. 1997), and acetylation 
neutralizes the charge of these residues and abolishes the interaction. An in vitro study 
using recombinant nucleosome showed that acetylation of lysine 16 on histone 4 
(H4K16ac) affects nucleosome folding compared to unmodified H4K16 (Shogren-
Knaak, et al. 2006). Additionally, histone acetylation can facilitate displacement of 
H2A/H2B dimer from nucleosomes by histone chaperones, which provide more open 
structure (Ito, Ikehara, et al. 2000). In addition, studies in Drosophila showed that 
acetylation at H4K16 and H4K12 interfere with nucleosome spacing factors in mediating 
chromatin compaction (Corona, et al. 2002). In yeast, acetylation at K56 at the core of 
H3 reduces DNA-binding to the nucleosome and promotes nucleosome disassembly 
(Williams, Truong and Tyler 2008). These findings suggest that acetylation opens 
chromatin structure and promotes accessible chromatin confirmation. Indeed, genome 
wide localization of different acetylated lysine residues showed association with active 
regions. In mouse embryonic stem cells (mESCs), H4K16ac showed enrichment at 
transcription start sites (TSSs) of active genes (Taylor, et al. 2013). Genome wide study 
investigating enhancer elements in mESCs and adult tissues showed that acetylation of 
lysine 27 on histone 3 (H3K27ac) is enriched at active enhancers versus poised 
enhancers (Creyghtona, et al. 2010). In addition, investigation of acetylation of lysine 9 
on histone 3 (H3K9ac) and lysine 4 on histone 3 (H3K4ac) localization revealed 
enrichment over bivalent promoters mESCs (Karmodiya, et al. 2012). The acetylated 
lysine can also facilitate open chromatin structure through recruitment of bromodomain 
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containing ATP-dependent chromatin remodeling complexes (Clapier and Cairns 2009) 
(discussed below).  
Methylation occurs mainly on lysine residues and to less extent on arginine 
residues (Kouzarides 2007). Methylation on lysine is a well-characterized modification 
and it mediates its effect through recruitment of chromatin binding factors. Depending 
on the modified lysine reside, methylation can be associated with euchromatin, 
constitutive or facultative heterochromatin. Euchromatin marks include mono-,di and tri 
methylation on lysine 4, di and tri-methylation on lysine 36 and tri-methylation on lysine 
79 on histone 3, (H3K4me1/2/3), (H3K36me2/3) and (H3K79me3), respectively 
(Kouzarides 2007). H3K4me3 marks active promoters and recruits important factors 
that modulate open chromatin confirmation. For example, it can recruit ATP-dependent 
chromatin remodeling complexes such NURF (Wysocka, et al. 2006) and the 
chromodomain helicase DNA binding1 (CHD1) (Sims, et al. 2005) to promoter regions 
to facilitate gene expression. Genome wide localization of H3K4me3 showed 
localization at TSSs and high correlation with gene expression (Barski, et al. 2007). 
H3K4me1 localizes within genes and at distal enhancer regions, which are marked by 
presence of p300 histone acetyl transferase, DNase hypersensitivity sites (DHSs), and 
conservation among species (Heintzman, et al. 2007). H3K36me2/3 exist as a broad 
domain within open reading frame of active genes (Barski, et al. 2007). Within active 
transcripts H3K36me3 is more enriched at exons than introns (Spies, et al. 2009) 
(Kolasinska-Zwierz, et al. 2009) suggesting a role in messenger RNA (mRNA) 
processing through altering elongation rate (Sims and Reinberg 2009). Indeed, many 
studies document the role of H3K36me3 in recruiting factors important for alternative 
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splicing (discussed in section 1.5.2). Studies in yeast showed the role of H3K36me3 in 
maintaining the integrity of nucleosomes during transcription elongation, and reducing 
H3K36me3 levels results associated with initiation of incryptic transcription within genes 
(Smolle, et al. 2012). H3K36me3 is recognized by the histone deacetylase Rpd3S 
complex that mediate deacetylation of the nucleosomes behind the RNA-polymerase II 
(RNA-pol 2) to condense the chromatin and prevent cryptic transcript (Li, et al. 2009).  
However, in Drosophila Bell, et al. showed that H3K36me2 recruits histone acetyl 
transferase (HAT) to mediate H4K16ac and decondense chromatin while H3K36me3 
recruits the histone deacetylase (HDAC) Rpd3S to condense the chromatin (Bell, et al. 
2007). Although, the human homolog of Rpd3S complex has been recently isolated, it 
only promotes deacetylation around TSSs suggesting that this mechanism is not 
conserved in mammals (Jelinic , Pellegrino and David 2011). Also, H3K36me3 can 
recruit ATP-dependent chromatin remodeling complexes (discussed in section 1.5.1) 
(Maltby, et al. 2012) (Smolle, et al. 2012).  
Tri-methylation of lysine 9 on histone 3 (H3K9me3) is usually associated with 
constitutive heterochromatin and condensed chromatin structure. This effect is mainly 
mediated by recruiting the heterochromatin protein 1 (HP1) through its chromodomain. 
Subsequently, HP1 recruits factors such HAT and DNA-methyl transferase (DNMT) to 
create and maintain a repressed environment. For example, binding of HP1 to 
H3K9me3 can recruit H3K9 methyltransferase that methylate adjacent H3K9 which then 
serve as a binding site for a new HP1 protein. This mechanism likely involves in the 
spreading of the heterochromatin regions (Campos and Reinberg 2009). In ESC, 
H3K27me3 (repressive mark) and H3K4me3 (active mark) overlap over promoter 
	  
	   10	  
regions of genes that are regulated during differentiation. Upon differentiation to specific 
cell lineage, genes required for the determined fate exhibit the H3K4me3 and actively 
expressed while genes that are not required for the fate exhibit H3K27me3 and 
remained repressed (Rando and Chang 2009).   
Role of ubiquitination is dependent on the modified residue. Monoubiquitination 
of H2A functions as a recruiter of polycomb repressive complex 2 (PRC2) complex that 
mediate H3K27me3, which is recognized by polycomb repressive complex 1 (PRC1) 
repressor complex (Kalb, et al. 2014). Monoubiquitnation of H2AK119 (H2AK119ub1) 
has a repressive effect as it prevents dissociation of linker histone H1 and prevents 
recruitment of the H2A/H2B histone chaperone facilitates chromatin transcription 
(FACT) which is important for RNA-pol 2 elongation (Zhou, et al. 2008). While 
H2AK119ub1 acts as a repressor, ubiquitination of human H2BK120 (H2BK123 in 
yeast) is associated with active gene expression. Its role in gene expression occurs by 
facilitates FACT recruitment (Pavri, et al. 2006). 
	  
1.2.2 Histone Variants 
Histone variants are non-canonical histones that are deposited into nucleosomes 
in replication independent manner. Due to sequence differences, incorporation of 
histone variants alters the nucleosomal properties. Two important histone variants are 
the H2A variant H2A.Z and the H3 variant H3.3 (Venkatesh and Workman 2015).  
H2A.Z is a highly conserved protein and its incorporation into nucleosomes is 
mediated by the ATP-dependent chromatin remodeling complex Snf2-related CBP 
activator protein (SRCAP) in human (SWR1 in yeast). Due to sequence differences, 
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H2A.Z containing nucleosomes are less stable compared to H2A containing 
nucleosomes (Campos and Reinberg 2009). In addition H2A.Z increases association of 
chromatin remodelers to nucleosomes as opposed to H2A (Goldman, Garlick and 
Kingston 2010). Genome wide studies showed that H2A.Z is enriched in promoters, 
enhancer regions and CTCF binding sites (Hu, et al. 2013)(Fu, et al. 2008). In mESC, 
loss of H2A.Z is associated with increased nucleosome occupancy at enhancer regions, 
which indicates its role in regulating accessibility to DNA (Hu, et al. 2013). In human, the 
H2A.Z level at promoters is correlated with gene expression (Barski, et al. 2007).  
H3.3 is a replication independent histone 3 variant that only differ from the 
canonical H3 at 5 amino acids. H3.3 is found in TSS, gene bodies and distal regulatory 
elements. The histone chaperone DAXX in human mediates incorporation of this variant 
into nucleosomes (Drané, et al. 2010). Incorporation of H3.3 into nucleosomes 
decreases nucleosome stability (Jin and Felsenfeld 2007) and prevents incorporation of 
linker histone (Braunschweig, et al. 2009). KD of H3.3 is associated with increased 
localization of H1 linker histone at TSS and cis-regulatory elements, suggesting that 
H3.3 maintains open chromatin conformation at these regions. Genome wide studies in 
mESCs shows that high turnover rate of H3.3 at nucleosomes free regions (NFRs) at 
the TSS and enhancers. The H3.3 turnover rate is directly associated with gene activity 
(Ha, Kraushaar and Zhao 2014). 
 
1.2.3 ATP-dependent chromatin remodeling complexes 
The nucleosome structure can mask or disrupt binding sites for sequence 
specific TFs or DBPs. As the double stranded DNA (dsDNA) is wrapped around the 
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histone octamer, there are 14 DNA-histone contacts in a nucleosome that need to be 
disrupted in order to mobilize the nucleosomes. Major regulators of chromatin structure 
that utilize ATP as energy source are the ATP-dependent chromatin remodeling 
complexes. These complexes are involved in regulation of gene expression, DNA 
damage response and DNA replications (Bartholomew 2014). 
Generally, these are multi-subunit complexes; although some function as 
monomer.  In each complex, accessory subunits are assembled with an ATPase 
subunit, which is required for the enzymatic activity (Clapier and Cairns 2009). These 
complexes belong to the sucrose non-fermenting 2 (Snf2) family of ATP-dependent 
helicases (Flaus, et al. 2006 ). Based on the sequence homology of the ATPase domain 
and additional domains within the ATPase subunit this family can be further divided into 
subfamilies. The major four subfamilies are Switching defective 2/sucrose non-
fermenting 2 (SWI/SNF), Imitation switch (ISWI), Chromodomain, helicase and DNA 
binding (CHD) and Inositol requiring 80 (INO80) (Bartholomew 2014).  
The ATPase subunits from all the subfamilies share the highly conserved 
ATPase domain which has the ATP binding domain DEXDc adjacent to a helicase 
domain HELICc that are required for the remodeling activity. However, each subfamily 
has characteristic features within the ATPase subunit. These include bromodomain in 
the SWI/SNF complexes, three conserved domains in the C-terminal region for the ISWI 
complexes (discussed in section 1.4.1) and tandem chromodomains for the CHD 
complexes. An extended insertion within the ATPase domain is characteristic for the 
INO80 complexes (Clapier and Cairns 2009).  
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Chromatin remodeling activity consists of sliding a nucleosome, ejecting histone 
octamer, loop or unwrap the DNA from the nucleosome or exchanging histone variants. 
Sliding can lead to either expose or mask a DNA motif that can be recognized by a DBP 
such as a TF. Ejecting nucleosome is required when a stretch of DNA free of 
nucleosome is necessary such as in DNA repair or DNA replication.  Histone variant 
exchange is required to mark regions in the genome with regulatory (Bartholomew 
2014) (Figure 1.2). 
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DBP 
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Chromatin 
Remodeling Factor 
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Figure 1.2: Outcomes of ATP-dependent chromatin remodeling complexes 
DNA (Black line) is wrapped around the histone octamer (Gray cylinder) to form nucleosomes. A 
DNA sequence (Red line) that can be recognized by a DBP (While oval) is inaccessible (Top). 
Recruiting a chromatin remodeling complex lead to either slide, eject, unwrap or loop the DNA 
or exchange histone variant (Bottom) which make the DNA element accessible to the DBP. 
	  
Figure 1.2 
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Recruiting remodelers to chromatin can be through recognition of histone 
modifications or interacting with DBPs. These interactions can be through domains in 
the catalytic subunits such as the case of the SWI/SNF bromodomain (recognizes 
acetylated histones) and the CHD chromodomain (recognizes histone methylation) 
(Clapier and Cairns 2009). In addition, accessory subunits that assemble with the 
catalytic subunit can further harbor reader domains that recognize modification over 
DNA or histones. As the case for the Bromodomain PHD transcription factor (BPTF) 
subunit of NURF that has PHD domain and bromodomain that specifically recognize 
H3K4me3 and H4K16ac, respectively (Wysocka, Swigut, et al. 2006) (Ruthenburg, et al. 
2011). Another example is the methyl binding domain 3 (MBD3) subunit of nucleosome 
remodeling and histone deacetylase (NURD) complex (CHD complex) that recognize 
methylated DNA (Marfella and Imbalzano 2007). However, accessory subunits can also 
function to enhance the remodeling activity of complexes or provide additional 
enzymatic activity. For example, in the ACF complex the accessory subunit Acf1 in 
Drosophila greatly enhances the ATPase activity of the ATPase subunit ISWI (Ito, 
Bulger, et al. 1997). The histone deacetylase HDAC subunit is a core subunit of NURD 
complex and allows NURD complex to have a deacetylase activity along with the 
ATPase activity (Denslow and Wade 2007). Although the remodeling activity requires 
interaction with nucleosomal DNA by the ATPase domain, these interactions are mostly 
sequence non-specific. However, remodelers interact with sequence specific TFs that 
can recruit them to chromatin (Becker and Workman 2013).  
The need of chromatin remodeling in transcription comes from the fact that 
transcription is mediated through a chromatin template. Initiation of transcription 
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requires binding of sequence specific transactional co-activators at promoter regions 
and assembling of pre-initiation complexes (PIC) at transcription start sites.  In addition, 
following initiation, the elongating RNA-pol 2 must traverse nucleosomes within the 
genes bodies (Campos and Reinberg 2009). Thus, along with other chromatin 
modifying factors such as histone chaperones, ATP-dependent chromatin remodeling 
complexes are required for normal regulation of transcription (Discussed in section 
1.5.1) 
In DNA replication, multiple remodelers are associated with replication foci 
required for DNA synthesis such as the ISWI containing complexes (Erdel and Rippe 
2011).  For example, the ATP-utilizing chromatin assembly and remodeling factor 1 
(ACF1) (a subunit of ACF complex discussed below) protein is associated with 
replicating heterochromatin and ACF1 KD showed delay in late S-phase, a time for 
heterochromatin replication (Collins, et al. 2002).  
 
1.2.3.1 SWI/SNF Chromatin Remodeling Complexes 
In mammals, the SWI/SNF subfamily are large multi-subunits complexes 
composed of 8 to 12 subunits which assemble with one of two ATPase subunits; 
Brahma (BRM) or Braham-related gene1 (BRG1) to form Brahma-associated factor 
(BAF) or polybromo-BAF (PBAF) complexes, respectively. Each complex assembles 
with one ATPase subunit (BRG1 or BRM), common accessory subunits and subunits 
specific for BAF complexes and specific for PBAF complexes (Hargreaves and Crabtree 
2011). The SWI/SNF complexes are essential for embryonic development, 
neurogenesis, erythropoiesis, thymocyte development and heart development. They 
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can slide or eject nucleosomes as remodeling mechanisms, and their main function is 
regulation of gene expression. They are recruited to chromatin through recognition of 
histone modifications and interaction with sequence specific transcription factors. The 
bromodomain in the ATPase subunit recognizes the acetylated histone tails. In addition, 
BRG1 interacts with TFs such as Erythroid Krüppel Like Factor (ELKF) and GATA-1 
and BRM interacts with proteins involved in Notch signaling pathways (Kadam and 
Emerson 2003). Additionally, the accessory subunits contain domains that provide 
additional contact surfaces to histone modifications (e.g. polybromo domains in 
BAF180), proteins (HSA in BRG1 and BRM) and DNA (AT-rich interactive domain 1 a/b 
(ARID1a/b)) (Hargreaves and Crabtree 2011). 
The effect on gene expression can be through remodeling activity at promoter 
regions. For example, SWI/SNF complexes are recruited to promoters of nuclear 
receptors targeting genes such as glucocorticoid receptor and vitamin D receptor 
(Hsiao, et al. 2003) (Kitagawa , et al. 2003). However, mammalian SWI/SNF can also 
function at distal regulatory regions. For example, BRG1 containing complex represses 
the CD4 gene in early stages of thymocyte development by facilitating the accessibility 
of runt-related transcription factor 1 (RUNX1) co-repressor to CD4 silencer elements 
(Jani, et al. 208). Genome wide mapping of BRG1 localization in different mouse 
tissues, show that 26% of BRG1 binding sites localize at transcription start sites and 
47% localize at distal (intergenic) regions. Comparison of the localization profiles 
revealed that the TSS binding sites are shared between different tissues, while the 
distal sites are more tissue specific and associated with active and repressed histone 
marks (Attanasio, et al. 2014). In mESC only 12% of BRG1 binding sites mapped at 
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TSS while the majority of the peaks are at distal regions and associated with H3K4me1 
(L. Ho, J. L. Ronan, et al. 2009). In addition, BRG1 containing complexes can mediate 
long-range chromatin interaction (chromatin looping) between distal regulatory elements 
and promoter regions. It has been shown that at the α globin locus, BRG1 is required for 
chromatin interaction between the major regulatory elements (MRE) and α2 promoter 
that are separated by ~40kb (Kim, Bresnick and Bultman 2009).  
In addition to transcription initiation, SWI/SNF are involved in mRNA alternative 
splicing. BRM is localized in coding regions of some of its target genes and helps to 
recruit the splicing machinery through direct interaction with the small nuclear 
ribonucleic proteins (snRNPs) U-rich 1 (U1) and U6. At these locations it promotes 
inclusion of alternatively spliced exons. BRM increases RNA-pol 2 occupancy at 
alternatively spliced exons, and BRM knock-down (KD) was associated with defects in 
RNA-pol 2 elongation and reduces the exon inclusion. The role of BRM in this context 
does not require ATP as BRM with mutated ATP domain showed similar effects 
(Batsche, Yaniv and Muchardt 2006). In addition, BRG1 has been reported to localize in 
gene body of the heat shock protein 70 (hsp70) gene and plays a role in RNA-pol 2 
elongation through hsp70 gene (Corey, et al. 2003).  
 In addition to their role in gene expression, studies in yeast showed that 
SWI/SNF are involved in DNA repair and chromosomal segregation. It has been shown 
that yeast SWI/SNF complexes are recruited to double stranded breaks (DSBs) sites 
and mediates homologues recombination repair mechanism (Chai, et al. 2005). Also, 
they localize to centromeric regions during cell cycle, and required for kinetochore 
function during chromosome segregation (Hsu, et al. 2003).  
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An interesting feature of SWI/SNF complexes is that they undergo combinatorial 
assembly of their subunits to form complexes with cell type specific function. Some of 
the subunits (BAF53, BAF45, BAF250) have different isoforms and encodes by different 
genes, and incorporation of specific isoform gives a cell type specific complex. This 
mechanism accounts for the diverse roles of this family in regulating gene expression at 
different cell types (Hargreaves and Crabtree 2011). 
In mESC, SWI/SNF assembles into a complex with subunits specific for mESC. 
The complex is, essential for normal embryonic stem cells (defined by self renewal and 
ability to differentiate into multiple tissues (pluripotency)), and inactivation of its subunits 
promotes ESC differentiation (L. Ho, J. Ronan, et al. 2009). ChIP-Seq in mouse ESC 
revealed that BRG1 localizes at genes highly expressed in mESC but not in 
differentiated cells, and those genes important for mESC phenotype such as Sox2, 
Nanog, C-Myc, Oct4 and Klf4 (Ho, et al. 2009). In addition, BRG1 is significantly 
localizes over genes targeted by master regulator of mESC such as OCT4, SOX2 and 
NANOG.  Moreover, BRG1 significantly overlaps with genes targeted by STAT3 and 
SMAD1 transcription factors which are downstream effectors for the leukemia inhibitory 
factors (LIF) and bone morphogenic protein (BMP) signaling pathways which are 
important for maintaining the pluripotency state  (Ho, et al. 2009). In support to these 
findings, overexpression of BRG1 and BAF155 in somatic cells along with OCT4, 
SOX2, C-MYC and KLF4 increased the re-programming efficiency and generation of 
induced pluripotent stem cells (iPS) (Singhal, et al. 2010).  
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1.2.3.2 INO80 Chromatin Remodeling Complexes 
In mammals, there are three complexes of the INO80 family; INO80, SRCAP and 
TRRAP/Tip60 which assemble with three ATPase subunits INO80, SCRAP and p400 
respectively. Similar to SWI/SNF, INO80 complexes are large multi-subunit complexes 
with 14 accessory subunits (Clapier and Cairns 2009). The INO80 ATPase differs from 
other ATPases because it has a spacer element within the ATPase domain. This 
element is important for the binding to other subunits to maintain complex integrity. The 
remodeling activity of this family includes sliding nucleosomes, evicting histone octamer 
and exchanging histone variant H2A with H2A.Z (Clapier and Cairns 2009). As the other 
ATP-dependent remodelers, the INO80 complexes are recruited to promoters and 
regulate gene expression. For example, INO80 interacts with yin yang 1 (YY1) and 
OCT4 transcription factors as well as WDR5, a subunit of HMT (Cai, et al. 2007) (Wang, 
et al. 2014). In addition, the SRCAP complex mediates incorporation of H2A.Z histone 
variant, which is associated with diverse cellular mechanisms including gene regulation. 
Along with regulation of gene expression, INO80 complexes involve in DNA 
damage response. INO80 complexes specifically recognize the phosphorylated H2A.X 
(γH2AX), a PTM that are associated with DNA damage sites, and are recruited to the 
sites of the DNA damage. INO80 complexes at these sites mediate histone eviction to 
expose the DNA for the repair mechanisms (Morrison and Shen 2009).  
In mESC, a resent study showed that INO80 is required for ESC self-renewal as 
INO80 KD reduces the pluripotency markers and induce differentiation. ChIP-seq 
analysis showed that 50% of INO80 peaks are enriched at TSSs and 98% overlap with 
DHSs. Also, INO80 is associated with H3K4me3 and H3K27ac peaks but not 
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H3K27me3 suggesting enrichment at euchromatin regions. In addition, INO80 co-
localizes with stem cell master regulators SOX2, NANOG, OCT4 and KLF4. Gene 
expression profiling of INO80 KO mESCs showed down regulation of pluripotency 
markers and genes that undergo down regulation following mESC differentiation (Wang, 
et al. 2014). In addition, Tip60-p400 is required for normal mESC phenotype and self-
renewal. Depletion of the complex showed defects in genes up regulated during 
differentiation, and significant overlap with NANOG dependent genes. ChIP-chip 
analysis showed that the complex highly localizes at promoters, and strongly associated 
with H3K4me3. This localization is dependent on H3K4me3 level and NANOG. 
However, no direct binding between NANOG and Tip60-p400 subunits suggesting the 
localization is indirect (Fazzio, Huff and Panning 2008).  
 
 
1.2.3.3 CHD Chromatin Remodeling Complexes 
The CHD subfamily is characterized by an N-terminal chromodomain in the 
ATPase subunit. There are 9 different ATPase proteins in this family some of them 
function as monomer. (Marfella and Imbalzano 2007).  The chromodomain in human 
CHD1 specifically interacts with promoter mark H3K4me3.  Genome wide localization of 
CHD1 and CHD2 in human cell lines showed that they localize to active chromatin 
regions and associated with active promoters (Siggens, et al. 2015). Additionally,	  CHD1 
also facilitates recruitment of subunits of spliceosome to transcripts and enhances 
splicing efficiency  (Sims III, et al. 2007). In yeast, CHD1 interacts with elongation 
factors and is important to maintain nucleosome integrity within active transcripts 
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(discussed in section 1.5.1) (Smolle, et al. 2012). This role is likely conserved as CHD1 
in mammals also interact with the structure- specific recognition protein 1 (SSRP1), 
which forms a heterodimer with SPT16 to form FACT, the positive elongation factor 
(Kelley , Stokes and Perry 1999). 
The CHD3 and CHD4 proteins (also known as Mi-2α and Mi-2β, respectively) 
contain double PHD domain in the N-terminal regions, and are the ATPase subunits of 
the multi-subunit complex the NURD. In addition to the ATPase activity, NURD has 
protein deacetylation activity through the histone deacetylase 1 and 2 (HDAC1 and 2). 
The complex contains 7 subunits CHD3 or CHD4, HDAC1/2, MBD2/3), the metastasis-
associated gene 1 , 2 or 3 (MTA1, MTA2 or MTA 3), the retinoblastoma associated 
protein 46 or 48 (RbAp46 or RbAp48) and GATA2A and B (Lai and Wade 2011). 
Domains in the CHD proteins as well as domains in the accessory subunits can recruit 
NURD to chromatin through recognition of histone tails, DNA methylation or sequence 
specific transcription factors. Combinatorial assembly of some of NURD subunits can 
provide specificity in the complex recruitment and function. For example incorporation of 
MBD2, but not MBD3, allows NuRD recruitment to methylated DNA (Lai and Wade 
2011). The presence of HDAC activity links NuRD to transcription repression. 
Consistent with its roles as a repressor KD of CHD4 mediates open chromatin 
confirmation and enhances gene expression (Gao, et al. 2009) (Ramirez-Carrozzi, et al. 
2006). Genome wide investigation of MBD3 subunits in cancer cell lines showed 
localization of MBD3 at promoters and within gene bodies of active genes as well as 
distal regulatory elements (Shimbo, et al. 2013). In mESC, MBD3 is required to repress 
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genes important for trophectoderm lineage thus it is required to maintain mESC 
pluripotency (Zhu, et al. 2009).  
Genome wide localization of CHD7 in mESCs showed strong localization at 
enhancers marked by H3K4me1, DNase hypersensitive sites and the enhancer binding 
protein p300. Also significant overlap with mESC master regulators OCT4, Nanog and 
SOX2 was detected. Further investigation reveals that the role of CHD7 is to fine-tune 
the mESC specific gene expression (Schnetz, et al. 2010). The CHD7 contains two 
copies of Brahma and Kismet domain (BRK) domain, which has been found to interact 
with CTCF (Allen, et al. 2007). CHD7 interactions at enhancers suggest that might 
mediate chromatin looping through CTCF. CHD8, which also has tandem BRK 
domains, interacts with CTCF and it is required for the insulator activity at some of 
CTCF sites (Ishihara, Oshimura and Nakao 2006).  
In mESC, ChIP-chip analysis showed that CHD1 is associated with H3K4me3 
and RNA-pol 2. KD of CHD1 increases chromatin condensation and localization of 
heterochromatin marks (H3K9me3 and HP1 proteins using immunofluorescence 
staining). In addition, it increases the expression of genes required for neuronal 
differentiation, and differentiation to embryoid bodies showed bias toward neuronal 
lineage (Gaspar-Maia, et al. 2009). Thus, similar to MBD3, CHD1 is required for mESC 
pluripotency.  
 
1.2.3.4 ISWI Chromatin Remodeling Complexes 
ISWI subfamily contains multi-complexes assemble with two to four subunits. 
There are two ISWI ATPase homolog in human and mouse the sucrose nonfermenting 
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2 homolog (SNF2H) and sucrose nonfermenting 2 (SNF2L), one in Drosophila the 
imitation switch (ISWI) and two in yeast Imitation switch 1 and 2 (Isw1 and Isw2) 
(Clapier and Cairns 2009).  These ATPase subunits associate with a variety of 
accessory subunits to create a diverse family of remodeling complexes that involves in 
regulating gene expression, DNA replication, DNA repair and maintaining chromosome 
structure (Erdel and Rippe 2011). 
The SNF2H and SNF2L are highly similar with 86% sequence homology and 
assemble around seven complexes; the nucleosome remodeling factor (NURF) 
(Tsukiyama and Wu 1995) (Barak, Lazzaro and Lane, et al. 2003), the CECR2-
containing remodeling factor (CERF) (Banting, et al. 2005), the remodeling and spacing 
factor (RSF) (LeRoy , Orphanides, et al. 1998), the chromatin-accessibility complex 
(CHRAC) (Varga-Weisz, et al. 1997), the ATP-utilizing chromatin assembly and 
remodeling factor (ACF) (Ito, Bulger, et al. 1997), the WSTF-ISWI chromatin remodeling 
complex (WICH) (Bozhenok, Wade and Varga-Weisz 2002) and the nucleolar 
remodeling complex (NoRC) (Strohner, et al. 2001). 
 
CERF is first identified as a SNF2L containing chromatin remodeling complex 
from HEK293T cells. (Banting, et al. 2005). However, study in mice showed that it also 
forms a complex with SNF2H in testis and embryonic stem cells. It composed of two 
subunits cat eye syndrome chromosome region candidate 2 (CECR2) and SNF2L. The 
complex requires nucleosomes as a substrate for the ATPase remodeling activity. 
CERC2 contains multiple domains localized in the N-terminal region of the protein and 
these include the DNA-binding homeobox-containing proteins and the different 
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transcription factor and chromatin remodeling factors in which it is found (DDT), AT-
hook and bromodomain (Banting, et al. 2005). All these domains are present in BPTF 
subunit of NURF, which suggest that these domains are characteristic of ISWI 
containing complexes (Alkhatib and Landry 2011). CECR2 expression is detected in 
many adult and fetal tissues. It localizes in the short arm of chromosome 22q11.2, a 
region present in multiple copies in patients with cat eye syndrome, which characterized 
by multiple congenital defects (Footz, et al. 2001). Gene trap induced mutation of Cecr2 
results in perinatal lethality with neuronal tube defects. The main effect on the nerves 
system is likely due to the high expression level of Cecr2 in the neuronal cells during 
mouse development (Banting, et al. 2005). Investigating the role of CECR2 in mice 
using null mutation approaches, showed its role in neurulation, spermatogenesis and 
ear development (Banting, et al. 2005) (Dawe, et al. 2011) (Thompson, et al. 2012). 
CERF is proposed to function as a regulator of gene expression (Erdel and Rippe 2011) 
however, less is known about how CERF complex regulates transcription. 
 
RSF is an SNF2H containing complex, however, it also assemble as SNF2L 
containing complex (Banting, et al. 2005). It contains two subunits; RSF-1 protein and 
SNF2H or 2L. RSF was first identified as a factor that is required for transcription 
initiation by RNA-pol 2 from chromatin template in vitro  (LeRoy , Orphanides, et al. 
1998). RSF-1 protein has a PHD domain and an acidic stretch at the C-terminal regions 
(Loyola, Huang, et al. 2003). Alternative start site generates a transcript that starts 253 
amino acids downstream of RSF-1 that is unable to interact with human SNF2H. This 
transcript is physically interacts with the viral X protein, a transcriptional activator, and 
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activate hepatitis B virus transcription (Shamay , et al. 2002). This suggests an ATP-
independent role of RSF-1 protein. Amplification of RSF-1 has been associated with 
ovarian cancer, and patients with high Rsf-1 expression have low survival time (Shih, et 
al. 2005). Overexpression of Rsf-1 in ovarian cancer cell lines showed resistance to 
chemotherapy (Choi, et al. 2009). 
In addition, RSF complex functions to assemble regularly spaced nucleosomal 
array independent of histone chaperones (Loyola, et al. 2001). In this capacity RSF is 
proposed to act as a histone chaperone for H3/H4. This leads to ATP-independent 
incorporation of H2A/H2B to form the nucleosome in chromatin. Then, RSF utilizes its 
ATP-dependent activity to assemble the nucleosomes in a regularly spaced array. This 
role of RSF does not require histone chaperone as required for ACF and CHRAC 
complexes (discussed below) (Ito, Bulger, et al. 1997). 
Another role of RSF complex is regulation of the centromere structure 
(Perpelescu, et al. 2009). RSF mediates deposition of the centromeric specific histone 3 
variant centromeric protein A (CENP-A) at the centromeric regions. RSF1 is associated 
with CENP-A containing chromatin at centromeric regions, and knockdown of Rsf-1 
reduces CENP-A localization and leads to defect in normal mitotic progression 
(Perpelescu, et al. 2009).  
 
ACF is a SNF2H containing complex, and contains two subunits the 
bromodomain adjacent to zinc finger domain1A (BAZ1) also known as ACF1, and 
SNF2H (LeRoy, Loyola, et al. 2000). ACF mediates nucleosome assembly (regularly 
space nucleosomal array) in combination with histone chaperones (Ito, et al. 1997). It 
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also regulates nucleosomes position to provide accessibility for transcription factors and 
promote transcription (Ito, et al. 1997) (LeRoy, Loyola, et al. 2000). The proposed model 
for the ACF function is that, following ATP-independent histone deposition ACF utilizes 
the ATP to mediate regularly spaced nucleosome assembly of the nucleosomal array. In 
mammalian cells, ACF is associated with replicating pericentromeric regions, and 
required for replication of heterochromatin (Collins, et al. 2002). Knockdown of Acf1 
lead to defect in DNA replication at late S phase, which is the time for heterochromatin 
replication. The role of the ACF is proposed to facilitate the DNA replication through the 
condensed chromatin, as de-condensation of heterochromatin by chemical agent 
rescued the ACF depletion (Collins, et al. 2002). ACF1 protein has multiple domains 
including; DDT domain, two PHD fingers, a highly acidic region, bromodomain and two 
uncharacterized domains named based on the proteins that has these domains along 
with ACF1 as determined by screening sequence databases. These motifs are WSTF/ 
Acf1/ Cbp146 (WAC) and WSTF/ Acf1/ KIAA0314/ ZK783.4 (WAKZ). Serial deletions of 
these domains revealed the importance of the region of the DDT domain in binding to 
the ATPase subunit ISWI and the role of the WAC domain in binding to DNA sequence 
(Fyodorov and Kadonaga 2002).  
Along with its role as a chromatin assembly factor, ACF can also promote 
transcription from chromatin template (LeRoy, Loyola, et al. 2000). In T-cells ACF 
complex directly regulates the IL-2 and IL-3 gene expression through regulating the 
accessibility to promoters and regulatory elements of these genes (Precht, Wurster and 
Pazin 2010).  
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CHRAC is a SNF2H containing complex. In human, CHRAC is similar to ACF 
complex with two addition proteins huCHRAC-15 and huCHRAC-17, which might 
function as histone fold proteins based on sequence homology (Poot, et al. 2000). 
    
NoRC is a SNF2H containing complex with two subunits the TTF-I-interacting 
protein 5 (TIP5) and SNF2H. TIP5 contains domains exist in ACF1 include; 
bromodomain, two PHD domains, WAKZ, and DDT domains, but lack the WAC domain. 
In addition, it contains four AT-hooks and a TIP5/ARBP/MBD (TAM) motif, which is 
highly similar to MBD domain exit in methyl-CpG binding proteins. The AT-hook and 
TAM found to cooperate to synergize TIP5 binding to DNA, and TAM domain can 
function as RNA-binding domain (Mayer, et al. 2006). NoRC was first isolated through 
screening for factors interact with the TTF-I a termination factor that binds to promoter 
of ribosomal RNA (rRNA) genes. Subsequent work showed the role of NoRC in 
repressing rRNA gene expression by RNA polymerase I through establishing 
heterochromatin architecture,  (Zhou, Santoro and Grummt 2002), and regulates the 
nucleosome structure at rRNA promoter regions (Li, La ̈ngst and Grummt 2006). NoRC 
interacts with histone methyl transferases to promote H3K9 and H4K20 methylation, 
histone deacetylase that promotes H3K9 deacetylation and HP1 (Postepska-Igielska, et 
al. 2013). Recruiting NoRC to ribosomal DNA (rDNA) is guided by; (i) the interaction 
between TIP5 (through TAM domain) and non-coding RNAs that has sequence 
homology to rRNA promoters, and (ii) the interaction between TIP5 (through the 
bromodomain) and H4K16ac (Zhou and Grummt 2005). In addition, NoRC establishes 
heterochromatin architecture at centromeric and telomeric regions, and knockdown of 
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TIP5 leads to defects in chromosomal segregation and mitotic abnormalities 
(Postepska-Igielska, et al. 2013). Overexpression of TIP5 has been observed in 
prostatic cancer, and its expression level can be used as a marker for the disease 
recurrence (Gu, et al. 2015).  
 
WICH is a SNF2H containing complex with two subunits the Williams Syndrome 
transcription factor (WSTF) and SNF2H. The WSTF gene localizes along with another 
15 genes in a chromosomal region that is deleted in patient with Williams Syndrome, 
which is an autosomal dominant disorder characterized by craniofacial and heart 
defects as well as metal retardation (Barnett and Krebs 2011). WSTF protein is widely 
expressed in adult and neonatal tissues, and homozygous KO mice die soon after birth 
with significant heart defects. WSTF protein has multiple domains characteristic for 
ISWI accessory subunits including WAC, WAKZ, DDT, PHD and bromodomain 
(Bozhenok, Wade and Varga-Weisz 2002). Similar to ACF complex, WICH complex 
localizes with replicating heterochromatin foci during S phase. This localization is 
mediated by direct interaction with the proliferating-cell nuclear antigen (PCNA) (Poot, 
Bozhenok, et al. 2004). The role of WICH in this regard is likely to assemble the 
chromatin following the replication fork (Poot, Bozhenok, et al. 2004). In contrast to 
ACF, WSTF through WICH is also localizes at chromosome in metaphase (condensed 
chromosome). This unique feature of WICH complex suggests a role in chromosome 
condensation or recruiting factors important to this stage of cell cycle (Bozhenok, Wade 
and Varga-Weisz 2002). WICH complex is also involves in regulating DNA damage 
response. It has been found that WICH is associated with H2A.X, an important histone 
variant associated with early stages of DNA damage response, and it is required for 
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DNA damage response. KD of WSTF reduces the γ-H2A.X phosphorylation which likely 
due to defect in active ATM recruitment, an important kinases for γ-H2A.X. Additionally, 
the WSTF has a kinase activity through the WAC domain that phosphorylates Tyr142 at 
H2A.X at the site of DNA damage (Xiao, et al. 2009). 
 
 
1.3 The Nucleosome Remodeling Factor NURF 
NURF complex belongs to the imitation switching (ISWI) family of the ATP-
dependent chromatin remodeling complexes. It was discovered in 1995 as a factor with 
enzymatic activity that disrupts the nucleosome structure and increases the accessibility 
of a sequence specific transcription factors in the presence of ATP and promote gene 
expression (Figure 1.3) (Tsukiyama and Carl 1995) (Mizuguchi , et al. 1997). Using in 
vitro reconstitution systems NURF disrupts nucleosomes at the hsp70 promoter to 
expose heat shock factor (HSF) binding sites, which activates transcription (Tsukiyama 
and Carl 1995). The role of NURF in regulating the heat shock gene expression (hsp70 
and hsp26) and facilitating the recruitment of HSF to their promoters in vivo was 
confirmed (Badenhorst, Voas, et al. 2002). These and other studies in Drosophila and 
mice (discussed below) show that NURF is a regulator of gene expression (discussed 
below) (Badenhorst, Voas, et al. 2002) (Barak, Lazzaro and Cooch, et al. 2004). 
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NURF is highly conserved from Drosophila to human and mammalian NURF has 
three conformed subunits; the bromodomain PHD finger transcription factor (BPTF), 
SNF2L (the ATPase subunit) and RbAp46/48 (Barak, Lazzaro, et al. 2003). BPTF and 
SNF2L are essential for the complex activity, and to date BPTF is unique to NURF 
(Barak, Lazzaro, et al. 2003) (Figure 1.4).  
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Figure 1.3: Model for NURF as a Chromatin Remodeling Complex  
A cartoon represents how the ISWI containing complex NURF remodel the nucleosome to 
provide accessibility for DBPs. Left, a DBP (white oval) can’t recognize its DNA binding site 
(red line). Middle, recruiting NURF at this site, which can be either by recognition of a histone 
modification or interaction with a TF that binds to adjacent region. Once recruited, NURF 
hydrolyze ATP to slide the nucleosome. Left, the outcome of NURF function provides the 
accessibility for the DBP to its DNA element.  
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Figure 1.4: Subunits of Mammalian NURF 
A cartoon shows the three subunits of mammalian NURF BPTF, SNF2L and RbAp46/48.  
Within each subunit functional domains are indicated. For BPTF, Acidic patch, DDT, 
PHD, WAC, WACZ, Poly glutamine (Q), C-PHD and Bromodomain. For SNF2L, AtuoN, 
ATPase domain, NegC, HAND, SANT and SLIDE. For RbAp46/48 WD repeat domain. 
 
 
 
1.3.1 BPTF 
BPTF is the largest subunit in the complex with ~320 kDa molecular mass. BPTF 
is essential for the complex and acts as a scaffold to maintain the complex integrity 
(Xiao, et al. 2001). Isolation of NURF from HEK293T cells, showed that the majority of 
endogenous BPTF bound with SNF2L which suggest that BPTF mainly exists in NURF 
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complex (Barak, Lazzaro and Lane, et al. 2003).  In Drosophila, BPTF homolog exists in 
different isoforms with different domain compositions. These isoforms can form 
complexes which have different impacts on gene expression (Kwon, Xiao, et al. 2009). 
Full-length human BPTF was identified in screening for novel bromodomain containing 
proteins (Jones, Hamana and Shimane 2000). However, an early report identified a 
truncated transcript of BPTF as a protein reactive to a monoclonal antibody raised 
against Alzheimer’s disease brain homogenate named as fetal alz-50-reactive clone 1 
(FAC1) (Bowser, Giambrone and Davies 1995). The full length BPTF has similar 
transcription start site and almost identical N-terminal region (Jones, Hamana and 
Shimane 2000) suggesting an alternatively spliced variant. In adult tissues, BPTF is 
ubiquitously expressed in many human tissues with high expression in spleen, thymus 
and testis (Jones, Hamana and Shimane 2000). In mouse, BPTF is highly expressed in 
embryonic tissues and adult testis, brain and spleen (Landry , et al. 2008). 
BPTF has multiple highly conserved domains that mediate its interaction with 
subunits of NURF, histone modifications and transcription factors. These include an 
acidic rich region, DDT domain, PHD finger, WAC and WAKZ domains in the N-terminal 
region and glutamine rich region, PHD and bromodomain in the C-terminal region 
(Figure 1.4) (Alkhatib and Landry 2011). Also it has multiple nuclear localization signals 
and LXXLL motifs that are recognized by nuclear receptors upon ligand activation 
(Jones, Hamana and Shimane 2000).  
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DDT domain  
The DDT domain (Doerks, Copley and Bork 2001) exists in BPTF, ACF1, TIP5, 
CECR2 and WSTF proteins, which are accessory subunits of ISWI containing 
complexes. The DDT domain is required for the interaction with the ISWI protein as 
deletion of the DDT domain region led to dissociation of the ISWI subunit from Acf1 
protein in the ACF complex (Fyodorov and Kadonaga 2002) (Eberharter , et al. 2004). 
Deletion analysis of the ISWI homolog in Arabidopasis thaliana showed that the DDT 
domain region interacts with SLIDE domain in ISWI, and similar finding observed for the 
human SNF2H (Dong, et al. 2013). Similar observation has been reported for the yeast 
ISWI homolog. However, in Drosophila an adjacent region to SLIDE domain, is required 
for the interaction with ACF1 protein. This interaction is likely essential for NURF 
integrity, as the interaction between BPTF and the ATPase subunit is essential for the 
complex assembly and function (Xiao, et al. 2001). In addition, a study in yeast showed 
that the DDT domain region of Swi1 protein interacts with the DNA in vitro, and it is 
required for recruiting the protein to chromatin (Noguchi, et al. 2012). The truncated 
version of BPTF in human, FAC1, has been shown to have a DNA binding activity to 
specific DNA motif CACAACA. The region responsible of this activity is the first 398 
amino acid that has the DDT domain along with the acidic patch and PHD domain (K. L. 
Jordan-Sciutto, et al. 1999). 
 
PHD finger 
PHD fingers are structural domains in which 4 cysteines, a histidine and 3 
cysteines (Cys4HisCys3) are maintained by two Zinc ions (Sanchez and Zhou 2011). 
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They are found in nuclear proteins that are associated with chromatin. Many chromatin-
modifying proteins contain PHD finger domains such as ATP-dependent chromatin 
remodeling complexes (e.g. BPTF in NURF and CHD4 in NuRD), histone deacetylases 
(e.g. Inhibitor of Growth Family, Member 2 (ING2), in HDAC), histone 
methyltransferases (e.g. Mixed-Lineage Leukemia Protein 1 (MLL1)), histone 
demethylases and DNA methyl transferases (DNMT3L) (Musselman and Kutateladze 
2011).  
PHD fingers mainly interact with histone tails that can be either modified or 
unmodified, by PTMs, and their interaction with their ligand is specific. For example, a 
class of PHD fingers with particular structure can recognize H3K4me3/2, another class 
with slight change in the structure has a strong affinity to unmodified histone 3 
(H3K4me0) but not H3K4me3/2. In addition other classes have been found to have 
strong affinity to H3K9me3 and H3K14ac (Musselman and Kutateladze 2011).  
However, specific interactions with non-histone proteins are reported (Ivanov, et al. 
2007) (Miller, et al. 2010). 
Mammalian BPTF has two PHD domains one in the N-terminal region (N-PHD) 
and one in the C-terminal region (C-PHD) of the protein. Both domains are highly 
conserved, and they differ in their amino acid contents around the Cys4HisCys3 residues 
(Alkhatib and Landry 2011). The C-PHD is one of the first PHD domains that have been 
found which strongly bind to H3K4me3/2 and weakly to H3K4me2 (Wysocka, et al. 
2006), and the crystal structure identified specific residues that mediate this interaction 
(Li, et al. 2006). Chromatin immunoprecipitation showed that this interaction is required 
for BPTF localization at HOXC8 locus, and it has functional consequences on gene 
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expression.  In frogs, depletion of xBPTF using morphlino injection leads to 
morphological changes in developing embryo. This phenotype has been rescued by 
introducing wild type human BPTF but not mutant BPTF that is unable to recognize 
H3K4me3 (Wysocka, et al. 2006). However, it should be noticed that BPTF has other 
domains that have the potential to interact with chromatin. Indeed, point mutation that 
abolishes the C-PHD interaction with H3K4me3 partially released (40-50%) BPTF from 
the chromatin suggesting other mechanisms recruit BPTF to chromatin (Wysocka, et al. 
2006). 
 
Bromodomain 
Bromodomain also exists in chromatin-associated proteins such as histone acetyl 
transferases (e.g. PCAF and p300), transcription initiation factor TFIID and ATP-
dependent chromatin remodeling complexes (e.g. BRG1 in BAF and BPTF in NURF). It 
mediates recruitment of these proteins to chromatin through specific recognition to the 
acetylated lysine residues in histone tails (Sanchez and Zhou 2011).  BPTF 
bromodomain has a potential to interact with H4K12ac, H4K20ac and H4K1ac in the 
peptide level. However, it specifically interacts with H4K16Ace in nucleosomes 
(Ruthenburg, et al. 2011).  Most of the bromodomain containing proteins have an 
adjacent a PHD finger domain, suggesting cooperation in recruitment to chromatin 
through recognition to multiple histone modification. In BPTF, the interaction with 
H4K16ac by bromodomain requires recognition of the H3K4me3 by the adjacent PHD 
domain. Both domains collaborate to enhance BPTF binding to modified nucleosomes. 
In vitro pull-down analysis showed that the C-PHD-bromodomain module strongly 
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enhances the binding to modified nucleosome over the C-PHD only module. Point 
mutation analysis showed that abolishing the C-PHD completely abolishes the 
interaction with histones while abolishing the bromodomain only reduced the binding 
affinity to level similar to the C-PHD only module (Ruthenburg, et al. 2011). The two 
domains are separated by α-helical linker that is important for the combinatorial 
interaction between H3K4me3 and H4K16ac with the C-PHD and bromodomain, 
respectively. In vivo ChIP showed that mutations in C-PHD, bromodomain or linker 
region reduces BPTF localization at HOXA9 locus enriched with H3K4me3 and 
H4K16ac modifications in HEK293 cells. This bivalent interaction to nucleosomes by C-
PHD and bromodomain has functional consequences in vivo.  BPTF lacking both 
domains was less efficient in rescuing BPTF KD phenotype in frog, comparing to BPTF 
with mutant C-PHD and functional bromodomain (Wysocka, et al. 2006). 
A splice variant of BPTF homolog in Drosophila (NURF301) creates a truncated 
version of the protein without the C-PHD and bromodomain that able to assemble as a 
NURF complex (Kwon, Xiao, et al. 2009). This variant is not essential for Drosophila 
development and repression of janus kinases / signal transducer and activator of 
transcription (JAK/STAT) pathway target genes as the full-length protein , and it is only 
required for spermatogenesis. Gene expression analysis revealed that 40% of NURF 
dependent genes in Drosophila require recognition of the H3K4me3 and H4K16ac by 
the C-terminal domains (Kwon, Xiao, et al. 2009).  This suggests that although 
recognition of modified histones by BPTF is important for NURF recruiting to the 
chromatin, other contact sites such DBPs and sequence transcription factors are 
important for BPTF recruitment to chromatin. 
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1.3.2 SNF2L  
SNF2L is an ISWI protein that is required for the catalytic activity for NURF 
complex, and it is essential for the remodeling function. As mentioned earlier, there are 
two ISWI homologs in mammals: SNF2L and SNF2H with 86% sequence homology.  
The expression pattern of these homologs is different in mice. In adult mice, SNF2L 
expression is limited to brain, testis, ovary and uterus tissues, while SNF2H expression 
is ubiquitous. During embryonic development, SNF2L expression is low, compared to 
high expression of SNF2H. However, two weeks after birth, the expression of SNF2L 
increases in brain tissues, which remains high to adult stage, while SNF2H decreases 
(Lazzaro and Picketts, Cloning and characterization of the murine Imitation Switch 
(ISWI) genes: differential expression patterns suggest distinct developmental roles for 
Snf2h and Snf2l 2001). Due to these observations, it has been suggested SNF2L is 
required for differentiated cells, while SNF2H is required for progenitor and 
undifferentiated cells. Indeed, SNF2H knock out (KO) mice die at day E4.5 (at during 
the peri-implantation stage) (Stopka and Skoultchi 2003), while mice with inactive 
SNF2L are viable with a normal phenotype in general. However, these mice have larger 
brain size comparing to control mice. This phenotype is linked to defects in neuronal 
progenitor cells self-renewal and delay differentiation, which leads to increase cell 
density. The role of SNF2L in this regard is linked to its role in regulating the expression 
of FOXG1, a regulator of neuronal stem cells self-renewal and differentiation, as ChIP 
analysis shows binding of SNF2L at Foxg1 promoter region (Yip, et al. 2012). 
Furthermore, overexpression of SNF2L induces differentiation in neuroblastoma cell 
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lines, which further indicates its role in neuronal cell differentiation (Barak, Lazzaro and 
Lane, et al. 2003).   
ISWI proteins contain the highly conserved ATPase domain in the N-terminal 
region. This domain has two loops the DEXD, the ATP binding domain, and the HELIC 
helicase domain, that mediate the translocase activity. The ATP binding domain 
interacts with nucleosome ~ 20 bp form the dyad axis where the H4 N-terminal tail 
protrude (Dang and Bartholomew 2007). The H4 N-terminal is required for nucleosomal 
recognition by ISWI (Clapier, Längst, et al. 2001) and the remodeling activity (Hamiche, 
Kang, et al. 2001). The DEXD domain has an acidic patch that has been suggested to 
interact with the basic patch in the H4 N-terminal region (Dang and Bartholomew 2007). 
Recent work by Mueller-Planits et al. showed that the ATPase domain is sufficient for 
the remodeling activity for the ISWI proteins. (Mueller-Planitz , et al. 2013).  
In the C-terminal region there are three domains the hand-like domain (HAND), 
the Swi3 Ada2 N-Cor TFIIIB domain (SANT) and the SANT-like domain (SLIDE), which 
are characteristic for the ISWI proteins (Figure 1.4) (Clapier and Cairns 2009). The 
HAND domain is a structural domain unique to ISWI proteins. It interacts with the 
nucleosomal DNA at the entry/exit site (Dang and Bartholomew 2007). Adjacent to the 
HAND domain is the SANT domain. SANT is similar to the Myb DNA binding domain, 
but it lacks conserved residues that mediate the Myb interaction with DNA. It is not 
required for the ISWI recognition to the nucleosome or the remodeling activity (Dang 
and Bartholomew 2007). However, it has been suggested that SANT domains can 
mediate interaction with histone H3 (Boyer, Latek and Peterson 2004). The SLIDE 
domain is similar to SANT domain but it has different architecture (Grüne, et al. 2003). It 
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has basic residues similar to the Myb DNA binding domain, and it interacts with linker 
DNA in sequence independent manner (Dang and Bartholomew 2007). This interaction 
proposed to involve in the remodeling activity of the ISWI protein (Hota , et al. 2013). In 
addition it can interact with the DDT region in ISWI accessory subunits (Dong, et al. 
2013) (Grüne, et al. 2003). Recently, two domains have been identified that have 
significant impact on the ATP remodeling activity of the ISWI proteins (Clapier and 
Cairns 2012). The N-terminal region has an AutoN domain which has basic residues 
highly similar to the H4 N-terminal regions. This domain inhibits the activity of the 
ATPase domain when not bound to nucleosomes (Clapier and Cairns 2012). Same 
work identified another domain in the C-terminal region adjacent to the HAND domain 
named NegC. This domain is required for coupling the ATPase activity to the 
transclocase activity in the ATPase domain. These two domains function as auto 
inhibitors for the remodeling activity of the ISWI proteins when not bound to chromatin 
(Clapier and Cairns 2012). 
SNF2L exists in multiple isoforms that can modulate its function. In human 
tissues, a splice variant that has inactive ATPase domain due to inclusion of an extra 
exon that disrupt the domain sequence, named SNF2L+13. This isoform is ubiquitously 
expressed in adult tissues, while the active isoform is expressed in brain tissues (Barak, 
Lazzaro and Cooch, et al. 2004). This isoform is able to assemble  into a NURF 
complex, which suggest a role in regulating NURF activity. Another isoform that also 
ubiquitously expressed is a truncated version of SNF2L that lack the C-terminal 
domains, which named as SNF2LT (Ye, et al. 2012). However, this isoform likely can’t 
assemble a complex since it lacks the SLIDE domain required for interaction with the 
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DDT domain in the accessory subunits. Also, an isoform that lacks a nuclear localization 
signal due to use of alternative splicing disrupts its nuclear localization signal has been 
detected in human tissues (Lazzaro, Matthew, et al. 2008). 
 
1.3.3 RbAp46/48 
RbAp46 and RbAp48 (also known as RBBP7 and RBBP4, respectively) are two 
homolog proteins with ~ 90% identical amino acid sequences (Qian and Lee 1995). 
These proteins are characterized by Tryptophan – Aspartic acid (WD) repeats, in which 
each repeat consists of a core amino acid sequence start with Glycine – Histidine (G-H) 
dipeptides and end with WD dipeptides, that function as a protein-protein interaction 
platform (Figure 1.4) (Xu and Min 2011). Both proteins are ubiquitously expressed with 
high expression observed in brain, thymus, lung spleen, kidney, testis and ovary. 
Although most tissues show equal expression of both homologs some tissues show 
higher expression of one over the other. In testis and thymus RbAp48 is highly 
expressed, while in ovary and uterus RbAp46 is highly expressed (Qian and Lee 1995).  
RbAp46, RbAp48 and protein 55 (p55) (the Drosophila homolog) are known to function 
as histone chaperones which directly interact with H4 tail and H3 tail at different region 
within the WD repeats domain (Verreault, Kaufman, et al. 1998) (Song, Garlick and 
Kingston 2008) (Nowak , et al. 2011). The H4 epitope recognized by RbAp46 and 
RbAp48 is masked when H4 incorporates into chromatin, which suggests that it is not 
involve in mediating the proteins to nucleosomal histone (Verreault, Kaufman, et al. 
1998). Recent study showed that RbAp48 interact with H3-H4 dimer complex which is 
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important to mediate the incorporation of the dimer to newly synthesize chromatin 
(Zhang, et al. 2013). 
RbAp46 and RbAp48 are found in many complexes associated with chromatin. 
These include the ATP-dependent chromatin remodeling complexes NURF and NURD 
(Barak, Lazzaro and Lane, et al. 2003) (Tsukiyama and Carl 1995) (Zhang, Ng, et al. 
1999), PRC2, a complex involves in heterochromatin formation through H3K27 
methylation (Nowak , et al. 2011), the histone deacetylases HDACs (Taunton, Hassig 
and Schreiber 1996) (Zhang, Iratni , et al. 1997), and the CREB-binding protein complex 
(CBP), a histone acetyl transferase complex ( Zhang, Vo and Goodman 2000). In most 
of these complexes (PRC2, HDACs, CBP and NURD) the RbAp46/48 are involved in 
tethering the complexes to their chromatin template. In addition, the two proteins can be 
a component of different complexes. The RbAp46 but not RbAp48 is a subunit of the 
human histone acetyl transferases 1 (HAT1) that acetylates newly synthesize histone 
H4 in the cytoplasm, an important step for incorporation of histone into chromatin 
(Verreault, Kaufman, et al. 1998), while RbAp48 but not RbAp46 is a component of 
CAF1, which assembles nucleosomes during the S-phase of the cell cycle (Verreault, 
Kaufman , et al. 1996).  
In addition, they interact with sequence specific transcription factors. They were 
first identified as proteins associated with the retinoblastoma protein (RB), a tumor 
suppressor protein mutated in many types of cancers. RB is known as a cell cycle 
regulator for the G1 to S phase transition, and a regulator of cell differentiation (Qian 
and Lee 1995). The RbAp46 and 48 also directly interacts with friend of GATA-1 
(FOG1), a transcription regulator (Lejon, et al. 2011). FOG1 interacts with GATA-1 
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transcription factor, which is important for gene expression in the erythrocyte lineage. 
The interaction between FOG1 and RbAp48 mediate recruitment of NuRD complex to 
certain loci in the chromatin ( Hong, et al. 2005). Also, the p55 directly interact with 
suppressor of zeste 12 (Suz12) a subunit of PRC2 (Nowak , et al. 2011). These 
interactions with histones and transcription factors suggest that RbAp46/48 can function 
as a recruiter for NURF to chromatin. 
 
1.3.4 NURF Remodeling Activity  
Recruiting NURF to chromatin is thought to be through recognition of PTMs on 
histones and/or protein-protein interaction with sequence specific TFs. Once recruited, 
NURF slides the nucleosome to regulate the accessibility to DNA. As mentioned above 
BPTF has functional domains that recognize H3K4me3 and H4K16ac and mediate 
interaction with number of TFs and DBPs. Also, the RbAp46/48 can mediate 
interactions with TFs as well as H3 tail. Although the ATPase subunit can interact with 
the nucleosomal DNA and linker DNA, these interaction are sequence non-specific 
(Alkhatib and Landry 2011). 
Studying SNF2L and its homolog SNF2H dynamic in vivo using photo-bleaching 
fluorescence microscopy approaches showed that they continuously sample 
nucleosomes by ATP independent transient interaction with resident time less than 2 
milliseconds (ms). In this transient interactions, ISWI complex screens the chromatin 
until a localization signal at a specific locus increases its resident time (150 to 500 ms), 
which allow the remodeling activity (Erdel, Schubert, et al. 2010) (Erdel and Rippe 
2012). 
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Biochemical investigations of Drosophila NURF revealed that the ATPase activity 
of NURF is stimulated by nucleosome (not DNA or histone octamer), and it slides 
nucleosome over DNA in either directions in 10bp moving step without eviction of 
histone or altering the histone octamer composition (Tsukiyama and Carl 1995) 
(Hamiche, Sandaltzopoulos, et al. 1999) (Schwanbeck, Xiao and Wu 2004). The 
direction of nucleosome sliding by NURF can be determined by the presence of a 
barrier at one direction such as a localized TF or a positioned nucleosome which 
promoter sliding to the other direction (Kang, Hamiche and Wu 2002). NURF requires 
nucleosomes as a substrate and the recognition of histone tails especially the histone 4 
tail are important for the recognition as well as the remodeling activity (Hamiche, Kang, 
et al. 2001) (Clapier, Längst, et al. 2001). The importance of H4 tail, specifcally the 
basic amino acids between 16 to 19 the lysine, arginine, histidine and arginine (16-
KRHR-19) are likely due to their binding to the ATPase domain in the ISWI proteins, 
which is required to stimulate the ATPase and remodeling activity (Clapier and Cairns 
2012). Indeed, NURF binds a nucleosome at two separate locations: at the linker DNA 
near the entry site and the nucleosomal DNA ~ 20 bp from the dyad axis at region 
where the H4 tails protrude from the nucleosome (Schwanbeck, Xiao and Wu 2004). 
The length of the linker DNA is important for the remodeling activity by ISWI containing 
complexes (Zofall, Persinger and Bartholomew 2004) (Schwanbeck, Xiao and Wu 
2004). 
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1.3.5 Regulation of NURF Remodeling Activity 
Although the ATPase subunit (ISWI) has intrinsic ATPase activity, this activity is 
significantly more efficient in context of NURF complex, and it requires at least the ISWI 
and NURF301 (BPTF homolog in Drosophila) subunits (Xiao, Sandaltzopoulos, et al. 
2001). Regulation of the remolding activity of NURF can be through incorporation of 
inactive ATPase subunit, PTMs or interfering with substrate recognition (Alkhatib and 
Landry 2011).  
NURF remodeling activity can be regulated by incorporation of ATPase inactive 
isoform of the ATPase subunits. In human tissues, SNF2L+13 exist and is able to 
assemble NURF complex (Barak, Lazzaro and Cooch, et al. 2004). This finding 
suggests existence of a population of NURF in the cells that is unable to remodel 
chromatin.    
In Drosophila, it has been shown that the ISWI is a target of poly-ADP 
ribosylation by the poly-ADP-ribose polymerase (PARP). Poly-ADP ribosylation of ISWI 
by PARP reduces the ISWI remodeling activity and its association with chromatin (Sala, 
et al. 2008).  Also, ISWI can be subjected to acetylation by the histone acetyl 
transferases GCN5 (Ferreira , et al. 2007). It has been shown that GCN5 acetylate 
lysine 753, which is located in the HAND domain of ISWI. The modified ISWI is likely 
associated with NURF complex, as KD of NURF301 reduces the abundance of the 
acetylated ISWI (Ferreira , et al. 2007).  Although, the role of this modification in ISWI 
activity is not known, the modified residue is a conserved residue in Drosophila, 
Xenopus and human which suggests that it might has an impact in its activity (Ferreira , 
	  
	   46	  
et al. 2007). In addition, acetylation of mammalian BRM, the ATPase subunit of 
SWI/SNF complex, regulates its activity (Bourachot, Yaniv and Muchardt 2003).   
Additionally, NURF activity can be affected by the composition of the histone 
octamer and the nucleosome structure. It has been shown that H2A.Z histone variant 
increases the ATPase hydrolysis and remodeling activity of ISWI containing complexes 
(Goldman, Garlick and Kingston 2010). This activity has been shown to require the 
acidic patch of H2A.Z that interacts with the H4 tail of adjacent nucleosome. Same work 
showed that BPTF co-IPs with H2A.Z variant 9-fold greater than H2A (Goldman, Garlick 
and Kingston 2010).  Role of the linker histone (H1) on modulating the NURF activity 
has been debated. It has been shown that H1 incorporation does not affect NURF 
remodeling activity (Clausell, et al. 2009 ).  However, early reports showed that 
incorporation of linker histone has inhibitory effect on ISWI remodeling activity (Horn, et 
al. 2002). 
Moreover, the H4 N-terminal tail is required for ISWI recognition to nucleosome 
(Clapier, Längst, et al. 2001). For NURF, the basic residues in H4 tail (16-KRHR-19) is 
critical for NURF ATPase and remodeling activity, and mutation of these residues has a 
negative effect on NURF activity (Hamiche, Kang, et al. 2001). In addition, acetylation at 
H4K12 and H4K16 mask a critical epitope formed by H4 N-terminal tail and DNA that is 
essential for ISWI to recognize the nucleosome (Clapier, Nightingale and Becker 2002).  
The role of H2A C-terminal tail on modulating the ISWI activity has been studied. It has 
been shown that nucleosome remodeling by human SNF2H and Drosophila ISWI 
subunits is reduced with a truncated H2A C-terminal tail  (H2A 1-122aa). However, in 
the context of a full complex the ACF complex remodel the nucleosomes with the 
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truncated H2A C-terminal tail with similar efficiency as full length H2A (Vogler, et al. 
2010).    
 
1.3.6 NURF’s Biological Function and Interacting Partners 
Studying the role of the NURF complex is achieved in vivo by investigating its 
essential and specific subunit BPTF (Xiao, et al. 2001) (Barak, Lazzaro, et al. 2003). 
Many reports from Drosophila, mouse and human showed that NURF can interacts with 
multiple TFs and DBPs and these interactions have impacts on gene expression.  
These include GAGA, HSF, VP-16, Ken, ecdysone receptor (EcR), heterochromatin 
protein 2 (HP2), NAP-1 (Drosophila), upstream transcription factor 1 (USF1) (chicken), 
serum response factor (Srf), Smad2 (mouse), myc-associated zinc finger protein 
(ZF87/MAZ), Kelch-like ECH-associated protein 1 (KEAP1), progesterone receptor 
(PR), Smad2, CTCF, structural maintenance of chromosomes (SMC1), H2A.Z (human) 
(Alkhatib and Landry 2011) (Qiu, et al. 2015). Some of these proteins interact at multiple 
surfaces in BPTF as well as other NURF subunits such as GAGA (Xiao, et al. 2001). In 
Drosophila, the interaction sites for GAGA were mapped at regions contain the HMG, 
PHD and the glutamine rich, while the VP16 and HSF bind to glutamine rich region. 
Also, ISWI interacts with GAGA, suggesting collaborate interaction (Xiao, 
Sandaltzopoulos, et al. 2001).  
The biological role of NURF is mostly studied in Drosophila. Truncated mutations 
of NURF301 (BPTF homolog in Drosophila) showed that NURF is essential for 
Drosophila development and is specifically required for the transition from the larva 
stage to the adult stage (Badenhorst, Voas, et al. 2002). In addition, NURF301 is 
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required for normal expression of the homeotic genes Ultrabithorax (Ubx) and engrailed 
(EN) important for determination of body segments (Badenhorst, Voas, et al. 2002). The 
requirement of BPTF on homeotic genes expression is also conserved in human 
(Barak, Lazzaro and Cooch, et al. 2004). Additionally, truncated mutations on NURF301 
induce melanotic tumors (over proliferation of immature blood cells). This likely because 
NURF negatively regulates set of the JAK/STAT signaling pathway target genes, which 
activation of this pathway associated with the melanotic tumor phenotype (Badenhorst, 
Voas, et al. 2002). Subsequently, NURF has been identified as a co-repressor of the 
JAK/STAT genes through direct interaction with the Zinc finger protein Ken (Ken), a 
repressor for JAK/STAT target genes.  The proposed model is that Ken mediates the 
repressor effect through recruiting NURF to the promoter regions, which modulates the 
nucleosome to repress transcription (Kwon, Xiaob, et al. 2008). The human B-cell 
lymphoma 6 (BCL6) proto-oncogene is an ortholog of Ken and preliminary data in our 
lab suggest an interaction between BCL6 and human NURF. Confirming this 
observation will shed light on a role of NURF in lymphoblastic leukemia and other type 
of cancers associated with BCL6 such as breast cancer. 
Additional work further showed that the location of the truncated mutations in 
NURF301 gave different phenotypes on Drosophila development. Mutations that 
truncate NURF301 at the N-terminal region failed to undergo transition from the larva 
stage to adult stage (pupation). However, truncated mutations at the C-terminal region 
(before the PHD and the Bromodomain) can undergo this stage with developmental 
abnormalities and sterile phenotype (Badenhorst, Xiao, et al. 2005). The effects of the 
N-terminal truncated mutations are likely due to the role of this region in the complex 
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integrity (binding to other subunit of NURF complex). This also, suggests that the C-
terminal part of the protein is not essential for the function of NURF.  This is supported 
later by identifying different isoform of NURF301 in Drosophila, which show that the C-
terminal region is not required for gene expression of the majority of NURF-dependent 
genes (Kwon, Xiao, et al. 2009), in particular the repressive effect on the JAK/STAT 
pathway. 
Microarray for the N-terminal truncated mutations show deregulation of 477 
genes with 274 a down regulated and 203 are up regulated. It has been shown that the 
N-terminal but not the C-terminal region of NURF is required for expression of ecdysone 
response genes. The ecdysone is a steroid that is equivalent to human sex steroids 
(androgen, estrogen and progesterone), and it is a ligand for EcR of the ecdysteroid-
signaling pathway, a nuclear signaling pathway important for larva development. 
It has been shown that the EcR directly interacts with NURF in the presence of the 
ligand, and ChIP using ISWI antibody, detect enrichment at EcR target genes that is 
reduced in mutant NURF301. Together, this suggests that upon ligand activation the 
EcR recruits NURF to its target genes to promote gene expression (Badenhorst, Xiao, 
et al. 2005).  
In addition, NURF function as a co-activator of Wingless (Wg) signaling 
pathways, an important pathway for embryonic development, which is deregulated in 
cancer (Song, Spichiger-Haeusermann and Basler 2009) (Howe and Brown 2004). It 
has been shown that the β-Catenin/Armadillo transcription factor, a signal transducer for 
the Wg pathway, directly interacts with NURF301 and mediates its recruitment to 
promoter regions of some genes downstream of Wg pathway (Song, Spichiger-
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Haeusermann and Basler 2009). As β-Catenin/Armadillo transcription can recruit many 
co-activators such as HATs, the RNA polymerase II associated factor 1 (PAF1) and the 
SWI/SNF complex upon signal induction, recruiting NURF to their target promoters 
further support the requirement of NURF as a co-activator of gene initiation (Song, 
Spichiger-Haeusermann and Basler 2009).  
As mentioned earlier, the full length NURF301 (with the PHD and bromodomain) 
is not required for the developmental defects in Drosophila embryo and the animal is 
viable. However, both male and female are sterile and defects in spermatogenesis and 
oogenesis were observed (Kwon, Xiao, et al. 2009). NURF is required for germ line 
stem cells self renewal. In testis, NURF is required for maintaining two stem cell 
populations the germ line stem cells, which generate the germ cells, and somatic stem 
cells (cyst cells), which help the differentiation of germ cells, and primary spermatocyte 
differentiation (Kwon, Xiao, et al. 2009) (Cherry and Matunis 2010). Stem cell 
populations are maintained within microenvironment (niche) that mediate extrinsic 
signals required for maintain stem cells state. Mutant NURF301reducesstem cell 
populations and results in premature differentiation. Further investigation showed that 
NURF acts as a positive regulator of JAK/STAT pathway in these cells (Cherry and 
Matunis 2010). Together with the role of NURF as a negative regulator of JAK/STAT 
pathway in the immune system, these findings showed that NURF can has different 
roles downstream of one pathway in cell type specific manner.   
In the Drosophila ovary, ISWI mutants lose germ stem cell populations likely due 
to defects in self-renewal. The observed effect could be due to defect in bone BMP 
pathway, which is important for maintaining a stem cell state (Xie and Xi 2005).  An 
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equivalent phenotype observed in NURF301 mutant suggesting that this effect is due to 
NURF complex. Defects in BMP signaling can result from defects in ecdysone signaling 
(Ables and Drummond-Barbosa 2010).  As mentioned earlier NURF physically interact 
with the ecdysone receptor, it has been suggested that through these functions NURF 
regulates germ line stem cell population in the ovary (Ables and Drummond-Barbosa 
2010).  
Additionally, in progesterone signaling pathway NURF is one of the first 
complexes recruited to promoters upon progesterone exposure in breast cancer cell 
lines (Vicent, et al. 2011). Progesterone Receptor (PR) directly interacts with BPTF, and 
recruits NURF complex to promoter regions at set of downstream genes in human 
breast cancer cell lines. At promoters, H3K4me3 maintains NURF and its remodeling 
activity facilitate binding of a protein kinase that phosphorylates the linker H1, prior to its 
displacement from the chromatin (Vicent, et al. 2011). These steps are required for 
additional recruitment of co-activators such as SWI/SNF remodelers to promote gene 
expression. 
In human, FAC1 expression level and cellular localization is different in fetal brain 
and adult brain. It is highly expressed in fetal brain and undifferentiated neuron and 
localizes in nucleus and cytoplasm. In adult tissues and differentiated neurons is 
decreased but still detected in nucleus. However, in brain tissues from patient with 
Alzheimer’s disease and amyotropic lateral sclerosis the expression increased and 
localize in the nucleus, cytoplasm and hallmark features of this disease such β-amyloid 
plaque, pathological accumulation of protein degradation between neurons (Bowser, 
Giambrone and Davies 1995). Investigating role of FAC1 shows that it acts as a 
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transcription repressor and can recognize specific DNA motif through the N-terminal 
region (K. L. Jordan-Sciutto, et al. 1999). Screening for factors that can interact with 
FAC1 using yeast two-hybrid system revealed an interaction between FAC1 and the 
sequence specific transcription factors ZF87/MAZ and KEAP1, a protein function as a 
regulator for oxidative stress response. ZF87/MAZ is an activator of SV40 promoter in 
NIH3T3. Using luciferase reporter assay derived by SV40 promoter, FAC1 significantly 
reduces the ZF87/MAZ activity. However, mutant FAC1 that can’t bind the ZF87/MAZ 
has no effect on the promoter activity (K. Jordan-Sciutto , et al. 2000). The interaction 
with KEAP1 is likely regulate its cellular localization during neurodegenerative disease, 
and its stability, as the interacting surface with KEAP1 require the PEST domain, a 
domain required for protein degradation by proteasomes (Strachan, et al. 2004). 
Moreover, NURF has a role in regulating higher ordered chromatin structure.  In 
Drosophila, mutant ISWI (the ATPase subunit in NURF) show de-condensation of X-
chromosome (Badenhorst, Voas, et al. 2002) as well as metaphase chromosomes, with 
more pronounce defect in euchromatin regions, not heterochromatin regions (Corona , 
et al. 2007).  In Drosophila, regulation of chromatin structure in male X-chromosome is 
important for dosage compensation of gene expression. There are two X-chromosomes 
in female and one in male, so males up regulate gene expression to adjust for gene 
expression in female. These defects in higher-ordered chromatin structure in male X-
chromosome has been associated with defect in linker histone H1 incorporation.  
Although, ISWI subunit can be in NURF and other complexes (ACF, CHRAC), only 
mutation in NURF301, not Acf1, the subunit of ACF and CHRAC, shows defect in 
condensation of male X-chromosome (Badenhorst, Voas, et al. 2002) (Corona , et al. 
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2007).  The defect in X-chromosome structure following NURF mutation has been 
linked to the histone acetylation activity of ATAC, a histone acetyl transferase complex 
specific for H4K5/K12 acetylation in Drosophila. It has been shown that mutant NURF 
significantly reduces H4K12 acetylation, likely through reduction in ATAC association to 
the X chromosome. Abolishing of ATAC activity show similar phenotype in X-
chromosome structure as NURF mutilation (Carre ́, et al. 2008).  
 Furthermore, it has been shown that NURF directly binds with the HP2 in 
Drosophila. HP2 interacts with HP1, which is required to maintain repressed 
environment at heterochromatin regions. Another, ISWI complex ACF, is required for 
maintaining the integrity of the heterochromatin structure, however, the role of NURF in 
this regard need to be investigated. Also, NURF directly interacts with the H2A/H2B 
histone chaperone NAP-1, which is involved in regulation of heterochromatin structure 
and nucleosome assembly (Stephens , et al. 2006).   
In addition, NURF can function to maintain chromatin boundaries between active 
and repressed chromatin regions. In chicken erythroid cells, USF1 protein binds at 5’ 
HS4 element upstream of the β-globin locus. This element functions as a barrier 
element to prevent the spread of heterochromatin into the active globin locus, and USF1 
is required for this function. It has been shown that USF1 interacts and recruits NURF 
along with SET1, a histone methyl transferase, to the 5’ 4HS element. Knockdown of 
BPTF led to increase nucleosome occupancy and loss of the barrier activity of the 5’ 
4HS (Li, et al. 2011). The role of NURF in regulating chromatin structure further 
suggested as NURF directly interaction with CTCF, which is a multi-functional protein 
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that involves in regulating chromatin looping and create boundary elements (Qiu, et al. 
2015).  
In agreement with role of NURF in Drosophila development and regulating 
signaling pathways important for animal development, BPTF is essential for mouse 
embryonic development (Landry , et al. 2008). BPTF KO in mice is embryonic lethal by 
day E8.5. Further investigation showed that BPTF KO embryos failed to develop distal 
visceral endoderm (DVE). This phenotype can be in part due to role of BPTF as a co-
activator for TGF/Smad pathway, which is essential for formation of DVE tissues. It has 
been shown that Smad2 transcription factors physically interact with recombinant BPTF 
and mediate NURF to promoter regions of target genes (Landry , Sharov , et al. 2008).  
A similar finding has been observed recently in zebrafish where BPTF interacts with 
Smad2, which mediate its recruitment and remodeling activity at wnt8a promoter region, 
an important regulator of neuroectodermal posteriorization. In this work BPTF has been 
found to be essential for normal development of early stage of central nerves system 
(Ma, et al. 2015).  
In addition, Landry et al. further characterized the role of BPTF in mouse mESC.  
It has been shown that mESCs with Bptf KO do not spontaneously differentiate and they 
are viable with no defects in cell viability, cell growth or self-renewal. They do show a 
minor reduction in cell proliferation as indicated by 6 hours increase in doubling time. 
However, measuring the ability of mESC to differentiate using embryoid bodies and 
teratoma formation approaches showed that BPTF is required for ESC differentiation 
(Landry , et al. 2008).  
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Gene expression profiles of BPTF KO in mESC showed that BPTF regulate 
genes important for cell differentiation to mesoderm, endoderm and ectoderm cell 
lineage. In agreement with previous work in Drosophila (Badenhorst, Voas, et al. 2002) 
and human (Barak, Lazzaro, et al. 2003), BPTF in mice is required for regulation of 
HOX gene clusters.  In addition, most BPTF dependent genes have bivalent histone 
markers in their promoters (H3K4me3 and H3K27me3) indicating a role in regulating 
developmentally regulated genes.   
 Role of NURF in differentiation further studied in thymocyte (T-cell) development 
using conditional BPTF KO mouse model (Landry, et al. 2011). Similar to mESCs, 
thymocytes lacking BPTF are viable with no defects in cell proliferation. During T-Cell 
development, BPTF is required for maturation from DP thymocyte to lineage committed 
CD4 or CD8 cells. The role of BPTF and by extension NURF complex is different than 
other chromatin remodeling complexes such as SWI/SNF and NURD were they showed 
defects in early stages and are required for cell viability and proliferation (Gebuhr, et al. 
2003) (Williams, et al. 2004). Further investigation revealed physical interaction 
between BPTF and the Srf and AP-1 transcription factors that are required for mediating 
TCR receptor signaling pathway. Srf recruits the NURF complex to Egr1 to regulate its 
expression (Landry, et al. 2011). Egr1 is a TF that involve in thymocyte maturation in 
response to TCR signaling (Rothenberg and Taghon 2005). This work suggests that 
NURF is required for gene expression profile for lineage committed T-cell (Landry, et al. 
2011).   
 Recently, our lab documents that BPTF and by extension NURF can function as 
a cell type specific regulator of gene expression (Qiu, et al. 2015). This is interesting as 
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NURF known to interact with common histone modifications such as H3K4me3 and 
H4K16ac and common TFs found in different cell types. By comparing the BPTF 
dependent genes from three different primary cell types mESCs, mouse embryonic 
fibroblasts (MEF) and DP thymocytes, we showed that BPTF regulate different set of 
genes in each of these cell types. Interestingly, BPTF/NURF dependent changes in 
chromatin structure measured by micrococcal nuclease (MNase) digestion for 3.3 Mega 
base (Mb) of mouse genome showed that BPTF, and by extension NURF, regulates 
chromatin structure at sites common between cell types as well as sites that are specific 
for each cell types. The BPTF/NURF dependent changes in chromatin structure, which 
identified by this technique, are mainly over nucleosome free regions (NFRs), a feature 
that are associated with regulatory elements (Cockerill 2011). Although, these changes 
can be indirect effect of BPTF KO, it suggests that BPTF/NURF is a regulator of 
chromatin structure at regulatory elements. In addition, this work documents a direct 
interaction between NURF and CTCF, and further characterization of this interaction 
suggests that CTCF is a recruiter for NURF to chromatin (Qiu, et al. 2015). The CTCF-
NURF interaction can influence cell type specific gene expression through regulating 
the binding of cell type specific TFs (Qiu, et al. 2015). In addition, the work also 
documents a direct interaction between NURF and cohesin subunit SA2. Cohesin is a 
ring like structure that mediate CTCF dependent chromatin looping, and CTCF 
independent enhancer-promoter looping ( Nasmyth and Haering 2009).  
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1.3.7 Role of NURF in Human Disease 
Less in is known about the role of NURF complex in human diseases. However, 
recent reports showed overexpression of NURF subunit BPTF in some type of cancers. 
While it is not clear whether BPTF and NURF complex is advantageous for the 
tumorigenesis, the role of NURF in signaling pathways important for development 
suggest a positive role in cancer. 
The chromosomal location of BPTF is 17q24.2, and the gain of the 17q arm is 
highly occurring in neuroblastoma and associated with adverse effect (Bown, et al. 
1999). It also found in breast cancer (Monni, et al. 2001), prostatic cancer (Levin, et al. 
2008), liver cancer (Raidl, et al. 2004) and lung cancer (Choi, et al. 2006). This suggest 
over expression of BPTF, along with other genes in these segment is advantageous for 
tumor growth. Indeed, a naturally occurring non-reciprocal translocation at 17q24.3 has 
been identified in human lung embryonic stem cells that lead to over expression of 
BPTF (Buganim, et al. 2010). In screening for gain of BPTF locus in 143 tumor samples, 
it has been shown that gain of BPTF locus is found in 55% of neuroblastoma, 27% in 
lung, 20% leukemia and 14% of colon tumors (Buganim, et al. 2010). This further 
suggests the requirement of BPTF to cancer. 
Recently some studies show the adverse effects of BPTF in human cancer. In 
colorectal cancer (CRC) and hepatocellular carcinoma (HCC), recent reports showed 
that BPTF expression is significantly over expressed in CRC and HCC tissues 
comparing to control tissues. The high expression of BPTF is associated with the 
severity of the disease, and associated with the expression of the endothelial 
mesenchymal transition proteins vimentin and E-cadherin (Xiao, Liu and Lu, et al. 2015) 
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(Xiao, Liu and Fang, et al. 2015). Also, BPTF is overexpressed in melanomas. In a 
cohort study, BPTF overexpression is associated with poor prognosis in melanoma 
patients. KD of BPTF in melanoma cell line showed significant reduction in cell 
proliferation in vitro, and reduction in tumor growth following subcutaneous injection 
(Dar, et al. 2015). In bladder cancer, H2A.Z is over expressed in bladder cancer cell 
lines as well as bladder cancer tissues. As mentioned above, H2A.Z interacts with 
BPTF. This interactions recruit BPTF to genes deregulated in bladder cancer. Similar to 
H2A.Z KD, BPTF KD shows significant reduction in cancer cell proliferation and cell 
migration (Kim, et al. 2013).  
Studying the effect of KD of SNF2L gene expression in cancer cells show 
reduction in cell growth, increase DNA damage and induction of cell death (Ye, et al. 
2012). Interestingly, the expression level of SNF2L in normal cells lines is equivalent to 
high malignant cell lines. However, the observed reduction in the cell growth and 
induction of cell death is only observed in the tumor cell lines (Ye, et al. 2012). This 
suggests that the cancer cells are more sensitive to loss of SNF2L than the normal 
cells. 
Although more studies are required to establish a strong correlation between 
BPTF and NURF complex with cancer development or progression, the above 
mentioned studies suggest that BPTF and likely SNF2L subunits are advantageous for 
the cancer cells. This is further supported by the fact that NURF function down stream 
of important signaling pathways that has a role in tumorigenesis such as TGFβ/Smad, 
PR and JAK/STAT pathways (Alkhatib and Landry 2011). 
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1.4 Transcription  
 
1.4.1 Transcription and Chromatin Structure  
In eukaryotes RNA-pol 2 transcribes protein-coding genes. Transcription is 
divided into three stages transcription initiation, elongation and termination. As the 
transcription occurs through chromatin template, regulating the chromatin structure is 
crucial for all these stages (Li, Carey and Workman 2007).  
At active genes, the TSS is a nucleosome free region (NFR) flanked by well-
positioned nucleosomes -1 and +1 downstream and upstream, respectively. 
Nucleosomes are positioned immediately downstream of +1 and phased at regular 
intervals but this phasing gradually lost towards the 3’ end of genes (Rando and Chang 
2009) (Campos and Reinberg 2009). At the +1 and -1 nucleosomes the ATP-dependent 
chromatin-remodeling complex SCRAP (SWR1 in yeast) deposits the H2A.Z histone 
variant. The H2A.Z containing nucleosomes are less stable compared to canonical H2A 
(Venkatesh and Workman 2015), and in humans, the level of H2A.Z at these sites is 
correlated with gene expression (Bargaje, et al. 2012) (Barski, et al. 2007). In addition, 
histone H3.3 is also enriched at TSS, which further decreases nucleosomes stability 
(Jin and Felsenfeld 2007) (Ha, Kraushaar and Zhao 2014). Studies in yeast showed 
binding of multiple chromatin remodeling complexes with the +1 nucleosomes such as 
Isw1a, Isw2, Ino80 and RSC complexes (Yen, et al. 2012), and some of these 
complexes involve in regulating the NFRs (Hartley and Madhani 2009) (Whitehouse, et 
al. 2007). 
Transcription begins by TF binding to promoters, which facilitate recruitment of 
histone modifying enzymes and chromatin remodeling complexes. These co-activators 
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modulate the chromatin structure further to facilitate the binding of general transcription 
factors and assembly of the pre-initiation complex (PIC), which includes RNA-pol 2 (Li, 
Carey and Workman 2007). The kinase activity of TFIIH phosphorylates the C-terminal 
domain (CTD) of the RNA-pol 2 largest subunits at serine 5 (p-Ser5) The CTD contain 
highly conserved seven amino acids YSPTSPS that in human exist in 52 repeats. The 
phosphorylation of ser5 allows release of RNA-pol 2 from the promoter and begins 
elongation (Jonkers and Lis 2015). 
The presence of nucleosomes acts as a barrier for the elongating RNA-pol 2 
during transcription elongation. Thus, cooperation of histone modifying enzymes, 
histone chaperones and ATP-dependent chromatin remodeling complexes facilitate the 
elongation. Recruitment of such complexes can be mediated directly through the CTD 
of RNA-pol 2. For example the histone acetyl transferases CBP/p300 and PCAF and 
the SWI/SNF complex co-purify with the RNA pol2 (Cho, et al. 1998). Histone 
acetylation is associated with active transcription as it mediates open chromatin 
confirmation and recruits factors that facilitate transcription (Carey , Li and Workman 
2006) (Mizuguchi , et al. 1997) (Campos and Reinberg 2009). In addition, histone 
chaperones can further modulate the nucleosomes within the coding regions. The 
histone chaperone FACT is associated with the CTD and it mediates displacement of 
H2A/H2B dimer from nucleosomes (Orphanides, et al. 1998). Also, the H3.3 variant is 
enriched in gene bodies of active genes. Incorporation of this variant makes the 
nucleosome less stable, and high turn over of H3.3 has been association with gene 
activity (Ha, Kraushaar and Zhao 2014). Additionally, the H3/H4 histone chaperone 
Spt6 is directly associated with RNA-pol 2 and it maintains the nucleosome integrity 
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within the open reading frame. Loss of Spt6 induces cryptic transcription within genes 
and defects in mRNA processing (Kaplan, Laprade and Winston 2003)(Yoh, Cho, et al. 
2007). Together, these histone chaperones can coordinate nucleosome assembly and 
disassembly during transcription.  
In addition, Setd2 is a histone methyl transferase that methylates H3K36, an 
important elongation marks. H3K36me3 is enriched in gene bodies and 3’end of active 
genes (Barski, et al. 2007) (Spies, et al. 2009). In yeast, H3K36me3 is recognized by 
the histone deacetylase Rpd3S complex. Once recruited, Rpd3S deacetylates 
nucleosomes and maintains closed chromatin confirmation to prevent cryptic transcripts 
(Campos and Reinberg 2009). It also reduces histone exchange within active genes. 
Although the human homolog of Rpd3S has been identified, it only regulates 
deacetylation around the TSS (Jelinic , Pellegrino and David 2011). However, in 
humans Set2 is also recruited to active genes by the histone chaperone Spt6 partner 
the interacting with Spt6 1 (Iws1). Iws1 is associated with CTD and depletion of Iws1 
leads to increase histone acetylation in coding regions suggesting a role in recruiting 
HDACs to gene bodies (Yoh, Lucas and Jones 2008). In addition to histone chaperones 
and histone modifying enzymes, ATP-dependent chromatin remodeling complexes are 
involved in regulating RNA-pol 2 elongation. 
 
CHD Functions in Transcription Elongation 
In yeast, Chd1 is associated with RNA-pol2 associated factors PAF complex, 
Spt5 and FACT, which suggest a role for Chd1 in RNA-pol 2 elongation (Simic, et al. 
2003). Genome wide investigation of nucleosome occupancy in Chd1 mutants showed 
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defects in chromatin structure within coding regions (Gkikopoulos, et al. 2011). This 
effect is associated with increases histone exchange and initiates cryptic transcription 
within genes (Smolle, et al. 2012). These results highlight a requirement of Chd1 to 
maintain chromatin structure integrity following RNA-pol 2 passing. This function is likely 
conserved in mammals, as the human CHD1 also interact with the FACT subunit, 
SSRP1 (Kelley , Stokes and Perry 1999) (Orphanides, Wu, et al. 1999). In addition to its 
role in gene bodies, Chd1is required for normal transcription termination at subset of 
target genes (Alén, et al. 2002).  Additionally, CHD1 is involved in mRNA processing. In 
human, CHD1 directly interacts with and recruits components of the spliceosome to 
active genes, and depletion of CHD1 shows reduces the efficiency of mRNA splicing 
(Sims III, et al. 2007). 
 
ISWI functions in transcription elongation 
In yeast, there are three ISWI complexes Isw1a, Isw1b and Isw2. Genome wide 
studies show that Isw1a and Isw2 are localized at TSS and 3’ end sites of genes, while 
Isw1b is localized in gene bodies and 3’end of genes (Yen, et al. 2012). Role of Isw2 at 
upstream and downstream of genes is to slide nucleosomes to decrease NFR size and 
repress transcription (Whitehouse, et al. 2007). The Isw1b complex directly interacts 
with H3K36me3 through the PWWP domain of Ioc4 subunits (Maltby, et al. 2012). This 
interaction recruits the complex to gene bodies and downstream of genes (Smolle, et al. 
2012). Similar to depletion of H3K36me3, depletion of Isw1b complex increases histone 
exchange and H4 acetylation within genes and generates cryptic transcripts. This 
phenotype requires the remodeling activity as an ATPase inactive mutant showed 
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similar results (Smolle, et al. 2012). Additionally, together with Chd1, the Isw1 and Isw2 
complexes are required for transcription termination at GAL10 (Alén, et al. 2002).  
 
RSC and SWI/SNF functions in transcription elongation 
RSC is a SWI/SNF containing complex in yeast that is required to maintain open 
NFR regions upstream of the TSS (Hartley and Madhani 2009). Genome wide 
investigation showed localization of RSC and SWI/SNF complexes at TSSs (Yen, et al. 
2012). However, RSC directly interacts with RNA-pol 2 (Soutourina, et al. 2006), and it 
enhances RNA-pol2 elongation through chromatin using an in vitro system (Carey , Li 
and Workman 2006). These suggest a role of this complex in regulating RNA-pol2 
elongation in vivo. In addition, BRG1, the human SWI/SNF protein is also associated 
with RNA pol2 (Neish , et al. 1998). BRG1 has been reported to localize in gene body of 
the hsp70 gene and plays a role in RNA-pol2 elongation (Corey, et al. 2003). Also, 
BRM, the second SWI/SNF protein in human, localizes in coding regions in some of its 
target genes and helps recruiting the splicing machinery through direct interaction with 
snRNPs U1 and U6 to facilitate alternative splicing (Batsche, Yaniv and Muchardt 
2006). 
 
1.4.2 Transcription and Messenger RNA Processing 
Messenger RNA processing involves 5’ capping, exon splicing and 
cleavage/addition of poly polyadenylation signal to ensure maturation of mRNA. These 
processes occur co-transcriptionally as many of factors required for this process are 
associated with the CTD of RNA-pol 2 (Bentley 2014). In general, following 
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phosphorylation of Serine 5 at CTD of RNA-pol 2 and the release from the TSS, the 
RNA-pol 2 pauses at downstream of TSS. This pausing step is mediated by factors 
such as the negative elongation factors (NELF) and DRB-sensitive inducing factor 
(DSIF) (Jonkers and Lis 2015). As capping enzymes and cap-binding complex (CBP) 
interacts with DSIF, this step can function as a checkpoint to ensure proper mRNA 
capping (Bentley 2014). Recruitment of the positive elongation factor-b (P-TEFb), which 
contains cyclin-T and cyclin-dependent kinase 9 (CDK9), phosphorylates the Serine 2 
(p-Ser2) of the RNA-pol 2 CTD and release the effect of the negative elongation factors. 
This step allows RNA-pol 2 to engage in active elongation. 
Splicing is a process by which introns are removed from the pre-mRNA. Splicing 
requires assembling of spliceosome, a large ribonucleoprotin complex, in the intron 
boundaries. Spliceosomes are composed of 5 U-rich (snRNAs), U1, U2, U4, U5 and U6 
that are associated with proteins to form the snRNPs. Splicing occurs co-
transcriptionally, and components of spliceosome are recruited through the CTD of 
RNA-pol 2 or histone modifications (Bentley 2014)(Gunderson , Merkhofer and Johnson 
2011). It also, promotes RNA-pol 2 elongation (Fong and Zhou 2001). Defects in 
spliceosome assembly leads to RNA-pol 2 pausing (Chathoth, et al. 2014), Which result 
in defects in mRNA processing. These lead to generate immature mRNA that can be 
targeted by the RNA degradation mechanisms such as nuclear exosomes in the 
nucleus or non-sense mediated decay (NMD) in the cytoplasm. These mechanisms are 
quality check step to insure a mature mRNA can be exported and translated (Houseley 
and Tollervey 2009) 
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Alternative splicing is a process that greatly increases unique gene products from 
the genome by generating up to several different mRNA splice forms one gene. 
Alternative splicing is influenced by elongation rate, and factors that induce inclusion of 
alternatively spliced exons can reduces the RNA-pol 2 elongation rate in order to 
provide more window time for splicing machinery to assemble at these sites (Bentley 
2014). It has been shown that reduction of RNA-pol 2 elongation increases inclusion of 
alternatively spliced exons in transcripts (Ip, et al. 2011). Furthermore, deletion of 
factors that influence alternative splicing reduces pausing RNA-pol 2 at alternatively 
spliced exons which lead to skip the inclusion of these sites in the transcript (Batsche, 
Yaniv and Muchardt 2006). Moreover, binding of DNA binding proteins can pause RNA-
pol 2 within genes and promote inclusion of alternatively spliced exons as shown for 
CTCF (Shukla, et al. 2011). 
Histone modifications also play a direct role in alternative splicing. For example, 
H3K36me3 is recognized by the MORF-related gene on chromosome 15 (MRG15), a 
protein associated with multiple complexes such as histone demethylases and 
deacetylases. MRG15 recruits the polypyrimidine tract–binding protein (PTBP1), which 
binds to silencing element in alternatively spliced exons (Luco, et al. 2010). Binding of 
PTBP1 represses inclusion of exons inclusion in transcripts, and KD of Set2 (the 
H3K36me3 methyl transferase), or KD MRG15 reduces PTBP1 binding to this element 
to help inclusion of these exons (Luco, et al. 2010). In addition, H3K36me3 can aid in 
recruiting processing factors, and regulate alternative splicing. The PC4 and SFRS1 
interacting protein 1 (Psip1) protein directly recognizes H3K36me3 within active genes 
and recruits spliceosome component U5 snRNPs and serine/threonine (SR) proteins to 
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promote splicing (Pradeepa , et al. 2012). Together, these suggest that mRNA 
processing greatly influenced by chromatin structure and the rate of RNA-pol 2 
elongation.   
One outcome of defective splicing is intron retention in which an intron is not 
removed from the mRNA (Ge and Porse 2013). In this case the intron containing mature 
mRNA is sensed as an unprocessed transcript and targeted by non-sense mediated 
decay (Wong , et al. 2013) or nuclear retention and nuclear exosome degradation (Yap , 
et al. 2012). As such intron retention can functions as a mechanism to regulate gene 
expression (Yap , et al. 2012) (Wong , et al. 2013). Intron retention is common in yeast, 
fungi and plant, and recently discovered in mammals as well (Braunschweig, Barbosa-
Morais , et al. 2014). In mammals, it can account for the regulation of cell-type specific 
gene expression. For example, expression of some of neuronal specific genes is down 
regulated in non-neuronal cells through intone retention and RNA degradation (Yap , et 
al. 2012). A genome wide investigation of intron retention in mESCs cells and neuronal 
cells shows that a subset of genes important for ESC biology retained introns and were 
down regulated upon differentiation to neuronal cells (Braunschweig, Barbosa-Morais , 
et al. 2014). In addition, intron retention involves in normal regulation of granulocyte 
differentiation (Wong , et al. 2013). Using RNA-seq approach Wong, et al. identified 86 
genes that retained introns and results in down regulation of the protein level during 
differentiation from promyelocytes to granyolocyte. In this work, the authors suggested 
that defects in exon intron recognition by the spliceosome components are the 
mechanism of retained introns in granulocytes (Wong , et al. 2013). 
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As the elongation rate can influence mRNA processing (Chathoth, et al. 2014) 
(Alexander , et al. 2010) (Fong and Zhou 2001), it can also impact intron retention. It 
has been found that retained introns are associated with increase occupancy of total 
RNA-pol 2 and the elongating form RNA-pol 2 p-Ser2. Inhibition of RNA-pol 2 
elongation increases intron retention in 13 out of 18 tested transcripts. In addition, 
retained introns are associated with high levels of chromatin modifying marks such as 
H3K27ac and the ATP-dependent chromatin factor CHD2 suggesting that it results in 
changes in chromatin structure (Braunschweig, Barbosa-Morais , et al. 2014). 
 Additionally, histone modification can promote intron retention. The H3.3K36me3 
interacting protein BS69 has been found to promote intron retention at a subset of its 
target genes (Guo, et al. 2014). BS69 physically interacts with a subunit of U5 snRNPs 
(EFTU2) and its role in inducing intron retention is likely through antagonizing the 
function of core spliceosome at a subset of its target genes (Guo, et al. 2014). 
Additionally, a resent report shows that PTBP1 binding to introns promotes intron 
retention (Yap , et al. 2012). Interestingly, different work showed that recruitment of 
PTBP1 to genes can be through direct interaction with MRG15 which physically 
interacts with H3K36me3. (Luco, et al. 2010). This further suggests a role of H3K36m3 
in recruiting factors that can regulate intron retention. 
 
1.4.3 THO Complex 4 (THOC4) 
THOC4 (also known as ALY/Ref) is a conserved and ubiquitously expressed 
RNA binding protein in mammals. It was first identified as a co-activator that directly 
interacts with lymphoid enhancer-binding factor 1 (LEF-1) and acute myeloid leukemia1 
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(AML-1) transcription factor, and enhances their binding to T-cell receptor alpha (TCRα) 
enhancer (Bruhn, Munnerlyn and Grosschedl 1997). As the activity of the TCRα was 
increased upon THOC4 overexpression, it has been suggested that THOC4 might 
mediate collaboration of trans-acting factors to augment TCRα enhancer activity (Bruhn, 
Munnerlyn and Grosschedl 1997). 
Additionally, THOC4 has been shown to acts as co-activator at cis regulatory 
element (Suganuma, et al. 2005). In erythroleukemia cell line, a novel DNase I 
hypersensitive site was identified upstream of RH gene that enhances promoter activity 
using luciferase reporter assays. Serial deletions and EMSA analysis of this region 
revealed a 34 bp C-rich DNA element (TCCCCCTCCCC) that is associated with the 
enhancer activity. Mass spec analysis identified THOC4 as the factor associated with 
this elements (Suganuma, et al. 2005).  
THOC4 also functions as a mRNA export factor through transcription export 
complex (TREX). TREX is composed of THOC4, UAP56, CIP29 and THO complex 
(Dufu, et al. 2010). UAP56 directly interacts with THOC4 and mediates its association 
with the THO complex (Dufu, et al. 2010). Following 5’ capping and intron splicing, 
THOC4 interacts with CBP80, a cap binding protein, to mediates the TREX to mRNA 
(Cheng, et al. 2006). Subsequently, TREX mediates the TAP/NXF1 recruitment to 
spliced mRNA through the direct interaction between THOC4 and TAP. These 
interactions in turn mediate the export of mRNA through the nuclear pore (Stutz, et al. 
2000).  
  Recruitment of THOC4 to genes can be through binding to mRNA as it has RNA-
binding domain, and through RNA-pol 2 as the THOC4 homolog in yeast (Yra1) directly 
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interacts with phosphorylated CTD of RNA-pol 2 (MacKellar and Greenleaf 2011). 
Another recruiter of THOC4 to active transcripts is mediated by the interaction with the 
IWS1 (Yoh, Lucas and Jones 2008). Spt6 is a H3/H4 histone chaperone and an 
elongation factor that interacts with RNA-pol 2 phosphorylated at p-Ser2. Knock down of 
IWS1 leads to depletion of THOC4 at gene bodies and defects in mRNA splicing (Yoh, 
Cho, et al. 2007). In addition to THOC4, IWS1 recruits the histone methyl transferase 
Setd2 to methylate H3K36 over gene bodies indicating a role in modifying the chromatin 
structure during elongation (Yoh, Lucas and Jones 2008). Genome wide localization of 
THOC4 in HeLa cells using ChIP-chip technique showed localization over gene bodies, 
mainly intron regions (Swinburne, et al. 2006). Investigation of enriched signal over 
representative genes, indicate that THOC4 is more enriched in the 3’ end than 5’ at 
subset of genes (Swinburne, et al. 2006). This pattern resembles the localization of its 
homolog in yeast Yar1 which localizes to 3’end of genes. Recently, Stubbs S. H. and 
Conrad N. K. showed that THOC4 has export independent roles in regulating gene 
expression (Stubbs and Conrad 2015). This work supported a previous report that 
shows defect in elongation following THOC4 D using a reporter vector (Domínguez-
Sánchez, et al. 2011). These suggest a role of THOC4 in on going elongation by RNA 
Pol II prior to exporting mRNA. 
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Figure 1.5: A diagram showing THOC4 localization within gene bodies 
THOC4 (red oval) can binds to mRNA through its RNA binding domain. In addition, it interacts 
(dashed black line) with IWS1 that binds to SPT6. SPT6 directly interact with phosphorylated 
Ser2 at CTD of RNA-Pol 2 (Yoh, Lucas and Jones 2008). In yeast, it directly interacts with 
phosphorylated CTD of RNA-pol 2 (MacKellar and Greenleaf 2011). Also, THOC4 directly 
interact with CBP80, a cap binding proteins (Cheng, et al. 2006).  
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CHAPTER TWO 
 
Methods 
 
 
 
 
2.1 Cell Culture 
The BPTF knockout (KO) mouse embryonic stem cells (mESCs) are described 
previously (Landry , Sharov , et al. 2008). Control (CJ7) and BPTF KO mESC were 
grown on gelatinized plates and grown in Dulbecco’s Modified Eagle Medium (DMEM) 
(Life technology) as a base medium supplemented with 15% ESC-grade fetal bovine 
serum (FBS) (Life Technologies), 1X penicillin-streptomycin (Quality Biological), 2 mM 
glutamine (Life technology), 1X nonessential amino acids (NEAA) (HyClone), 0.1 mM 2-
mercaptoethanol and 1,000 unit/ml (U/ml) leukemia inhibitory factor (LIF) (ESGRO; 
Millipore). 
P19 cells were grown in DMEM (Life technology) as a base medium 
supplemented with 10% FBS (Life Technologies), 1X penicillin-streptomycin (Quality 
Biological), 2 mM glutamine (Life technology) and 1X NEAA (HyClone). 
 
2.2 Generation and Purification of the Custom BPTF Antibody 
The amino acid sequences (NP_789820.2 amino acid between 2302-2372) 
correspond to the BPTF-2 epitope was cloned as two different constructs as a Maltose-
Binding Protein (MBP) tagged protein and a 6 X His tagged protein. The constructs was 
expressed in BL21 bacteria at 37°C with 0.5 mM of Isopropyl β-D-1-
thiogalactopyranoside (IPTG) and 3% Ethanol for 3 hours. The soluble lysate of bacteria 
with MBP-tagged epitope protein was purified using amylose resin (New England Bio 
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Labs). MBP-bound proteins were washed two times with 10 volumes of PBS to remove 
unbound proteins and eluted with 10 mM maltose in PBS. Purified epitope was sent to a 
custom polyclonal antibody production facility (Cocalico Biologicals, Inc.™, Reamstown, 
PA) to immunize two rabbits. The immunization protocol scheduled as follow at day 0 
pre-immune serum was collected before initial inoculation of the antigen (the purified 
GST-epitope for BPTF). Following inculcation, the rabbits were giving three boost doses 
at 14 days, 21 days and 49 days post-inoculation. Serum was collected from the rabbits 
at 35 days and 56 days post-inoculation.   
Antibody purification from the serum was performed using the 6X His tagged 
epitope. The construct expressed in BL21-CodonPlus(DE3)-RIPL bacteria at 37°C with 
0.5 mM IPTG and 3% Ethanol for 3 hours. The soluble lysate of bacteria was purified 
with nickel column Ni-NTA agarose (QIAGEN, Netherlands). ~ 2 ml of mixed Ni-NTA 
agarose were added to a disposable column. Then, the column was washed with 10 ml 
washing buffer (50 mM NaH2PO4, 300 mM NaCl and 20 mM imidazole) two times. The 
soluble lysate fraction was added to the column and the flow through was collected and 
added to the column one more time. Then, the column was washed two times with the 
washing buffer, and the bound protein was eluted with elution buffer (50 mM NaH2PO4, 
300 mM NaCl and 250 mM imidazole) in 1 ml aliquots. The protein concentration in the 
elution aliquots was measured using Bio-Rad protein assay (BioRad, Hercules, CA). To 
purify the BPTF antibody from the immunized serum, the purified 6X His tagged epitope 
was coupled in Amino Link column using AminoLink® Plus immobilization kit (Thermo 
Scientific, Waltham, MA). The coupling performed following at pH 10 accoring to the 
manufacture protocol. After coupling the antigen to the column, the column was washed 
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with washing buffer (100 mM Tris [pH 8.0], 500 mM NaCl). The immunized serum was 
run through the column with flow throw rate 1 ml/min. Then, the column washed three 
times with the wash buffer and eluted with elution buffer (3.4 M MgCl2, 10 mM PO4 [pH 
8.0]). The eluted samples were dialyzed in dialysis membrane with 3,500 Dalton 
molecular weight cut off against PBS overnight for three days. The protein was then 
quantified using Bio-Rad protein assay and concentrated to 1mg/ml using Centricon 
Micro Concentrators (Amicon).  
2.3 Chromatin Immunoprecipitation (ChIP) 
ESCs were fixed for 10 min with 1% neutral buffered formalin PBS pH 7.4, then 
washed three times with PBS for 5 minutes each wash. 10X106 fixed cells were 
suspended in lysis buffer (50 mM Tris [pH 8.0], 1% SDS, 10 mM EDTA and 1 X 
protease inhibitor cocktail (Roche). The DNA was sonicated with Bioruptor sonicator 
three times for 15 min of alternating 30 sec. on, 30 sec. off, on ice to yield DNA 
fragments between 200-500bp. Sonicated samples were centrifuged at high speed for 
10 minutes and 200 µl of soluble chromatin was diluted with 1:10 in dilution buffer 200 
µl of soluble chromatin was diluted with 1:10 in dilution buffer (16.7 mM Tris- HCl [pH 
8.1], 167 mM NaCl, 1.1% Triton X-100, 1.2 mM EDTA and 1 X protease inhibitor 
cocktail (Roche)) and mixed over night at 4°C with protein G Dynal beads (Life 
Technologies) pre-bound with antibodies (10 µl of beads with 5 µg antibody). For each 
pull-down 20% input was saved for determination of pull-down efficiency using qPCR. 
The antibodies used for ChIP in this study include BPTF-2 (custom), THOC4 
(Immunoquest, IQ221), RNA-pol 2 (Pol2) (abcam, ab817-100), H3K36me3 (abcam, 
ab9050), pan-Histone H3 (abcam, ab1791) and normal IgG Rabbit (Cell Signaling, 
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2729S). Next, bound chromatin subjected to series of washes 5 min each on ice; low-
salt buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 1% Triton X-100, and 2 mM EDTA), 
high-salt buffer (20 mM Tris [pH 8.0], 500 mM NaCl, 1% Triton X-100, and 2 mM 
EDTA), lithium chloride (LiCl) buffer (10 mM Tris [pH 8.0], 0.25 M LiCl, 1% NP-40, 1% 
deoxycholic acid, and 1 mM EDTA) and two times with TE buffer (10 mM Tris [pH 8.0], 
1 mM EDTA). The DNA was eluted from the beads using two elutions with 250 ul elution 
buffer (0.1 M NaHCO3, and 1% SDS) at room temperature for 30 min each. Eluted DNA 
and the 20% input DNA were reverse cross-linked with 200 mM NaCl and incubated 
overnight at 65°C. Next, samples were neutralized to 50mM Tris-HCl pH 6.8, 1mM 
EDTA then treated with 0.1 mg/ml proteinase k for 4 h at 45°C.  The DNA was extracted 
using phenol-chloroform extraction, precipitated with ethanol and dissolved in water 
treated with RNase A. sequences for primers used for ChIP-qPCR are provided in 
(Table 2.1). 
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A) Primers used to validate the BPTF-2 ChIP grade antibody 
  5' > 3' 
Site 1 For GTAAGCCCCAATCCCTGTTT 
Site 1 Rev GCTCCGTCTAGCCTGATGAC 
Site 2 For TCCTGTGTGCACTTCTCCAG 
Site 2 Rev ACCAACATCATGGTCCCTGT 
Site 3 For ACCAAGTCCCAGATTCAGTACG 
Site 3 Rev CTGGGATACCCGAGTGTGAAT 
B) Primers used to validate a representative ChIP-Seq peaks 
  5' > 3' 
Test 1 for ACGGACTGATGCTTTGGGAA 
Test 1 rev CCTGGGCAAAGAGCTGTACT 
Test 2 for TCACCTCCTGCAAAGTCCAC 
Test 2 rev GTCAGGAGAAGCGGGAACAA 
Test 3 for GCGGTACCCTGGGGAATCTA 
Test 3 rev TAGCGGTACTCCAACCTGGG 
Test 4 for TTCATCATCTCCCACCCAGC 
Test 4 rev TGCTGCCCCTTTCACATCAA 
Control 1 For GAACTTCGGGAAGGGGAAGG 
Control 1 Rev AGGATCACGTGGCCAGAAAG 
Control 2 For GCATGCCAGAACCTTGTCTTC 
Control 2 Rev GGTCTCAGGCTGTTCCTTTCT 
C) Primers used for ChIP over Ccnd1 gene 
  5' > 3' 
1 For ATCTCCTTCTGCACGCACTT 
1 Rev GCGTACCCTGACACCAATCT 
2 For CTGGCATTTTGGAGAGGAAG 
2 Rev CGGGTTGACCCAACTCTTTA 
3 For TCAGCATCTTTCCATTCACG 
3 Rev TGGAATACAGGTGGGGGTAA 
4 For GGCAAAAACCAGCATCTCTC 
4 Rev CACAGCGGTAGGGATGAAAT 
!
 
 
Table 2.1: Primers used for ChIP analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
	  
	  
A) Primers correspond to Figure 3.1  
B) Primers correspond to Figure 3.2 E  
C) Primers correspond to Figure 3.9 E 
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2.4 Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) 
FAIRE were performed as previously described (Simon, et al. 2012). 1X107 fixed 
cells were suspended in 500 µl lysis buffer (50 mM Tris [pH 8.0], 1% SDS, 10 mM 
EDTA) and 1 X protease inhibitor cocktail (Roche). The DNA was sonicated with 
Bioruptor sonicator three times for 15 min of alternating 30 sec. on, 30 sec. off, on ice to 
yield DNA fragments between 200-500bp. Sonicated samples were centrifuged at high 
speed, and 50 µl of soluble chromatin were used as an input. Input chromatin was 
subjected to RNase A treatment (10 µg) for 30 min at 37°C, and incubated with 
proteinase K (20 µg) at 55°C for 1 h and then over night at 65°C. Then, DNA were 
extracted with phenol-chloroform, precipitated with ethanol and dissolved in TE buffer 
(10 mM Tris-HCl [pH 7.4], 0.5 mM EDTA). The remaining 450 µl soluble chromatin 
(FAIRE DNA) were extracted with phenol-chloroform, precipitated with ethanol and 
dissolved in TE buffer. Then, treated with RNase A and proteinase K as described 
above. FAIRE and input DNA were then washed and purified using Zymo-I spin 
columns (Zymo research). DNA was mixed with DNA binding buffer in 2:1 (DNA binding 
buffer: Sample) and centrifuged at high speed for 1 min, then washed twice with 200 µl 
wash buffer. DNA was eluted with TE buffer (10 mM Tris-HCl [pH 7.4]), and used for 
qPCR or high throughput sequencing. 
 
2.5 FAIRE-qPCR 
FAIRE-qPCR was performed as described (Giresi and Lieb 2009). Primers were 
designed to amplify a reference region (region with low and similar enrichment in the 
control and BPTF-KO samples), test regions (regions differentially enriched at FAIRE 
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sample between control cells and BPTF-KO cells) and control regions (regions with 
similar enrichment in control and BPTF-KO cells). The enrichment level for the above 
regions were determined by visualizing mapped reads from the FAIRE-Seq. Then, 
signal from the test regions and control regions generated from the input and FAIRE 
samples were normalized to signal from the reference region in each sample. Next, 
relative enrichment from each region were calculated using comparative ΔΔCt method. 
Statistical significance was calculated using student’s t-test. Sequences for primers 
used for FAIRE-qPCR are provided in (Table 2.2).   
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Table 2.2: Primers used for FAIRE-qPCR 
	  A) Primers correspond to Figure 3.5.F  
B)  Primers correspond to Figure 3.9 D 
 
A)#Primers#used#to#validate#a#representative#of#FAIRE8Seq#sites#
## 5'#>#3'#
Test#1_For# TCTCACCTCCACCCTTCTCC#
Test#1_Rev# TGGGGCTTTAGCATGCCTTT#
Test#2_For# GGGTGAGACAGGTCAGGTTT#
Test#2_Rev# AATTGCGGGACTGGAACTTG#
Test#3_For# TTTCACACCCACCATTAGCCA#
Test#3_Rev# CTTTACTGCCACCAGGGAGC#
Test#4_For# TCTGGGGACTTGTAGGGACA#
Test#4_Rev# GGTGGATGCTGTCTGACCTG#
Control#1_For# AATAGAACGGCCCTGGGTTG#
Control#1_Rev# GGCTCTGCAAAATCCATGCC#
Control#2_For# GGCTGGGGATATAACAGTCAGA#
Control#2_Rev# AGCCTGCCGTTATGTTCTCTC#
Control#3_For# TCACGCTCCACAGTAAAAAGGA#
Control#3_Rev# AGCCTGCTAGTTTCTTCCAAGG#
B)#Primers#used#for#FAIRE8qPCR#over#Ccmd1#gene#
## 5'#>#3'#
A#For# ATCTCCTTCTGCACGCACTT#
A#Rev# GCGTACCCTGACACCAATCT#
B#For# CTGGCATTTTGGAGAGGAAG#
B#Rev# CGGGTTGACCCAACTCTTTA#
C#For# TCAGCATCTTTCCATTCACG#
C#Rev# TGGAATACAGGTGGGGGTAA#
D#For# CCCCAACAACTTCCTCTCCT#
D#Rev# ACTCTGGGAAGAAGCTCGTG#
E#For# GAGGGGGTCCTTGTTTAGCC#
E#Rev# GTCTCTGGCAGCTCTCACTG#
F#For# GGCAAAAACCAGCATCTCTC#
F#Rev# CACAGCGGTAGGGATGAAAT#
G#For# GACCCTCCAATAGCAGCGAA#
G#Rev# CATGGCGCTGCTACCGAT#
H#For# GAAAGGCCACCTTGGGTCTT#
H#Rev# CGCAAATGGGTGTTTGCTCT#
Standard#For# ATACAACCAAACAGACACACAACC#
Standard#Rev# CTACTGGCTGCCATGGCTTA#
!
	  
	   79	  
2.6 Library Preparation 
Library preparation for ChIP-Seq and FAIRE-Seq and high throughput 
sequencing were performed at the nucleic acid research facility (NARF), Virginia 
Commonwealth University (VCU). Qubit™ high sensitivity kit (Invitrogen) was used to 
determine DNA concentration. NEBNext® Ultra™ DNA Library Prep Kit for illumine® was 
used for library preparation for ChIP-Seq and TruSeq DNA sample preparation kit was 
used for library preparation for FAIRE-Seq. BioAnalyzer high sensitivity chip was used 
to check libraries sizes and KAPA library quantification kit was used to measure the 
libraries concentrations. Samples were run on Miseq then HiSeq 2000 or 2500.  
 
 
2.7 Data Analysis 
After removing barcodes, quality of the 100 nucleotides (nt) reads was assessed 
using FastQC version 0.10.1 (Babraham Bioinformatics). Reads were trimmed to keep 
nt between position 15 and 50 using a custom logarithm provided by Vishal N Koparde, 
Ph. (NARF, VCU) to keep nt with high quality score (Figure 2.1). Bowtie2 software 
(Langmead and Salzberg 2012) was used to map the reads to National Center for 
Biotechnology Information (NCBI) build 37 (mm9) mouse genome with masked 
repetitive elements. Mouse genome was downloaded from University of California, 
Santa Cruz genome browser (UCSC) as mm9.2bit from the following link 
(http://hgdownload.soe.ucsc.edu/goldenPath/mm9/bigZips/). Next, twoBitToFa utility 
from UCSC genome browser 
(http://hgdownload.cse.ucsc.edu/admin/exe/macOSX.x86_64/) was used to convert 
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mm9.2bit to mm9.fa that can be used in bowtie2. Masking repetitive element was 
performed using bedtools v2.17.0 (Quinlan and Hall 2010) with maskFasta command. 
Annotations for repetitive elements obtained from UCSC genome browser. The masked 
genome was indexed using bowtie2 as described in bowtie2 manual. Reads were 
mapped as unpaired reads with the following conditions: one alignment reported for 
each read and one mismatch allowed per seed. The resulting sam files from bowtie2 
were converted to bam files then sorted and indexed with samtools (Li, et al. 2009). 
Reads with mapping score less than 10 were filter out. For ChIP-Seq, SICER software 
(Zang , et al. 2009) was used to call peaks using the following conditions; window size 
200pb, gap size 200bp, fragment size 200bp and false discovery rate (FDR) 0.001 after 
normalizing the reads count between BPTF ChIP-Seq and Input. For FAIRE-Seq, 
Diffreps software (Shen , Shao, et al. 2013) was used to determine differential regions 
between the control FAIRE samples and the BPTF KO FAIRE samples using the 
following conditions; the two control replicates as treatment and the two KO replicates 
as control, window size 100bp, step size 10, gap size zero, p-value 0.001 and negative 
binomial test for statistical testing after normalizing the read count between the control 
and BPTF KO bam files. The following command was executed ($ diffReps.pl --
treatment wt-Rep1.bed wt-Rep2.bed --control KO-Rep1.bed KO-Rep2.bed -re Results --
window 100 --step 10 --gap 0 --pval 0.001 -me nb --gname mm9).  
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Figure 2.1: Trimming reads to keep bases with high quality scores.                                   
Top panels show two examples of quality score for the full read length. Bottom panel shows the 
quality score for the reads after trimming the first 15 bases and the last 50 bases. 
	  
 
 
 
 
 
 
Figure 2.1 
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2.8 Co-localization Analysis with Previously Published ChIP-Seq Data Sets 
 Previously published ChIP-Seq peaks for histone modifications and chromatin-
associated proteins from mouse ESC used for co-localization analysis were obtained 
from Gene Expression Omnibus (GEO) database (Table 2.4). Co-localization analyses 
to determine the enrichment of BPTF-peaks from ChIP-Seq or BPTF-dependent FAIRE 
sites from FAIRE-Seq over the previously published ChIP-Seq peaks were performed 
using Genome Runner tool (Dozmorov, et al. 2011). For background estimation of 
random co-localization, random data set with equal number of sites for BPTF peaks or 
BPTF-dependent FAIRE sites were generated from the portion of the mouse genome 
with annotated epigenomic data from the Encyclopedia of DNA elements (ENCODE) 
project. The co-localization analysis was performed by reporting the number of overlap 
between the BPTF peaks or BPTF-dependent FAIRE sites and ChIP-Seq peaks for 
each factor from the previously published ChIP-Seq peaks (Table 2.3). Co-localizations 
that can occur by chance only were assessed by selecting random data sets with equal 
number of sites for BPTF ChIP-seq peaks or BPTF-dependent FAIRE sites from the 
portion of the mouse genome annotated with epigenomic data from the Encyclopedia of 
DNA elements (ENCODE) project. The numbers of observed and expected by chance 
overlaps were used to calculate p-values using Chi-square test (Table 2.4). The 
pValues were corrected for multiple testing using False Discovery Rate procedure. 
Genome runner analyses were performed by Dr. Mikhail Dozmorov (Department of 
Biostatistics, VCU).    
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Table 2.3: List of ChIP-Seq data used in this study 
Factor Accession,# Factor Accession,#
c"Myc GSE11431 Brdm4 GSE36561
E2f1 GSE11431 Rbbp5 GSE22934
Esrrb GSE11431 Rest GSE27841
Klf4 GSE11431 Setdb1 GSE18371
n"Myc GSE11431 Sox2 GSE44286
Smad1 GSE11431 Suz12 GSE44286
Stat3 GSE11431 Tbp GSE22303
Tcfcp2l1 GSE11431 Tet1 GSE26832
Zfx GSE11431 Utx GSE37821
Med1 GSE22557 Wdr5 GSE22934
Med12 GSE22557 Ctcf ENCODEMRenMLab
Nipbl GSE22557 H3K4me1 ENCODEMRenMLab
Smc1 GSE22557 H3K4me3 ENCODEMRenMLab
Smc3 GSE22557 H3K9ac ENCODEMRenMLab
Ctr9 GSE20485 H3K9me3 ENCODEMRenMLab
RNA"PolMIIMSer2p GSE20485 H3K27ac ENCODEMRenMLab
RAN"PolMIIMSer5p GSE20485 H3K27me3 ENCODEMRenMLab
Spt5 GSE20485 H3K36me3 ENCODEMRenMLab
NelfA GSE20485 RNA"PolMII ENCODEMRenMLab
Dpy30 GSE26136 Cdk9 GSE44286
H4K16ac GSE43103 Ringb1 GSE26680
CtcfMChIA"PETMLoopMEnds PMID:21685913 YY1 GSE31785
Aff4 GSE30267 Capd3 GSE33346
Atrx GSE22162 Cbp GSE51522
CoRest GSE27841 Mbd3 GSE51522
Ell2 GSE30267 Caph2 GSE30919
Ell3 GSE30267 Tbx3 GSE19219
Hdac1 GSE27841 CtcfMChIA"PETMMLoopMEnds PMID:M21685913
Hdac2 GSE27841 E"PMSmcMChIA"PETMMLoopMEnds PMID:M25303531
Kap1 GSE31183 H2A.Z GSE34483
Lsd1 GSE27841 H2A.Zac GSE34483
Nanog GSE44286 H3.3MTurnMOverMSites GSE63641
Nr5a2 GSE19019 Smc1MChIA"PETMLoopMEnds PMID:M25303531
MOct4 GSE44286 RNA"PolMIIMChIA"PETMLoopMEnds GSE44067
p300 GSE36027MM Mrg15 EMBO,Mvol30,Mp1473
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2.9 Preparation of Nuclear Extract 
Extraction of nuclear fraction was performed as previously described (Wysocka 
2006). 1X107 cells were collected from 10 cm plate, washed one time with 1X PBS and 
re-suspended in 1 ml of Buffer A (10 mM HEPES [pH 7.5], 1.5 mM MgCl2, 10 mM 
potassium chloride (KCl), 1 mM DTT and 1X protease inhibitor cocktail (Roche)). Cells 
were incubated for 10 min on ice and lysed with 10 strokes using a 2 ml dounce 
homogenizer with a type A PVTF pestle. Then, the lysate were centrifuged at 3300 g for 
15 min at 4°C. The supernatant was removed and the pellet was re-suspended (the 
nuclear fraction) in buffer C (20 mM HEPES [pH7.5], 1.5 mM MgCl2, 450 mM KCl, 25% 
glycerol, 0.2 mM EDTA, 1 mM DTT and 1X protease inhibitor cocktail (Roche)). Next, 
the nuclear fraction was incubated on ice for 30 min and centrifuged for 15 min at 
21,000 g at 4°C to remove insoluble fractions. The supernatant was then adjusted to 
150 mM KCl with buffer D (20 mM HEPES [pH 7.5], 20% glycerol, 0.2 mMEDTA, 0.2% 
Triton X-100 and 1X protease inhibitor cocktail (Roche)). Then, the nuclear fraction was 
incubated either with pre-bound Dynabeads® M-270 Streptavidin with biotinylated 
peptides (as described in section 2.10	  Peptides pull down) or with pre-bound 
Dynalbeads® protein G (Life Technologies) with antibody for BPTF (custom), THOC4 
(Immunoquest, IQ221), or Normal IgG Rabbit (Cell Signaling, 2729S) (as described in 
section 2.11 In vivo co-immunoprecipitation). 
 
2.10 Peptides Pull-down 
Dynabeads® M-270 Streptavidin (Life Technology) were washed with PBS and 
incubated with 200 pico mole (pmole) biotinylated peptides (N-terminal Histone H3.1 
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amino acids 1-20, H3.1 amino acids 1-20 mono-methylated at lysine 4, H3.1 amino 
acids 1-20 tri-methylated at lysine 4, H3 amino acids 27-45 and H3 amino acids 27-45 
tri-methylated at lysine 36 (EpiCypher) for 3 h on shaker. Then, beads were washed 
three times with PBS, and re-suspended in PBS. Beads pre-bound with 200 pmole 
biotinylated peptides were incubated with P19 cells nuclear extract prepared as 
described in section 2.9 for 1 h on ice with mixing every 5 min. Following the incubation, 
beads were washed with washing buffer (20 mM HEPES [pH 7.5], 300 mM KCl, 0.2% 
Triton X-100) three times with 5 min each and one time with PBS. Proteins were eluted 
with 1% SDS at 65°C for 30 min. Eluted proteins were used for Western blotting. 
 
2.11 In vivo Co-immunoprecipitation 
BPTF antibody (Millipore), THOC4 antibody (D3R4R, Cell Signaling) and normal 
rabbit IgG antibody (2729S, Cell Signaling) was bound to protein G Dynal beads (Life 
Technologies). 40 µl Beads were washed three times with 1X PBS and in then re-
suspended in 100 µl 1X PBS and incubated with antibody for overnight at 4°C in rotator. 
Then, beads were washed 3 times for 5 min on ice with 1X PBS or pull down buffer to 
remove unbound antibody. Beads pre-bound with the antibody were incubated for 3 h 4 
°C rotator with mESC nuclear extract prepared as described in section 2.9 which 
additionally treated with MNase (Worthington) before incubation. Following incubation 
with nuclear extract, beads were washed with for three times with (20mM HEPES, 0.2% 
X-100, 150 mM KCl and 2mM MgCl2) and bound proteins were eluted with 1% SDS at 
room temperature for 30 min. Eluted proteins were used for Western blotting.   
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2.12 THOC4-NURF in vitro Pull-downs  
Protein expression: 
To generate MBP -tagged THOC4, sequence corresponds to mouse THOC4 was 
amplified from full-length mouse THOC4 containing plasmid (Urigene) with the following 
primers; forward 5’ GGGATATCATGGCCGACAAAATGGAC 3’ and reverse 5’ 
GGGGGATCCTTAGCTGGTGTCCATCCTTGCATTGTAAG 3’. The amplified sequence 
was cloned into pMAL c2X MBP (New England Biolabs), and recombinant proteins were 
expressed in BL21-CodonPlus(DE3)-RIPL (Agilent Technologies) using 0.5 mM IPTG at 
37°C for 3 h. The bacterial pellets were re-suspended in 1/10 culture volume with PBS, 
1% Triton X-100 and 1X protease inhibitor cocktail EDTA free (Roche) and expressed 
proteins were extracted by sonication on ice. Soluble extracted proteins were incubated 
with amylose resin (New England Bio Labs). MBP-bound proteins were washed two 
times with 10 volumes of PBS to remove unbound proteins, and stored in ~50% glycerol 
at -20°C as resin bound MBP-tagged proteins. To obtain purified THOC4, MBP-THOC4 
bound to resin was eluted with 10 mM maltose. Eluted protein then, dialyzed against 
PBS, quantified with BioRad DC Protein assay (BioRad) using bovine serum albumin 
(BSA) standards and diluted to100 ng/μl, which was used for in vitro pull-down. 
Purified recombinant NURF complex contains FLAG-tagged BPTF, SNF2L and 
RbAp48 were obtained from Dr. Joseph Landry (Qiu, et al. 2015). The N-terminal PHD 
domain of mouse BPTF was cloned as a GST-tagged pGEX4T-1 (GE Life Sciences) by 
Marissa Mack in Dr. Joseph Landry’s laboratory.   
 
In vitro pull down 
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 For in vitro pull-down of NURF complex with MBP-tagged THOC4, equal amount 
of resin bound MBP-THOC4 or MBP only were washed one time with wash buffer 
(25mM HEPES, 100mM NaCl, 0.01% NP-40, 0.5 mM MgCl2 and 10% glycerol) and re-
suspended in 100 µl the wash buffer and 2 µl of purified recombinant NURF (stock 2 
µg/µl) were added. Following incubation of 1 h on ice with mixing every 5 min, the resin 
was washed four times with the wash buffer with changing into new tube after the third 
wash. Next, bound proteins were eluted with 1% SDS at 65 °C for 30 min. Eluted 
proteins were used for Western blotting with BPTF antibody (Millipore).   
For in vitro pull-down of recombinant THOC4 with GST-N-PHD, equal amount of 
resin bound GST-N-PHD or GST only were washed one time with in vitro pull-down 
buffer (25mM HEPES 300mM NaCl, 1mM MgCl2, 0.01% NP40 and 10% glycerol) and 
1mM of ZnCl2. Then, extensive wash with the in vitro pull-down buffer were performed 
to remove the ZnCl2. Following the wash, the resins were re-suspended in 100 µl in vitro 
pull-down buffer and 1 µl of purified THOC4 (stock 100 ng/µl) was added and incubated 
for 1 h on ice with mixing every 5 min. Next, the resin were washed 5 times with in vitro 
pull down buffer with changing into new tubes after the 3rd wash. Next, the bound 
proteins were eluted with 1% SDS at 65°C, and eluted proteins were used for Western 
blotting with THOC4 antibody (D3R4R, Cell Signaling). 
 
2.13 Western Blotting  
Monolayer cells were washed with PBS for three times, and incubated with 1 ml 
of TRI-Reagent for 5 min. The homogenates were transferred into 1.5 ml tubes, and 
incubated with 200 µl chloroform for 15 min. Then, samples were centrifuged for 15 
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minutes at 20,000 RCF(relative centrifugal force) at 4°C. Three layers were formed; an 
aqueous phase contains the RNA, an interphase contains the DNA and an organic 
phase contains the proteins (bottom layer). After removing the aqueous and interphase, 
1 ml of isopropanol was added and the tubes were incubated at room temperature for 
10 min. Then, the samples were centrifuged at 20,000 RCF for 15 min at 4°C. The 
supernatants were discarded and 1 ml of 0.3 M guanidine in 95% ethanol was added for 
overnight wash at 4°C on shaker. Then, the guanidine was removed by centrifugation at 
high speed and protein pellets were washed overnight with 1 ml of 100 % ethanol at 4°C 
on shaker. Next, proteins were dissolved in 250 µl of 8 M urea in 1% SDS at 65°C 
overnight. Protein concentration was measured using Bio-Rad Dc Protein Assay 
provided by Bio-Rad Laboratories (Hercules, CA) using BSA standards. The proteins 
were dissolved in 2 mg/ml. 50 µg of protein was loaded into a 4% SDS-PAGE for BPTF 
or a 12% SDS-PAGE for THOC4, and run for 1 hour at 200 V and 300 mA. Next, 
proteins were transferred into polyvinylidene fluoride (PVDF) membrane provided by 
Bio-Rad Laboratories (Hercules, CA) for 17 hours at 20 V and 30 mA. Transfer buffer 
for Bptf was (10 mM CAPS-NaOH [ph10.5] and 2.5 mM DTT), and for all other proteins 
in this study was (25 mM Tris, 190 mM glycine and 20% methanol). After transfer, the 
PVDF membranes were blocked with 5% non-fat dry milk in PBST (PBS, 0.1% Tween-
20) for 1 h, and incubated with primary antibody for overnight at 4°C. Primary antibodies 
used in this study include BPTF 1:5000 (custom), SNF2L 1:5000 (Abcam), RbAp48 
1:5000 (Abcam) and THOC4 1:1000 (Cell Signaling). Next, membranes were washed 
three times with PBST for 10 min each, and the membranes were incubated with ECL 
peroxidase labeled secondary antibody at 1:10,000 dilution for 2 hour. The plots were 
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then washed for 10 min with PBST for three times and developed using super signal 
West Femto Substrate (Thermo Scientific). 
 
2.14 RNA Extraction and Quantitative RT-PCR  
 Total RNA was extracted using TRI-Reagent (Sigma-Aldrich) from mESCs grown 
in 10 cm plate. The cells were washed with PBS and 1 ml of TRI reagent was added 
and incubated for 5 minutes. Then, the contents were transferred to 1.5 ml centrifuge 
tubes and 200 µl chloroform was added. Samples were mixed by vortexing and 
incubated for 10-15 minutes. Tubes were then centrifuged at high speed for 15 min at 
4°C. The resulted aqueous phase, which contains the RNA, was transferred into a new 
1.5 ml tubes. 100 µl of acidic phenol was added and samples were centrifuged. RNA 
precipitation was achieved by adding 250 µl of isopropanol and 250 µl of RNA 
precipitation solution (1.2 M NaCl and 0.3 M disodium citrate). After mixing the contents 
and incubating the tubes for 10 minutes at room temperature, the tubes were 
centrifuged at high speed for 15 minutes at 4°C. The resulted pellets were washed two 
times with 70% ethanol and RNA was dissolved in 50 µl molecular grade water. RNA 
integrity was tested by 1.5% agarose electrophoresis. The absorbance at 260 and 280 
wavelengths was measured by NanoDrop® ND-1000 Spectrophotometer (Thermo 
scientific) 
 RNA was treated with DNase I to digest any traces of genomic DNA. 25 ug of 
total RNA was digested in a 100 ul volume with DNase I (Sigma) in a digestion buffer 
(10mM Tris pH 8.0, 3 mM MgCl2 and 2mM CaCl2) with RNAse Inhibitor (Life 
Technologies) for 30 min at 37°C. Next, the RNA was extracted with acid phenol 
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followed by chlorophorm:isoamyl alcohol. RNA was converted to complementary DNA 
(cDNA) using SuperScript II reverse transcriptase (RT) (Life Technologies). 5 µg of total 
RNA was converted using random hexamer and oligo dT primers following the 
manufactures protocol (Life Technologies). 
 Quantitative RT-PCR was performed using 2X SsoAdvanced™ Universal 
SYBR® Green Supermix (Bio Rad). The reaction mixture was prepared as follow: 5 µl of 
primers 280 nM (forward and reverse primers), 5 µl of diluted cDNA (1:100 to 1:500) 
and 10 µl of 2X SYBR Green ROX Mix. Quantification of the cDNA was performed using 
an Applied Biosystems 7900HT systems. The qRT-PCR condition was as follow: 95ºC 
for 15min, then 50 cycles of 95ºC for 10 seconds, 60ºC for 30 seconds and 72ºC for 30 
seconds. Disassociation curve cycle was added at the end to ensure one product was 
amplified. Primers used for qRT-PCR are provided in (Table 2.3). 
Data analysis for intron retention 
 Relative gene expression was calculated using ΔΔCt method. To measure intron 
retention, primers were designed to amplify exon-exon products (processed transcripts) 
and exon-intron products (unprocessed transcripts). Enrichment from each primer set 
was normalized to primers amplify GAPDH as ΔCT. Each normalized value was then 
normalized to primer product that amplify exon 1 to control for change in gene 
expression between control and BPTF KO cells as ΔΔCT. The relative abundance for 
each normalized product for processed and unprocessed transcripts was compared 
between control and BPTF KO mESCs. Statistical significant for the difference in the 
relative abundance between control and BPTF KO mESC was determined using the 
Student’s t-test. 
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Table 2.4: Primers used of qRT-PCR 
	  
A) Primers correspond to Figure 3.9 C processed transcripts 
B) Primers correspond to Figure 3.9 unprocessed transcript 
C)  Primers correspond to Figure 3.10 A 
A)#Primers#used#to#test#Ccnd1#processed#transcript#
## 5'#>#3'#
A#For# ATCTCCTTCTGCACGCACTT#
A#Rev# GCGTACCCTGACACCAATCT#
B#For# GATTGTGCCATCCATGCGGA#
B#Rev# GAAGACCTCCTCTTCGCACTT#
C#For# CATGAACTACCTGGACCGCTT#
C#Rev# TCGATGAAATCGTGGGGAGTC#
D#For# AGAGGCGGATGAGAACAAGC#
D#Rev# GCAGTCCGGGTCACACTTGA#
E#For# CCCCAACAACTTCCTCTCCT#
E#Rev# ACCAGCCTCTTCCTCCACTT#
F#For# GGCAAAAACCAGCATCTCTC#
F#Rev# CACAGCGGTAGGGATGAAAT#
B)#Primers#used#to#test#Ccnd1#unprocessed#transcript#
## 5'#>#3'#
A#For# ATCTCCTTCTGCACGCACTT#
A#Rev# GCGTACCCTGACACCAATCT#
B#For# TCAGCATCTTTCCATTCACG#
B#Rev# TGGAATACAGGTGGGGGTAA#
C#For# CCCCAACAACTTCCTCTCCT#
C#Rev# ACTCTGGGAAGAAGCTCGTG#
D#For# GAGCTGAGAGGTGCCAAATC#
D#Rev# CAGGAGCCCCAGACACTTAG#
E#For# AGGGCTTCAATCTGTTCCTG#
E#Rev# GAGTTTCCTCAAGCCTTGCTC#
F#For# GGCAAAAACCAGCATCTCTC#
F#Rev# CACAGCGGTAGGGATGAAAT#
C)#Primers#used#to#test#processed#and#unporcessed#transcripts#for#a#four#
BPTFAdependent#genes#
## 5'#>#3'#
GAPDH#For# #TGGCAAAGTGGAGATTGTTGCC#
GAPDH#Rev# #AAGATGGTGATGGGCTTCCCG#
Gldc#Exon2#For# ATCCAGAATTCTCCAGTAAGTTCC#
Gldc#Exon2#Rev# TCGAGACTCTGCATGCCATTG#
Gldc#E24#A#E25#For# TCGATCCGGGCAATGGTTG#
Gldc#E24#A#E25#Rev# AGAGGTAGCAGCATTTCCACT#
Gldc#E24#A#I#24#For# GGAACCTCAGGGGCAACAGG#
Gldc#E24#A#I#24#Rev# CGTATTCTAGAGAGGTAGCAGCATT#
Scd2#Exon2#For# GCAGATGTTCGCCCTGAACTA#
Scd2#Exon2#Rev## AGTGTGATCCCGTACAAGGC#
Scd2#E5#A#E6#For# TTAGCTCTCGGGAGAACATCTTG#
Scd2#E5#AE6#Rev# AACGTGGTGAAGTTGATGTGC#
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2.15 Integrating Reporter Assay 
pNI-P-MCS vector containing Neomycin resistant gene (Neo) as a reporter gene 
was obtained from (Qiu, et al. 2015). To test whether the Ccnd1 promoter is BPTF 
dependent, the 3.2kb of promoter region of Ccnd1 was amplified from mouse genomic 
DNA with Phusion polymerase (New England Biolabs) using the following primers; For 
5’ GGGGTACCTGCCTGGCCACGGGTGGCTCACC 3’ and Rev 5’ 
GGGGCGGCCGCAGTCTGTAGCTCTCTGCTACTGC 3’. The amplified fragment was 
cloned upstream of the Neo gene. Next, the plasmid was linearized with Sca I as it has 
a single restriction enzyme site in the pNI-P-MSC plasmid and phenol:chloroform: 
isoamyl alchol extracted. Four ug of the purified linearized plasmids (either pNI-P-MCS-
Ccnd1 or pNI-MCS control) were then transfected into 1-2 X 106 control and BPTF KO 
mESC using Lipofectamin 2000 (Life Technologies) following the manufactures protocol 
in 6 well plates. 48- h post-transfection, selection for Neomycin resistant colonies 
started with incubating the transfected cells with ESC media containing 300 µg/ml of 
geneticin (Life technologies). Following 3 week of selection, plates were stained with 
staining solution (0.1% methylene blue, 50% methanol) and destined with water. Then, 
the number of colonies was counted from control and BPTF KO mESC. Expression is 
shown as the ratio of pNI-P-MCS colonies / pNI-MCS. 
 
2.16 THOC4 KD in mESC 
 In order to generate stable THOC4 KD mESC line, the Retro-X™ system 
(Clonetech) and the retroviral expression vector murine stem cell virus (pMSCV) puro-
vector (Clonetech) were used. Short hairpin RNA (shRNA) were designed to target the 
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sequence at THOC4 (NM_011568) 256-274 (AGCAGACCGAAACAACTTC). Two 
complementary oligonucleotides (top strand and bottom strand) were designed to create 
shRNA using Sequence Selector tool from Clontech (Figure 2.2). The top strand 
oligonucleotides and bottom strands oligonucleotides were diluted were mixed as 1:1 
dilution to give double strand oligonucleotides. The ds oligos were cloned into pMSCV 
vector at BglI and EcoRI sites, and transfected into E. Coli GC10 super competent cells 
and plated into LB agar with 100 µg/ml ampicillin. Ampicillin resistant colonies were 
selected and analyzed with diagnostic restriction digest and right clones were 
sequenced to verify the sequence. Next, pMSCV constructs with shRNA targeting 
THOC4 and Puromycin resistant gene were transfected into packaging cell lines PT67 
(Cat. No. 631510) to create virus particles.  2-3 days following transfection, media that 
contain the virus particles were collected and filtered and added to mESC plated in 10 
cm plate. mESC were incubated with the virus for 3 days and then the media was 
replaced with a new media contains Puromycin (1 µg/ml) for selection of cells that 
integrated the viral genome. Stable clones were maintained in ESC media with 1 µg/ml 
of Puromycin. The efficiency of THOC4 KD was test by protein extraction and Western 
blotting as described in section (2.13). In parallel to shRNA specific to THOC4 target 
sequence, a shRNA targeting a non-specific sequence was used as a control (5’-
GTGCGTTGCTAGTACCAACTT-TCAAGAG-3’). 
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Figure 2.2: A cartoon showing the shRNA sequence specific to THOC4 
 
	  
	  
 
 
 
 
  
Figure 2.2 
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CHAPTER THREE 
 
 
NURF Localizes and Regulates Chromatin Structure within Genes, Interacts with 
THOC4 and Regulate Messenger RNA Processing 
 
3.1 Introduction 
The packaging of genomic DNA in chromatin reduces the accessibility to the 
DNA template, and affects nuclear processes such as gene transcription. Transcription 
initiation requires open chromatin confirmation at promoters and transcription start sites 
to recruit activators and pre-initiation complexes. Active elongation of RNA-pol 2 
through gene body requires nucleosomes disassembly and re-assembly to ensure 
efficient elongation and normal mRNA processing (Studitsky, et al. 2004). Thus, factors 
that regulate chromatin structure can have impacts on gene expression. 
Major regulators of chromatin structure are ATP-dependent chromatin 
remodeling complexes. These are multi-subunits complexes that are grouped into four 
families based on the ATPase subunit, SWI/SNF, ISWI, CHD and INO80. They are 
recruited to chromatin through histone modifications or DNA-binding proteins. Once 
recruited these complexes utilize ATP energy to provide accessibility to DNA through 
either slide, remove nucleosomes or change histone variants (Clapier and Cairns 2009). 
Members from each of these families are known to localize and regulate RNA-pol 2 
transcription initiation. In contrast to initiation, to date only members of CHD and 
SWI/SNF are involved in regulating RNA-pol 2 elongation and mRNA splicing (Sims III, 
et al. 2007) (Batsche, Yaniv and Muchardt 2006). However, studies in yeast showed 
that a member of ISWI family directly recruited to gene bodies and regulate RNA-pol 2 
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elongation (Smolle, et al. 2012). Whether this is a conserved function of ISWI family in 
mammals is unknown yet.  
One of the ISWI family members in mammal is NURF complex. NURF is 
essential for embryonic development, and normal differentiation of mESC but not 
viability (Landry , Sharov , et al. 2008). Work from Drosophila and mouse models and 
human cell lines show that NURF function as a regulator of gene expression 
(Badenhorst, Voas, et al. 2002) (Barak, Lazzaro and Lane, et al. 2003) (Landry, et al. 
2011) (Qiu, et al. 2015).  
The full extent to how NURF regulates gene expression is not known. It is known 
that NURF is recruited to promoters through interactions between the C-terminal PHD 
and Bromodomain of its specific subunit BPTF however whether this localization to 
promoter regions is a general feature of mammalian NURF is unknown.  
Genome wide investigation for protein localization using ChIP-Seq and changes 
in chromatin structure using FAIRE-Seq or DNase I-Seq has been widely used to study 
chromatin-associated proteins. Projects such as the Encyclopedia of DNA Elements 
(ENCODE) has successfully used such approaches to map PTMs on histone proteins, 
RNA-pol 2 and DNA binding proteins such as CTCF and identify regulatory elements in 
the genome in many of human tissues and mouse tissues (Rosenbloom, et al. 2013). In 
addition, ChIP-Seq has been used to map binding sites for ATP-dependent chromatin 
remodeling complexes and revealed valuable information on how such complexes 
function in the genome. For example, ChIP-Seq analysis for BRG1 and CHD7 
chromatin remodeling factors showed their localization at distal regulatory elements in 
mESC (Schnetz, et al. 2010) (L. Ho, J. L. Ronan, et al. 2009). In addition, mapping the 
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ISWI homolog in yeast advance our understanding for their role in regulating gene 
expression through upstream, downstream and within genes (Yen, et al. 2012) (Smolle, 
et al. 2012).  
In this work we wanted to explore how NURF, an ISWI containing complex, is 
involved in regulating gene expression using genome wide approaches. Studying the 
role of NURF in vivo is achieved by targeting its unique and specific subunit BPTF 
(Xiao, Sandaltzopoulos, et al. 2001) (Barak, Lazzaro and Lane, et al. 2003). We 
investigated the localization of NURF specific subunit BPTF using ChIP-Seq and BPTF 
dependent changes in chromatin structure using FAIRE-Seq. We also aimed to identify 
a novel mechanism for NURF recruitment to the genome. Our analyses show that BPTF 
localization in the genome and changes in chromatin structure are broadly localized in 
the genome with preferences to TSSs, gene bodies and downstream of genes. 
Biochemical investigations show that the N-terminal PHD of BPTF physically interacts 
with the RNA-pol 2 associated protein THOC4, which suggests a recruiting mechanism 
to intragenic regions. Further, investigating the role of BPTF within the BPTF-dependent 
gene Ccnd1 shows that BPTF is required for normal mRNA processing. BPTF KO 
induces intron retention in the Ccnd1 transcript, which results in an unstable transcript. 
Further analysis discovers that an additional subset of BPTF-dependent genes have 
defects in intron retention suggesting that this mechanism occurs more broadly across 
the genome. 
Collectively, our data suggest a model in which BPTF is recruited to gene bodies 
through THOC4 and once recruited, it is required for normal mRNA processing. This 
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work proposes a novel function of NURF independent from transcription initiation in 
vivo. 
 
3.2 Generation and Characterization of BPTF ChIP-Grade Antibody 
To map NURF localization in the mouse genome, we targeted its unique and 
essential subunit BPTF (Xiao, Sandaltzopoulos, et al. 2001) (Barak, Lazzaro and Lane, 
et al. 2003). Identifying BPTF localization using ChIP-seq was challenging due to 
lacking a specific ChIP-grade antibody. To solve this problem, we tested two custom 
rabbit polyclonal antisera, a previously published BPTF-1 antibody targeting an N-
terminal epitope (Landry, Sharov, et al. 2008) and a novel BPTF-2 targeting a C-
terminal epitope of mouse (Figure 3.1.A).  
Western blot analysis shows that both purified antibodies recognize a protein 
with a size equivalent of BPTF in total protein extract from control, but not Bptf KO 
mESCs, which indicates a specificity to BPTF protein (Figure 3.1.B). To test whether 
these antibodies can be used to pull-down BPTF bound chromatin, BPTF binding sites 
from previous studies (Qiu, et al. 2015) (Landry, et al. 2011) were tested using ChIP-
qPCR. BPTF-2 shows better efficiency in ChIP comparing to BPTF-1 and IgG control 
(Figure 3.1.C). To further confirm BPTF-2 performance, we did ChIP-Seq using BPTF-1, 
BPTF-2 and IgG control. The total number of mapped DNA fragments were more using 
BPTF-2 than using BPTF-1 or IgG (Figure 3.1.D). These suggest that BPTF-2 antibody 
specifically recognizes BPTF and can be used for ChIP-Seq experiment. 
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3.3 BPTF Broadly Localizes to the Genome, and Enriched at Sites of Proteins 
Known to Interact with NURF 
 Using our custom BPTF-2 antibody, we mapped BPTF and by extension the 
NURF complex localization to the mouse genome using ChIP-Seq. Two biological BPTF 
ChIP-Seq replicates and total genomic DNA, as an input control, were sequenced in the 
nucleic acid research facility (NARF) at Virginia Commonwealth University. High quality 
reads (see method section 2.7) were mapped to the mouse genome with masked 
repetitive element using Bowtie2 software (Langmead and Salzberg 2012) (Figure3.2.A). 
To measure the reproducibility between the two replicates, the deeptools package 
(Ramírez, et al. 2014) was used to calculate the Pearson Correlation Coefficient 
between the mapped reads of the two replicates as well as the input. This analysis 
shows good reproducibility between the two replicates (r=0.89) (Figure 3.2.B). Next, 
examining the ChIP-Seq signal over the genome using the integrative genome viewer 
(IGV) (Robinson, et al. 2011) indicates a broad BPTF localization through the genome 
(Figure 3.2.C). This localization pattern is different than the other chromatin remodeling 
complexes BRG1, CHD7, CHD4 and INO80 in mESCs (Figure 3.2.C). Moreover, to test 
whether this is a genome wide observation, we used deeptools package with the default 
parameters to calculate reads enrichments from each remodelers over 500,000 bins of 
the mouse genome with 500bp bin size. In the signal extraction scaling (SES) plot (Diaz, 
et al. 2012), the H3K4me3 and H3K27me3 were used as examples for narrow and broad 
peaks, respectively. H3K4me3 localization is very narrow and highly enriched at its 
binding sites, while H3K27me3 localization is very broad and less enriched at its binding 
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sites (Figure 3.2.D). The SES plot shows that BPTF has broader localization pattern 
compared to other remodelers, which have narrower enrichment (Figure 3.2.D). These 
suggest that a broad localization pattern of BPTF is likely a feature of ISWI containing 
complexes. 
 To determine regions of enrichment, we next used SICER (Zang , et al. 2009), a 
peak calling software used to identify broad peaks, to call for significantly enriched 
regions for BPTF compared to an input control. SICER identified 54,247 BPTF binding 
sites with false discovery rate (FDR) 0.001. Representative sites were validated using 
ChIP-qPCR (Figure 3.2.E). At these sites high enrichment of BPTF signal over the input 
signal was detected (Figure 3.2.F). Also, high enrichment of BPTF signal was detected 
over sties co-occupied by H3K4me3, H4K16ac, CTCF and cohesin, which are known to 
physically interact with NURF complex (Figure 3.2.G). This enrichment of BPTF over the 
sites of these factors indicates that they can recruit BPTF and the NURF complex to 
chromatin. The results from the ChIP-qPCR and the overlap with known NURF 
interacting factors suggest that the enrichment that we obtained from our ChIP-Seq 
experiments is specific to BPTF. 
 Collectively, these data are consistent with a previously suggested model for ISWI 
proteins where they continually sample the chromatin with short resident time, and more 
resident time at sites that occupied by a recruiter like the histone modifications 
H3K4me3, H4K16ac, CTCF or cohesin (Erdel and Rippe 2012). 
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3.4 BPTF Localization Is Correlated with BPTF Dependent Genes  
Previous work from our lab documents NURF complex as a regulator of gene 
expression in mESC (Qiu, et al. 2015). In order to investigate the correlation between 
NURF complex and gene expression, we examined BPTF localization from our ChIP-
Seq relative to BPTF-dependent genes from mESC, which were previously identified 
(Landry , Sharov , et al. 2008). In this analysis we looked for genes that have a BPTF 
peak within TSS and transcription terminator site (TTS) of Refseq genes, and then 
asked how many of these genes are BPTF dependent in their expression in mESC. A 
Venn diagram shows a significant correlation between BPTF peaks and BPTF-
dependent genes (pValue= 5.8X10E-9) (Figure 3.3.A). Similar analysis for other 
chromatin remodeling complexes shows that the correlation obtained for BPTF is 
equivalent to INO80 (pValue=1.5X10E-7), but not as significant as CHD7 and BRG1 
(pValue=1.5X10E-59, pValue=9.1E-188, respectively) (Figure 3.3.A). 
Next, previous genome wide studies identified set of enhancers in mESC (Hnisz, 
et al. 2013). To test whether BPTF localizes with these enhancers we performed similar 
co-localization analysis as performed to BPTF-dependent genes. This analysis shows 
that BPTF peaks do not have preferences over enhancers (pValue=1), while the other 
remodelers strongly overlap with these elements as previously reported (pValue< 9.2E-
320 for BRG1, CHD7 and INO80) (Figure 3.3.B) (L. Ho, J. L. Ronan, et al. 2009) 
(Schnetz, et al. 2010). Together these data suggest that BPTF and by extension NURF 
mainly localize within genes, and not significantly bind to distal regulatory elements at 
least in mESC.  
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3.5 BPTF Localization Enriched at TSSs, Gene Bodies and 3’End of Genes 
To better understand how BPTF functions at genes, we investigated BPTF 
localization over a 3kb of meta-gene. As expected, we observed high BPTF signal at 
promoters, transcription start sites and 5’UTRs similar to other chromatin remodelers 
(Figure 3.4.A). Interestingly, BPTF signal was high throughout gene bodies and higher 
at the 3’end of genes. The observed pattern of BPTF signal over the 3kb of meta-gene 
resembles a pattern of factors associated with active elongation such as H3K36me3 
(Shen , et al. 2012), RNA-pol 2 p-Ser2 and CTR9 (Rahl, et al. 2010) (Figure 3.4.B). To 
test whether BPTF signal is associated with active genes in mESC, we utilized a 
previously published RNA-Seq data for mESC (Shen , et al. 2012). Similar meta-gene 
analysis shows that BPTF signal is high at actively transcribed genes especially at 
TSSs and 3’end of genes (Figure 3.4.C). Next, we wanted to look for the distribution of 
BPTF peaks identified by SICER as a significant enrichment of BPTF over input control. 
To this end, we mapped BPTF binding sites identified by SICER to genomic annotations 
using the cis-regulatory element annotation system (CEAS) (Shin, et al. 2009). This 
analysis shows significant localization of BPTF ChIP-Seq peaks over gene features. 
(Figure 3.4.D). Comparing to other remodelers, BPTF peaks are more frequent at 
coding regions, introns and 3’UTR regions than upstream regions (Figure 3.4.D). 
Together, these results show that BPTF localizes at intragenic regions and is more 
enriched at coding regions and 3’end of genes than at promoters. These results suggest 
that NURF predominantly localizes to gene bodies with minimal localization to 
promoters. 
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3.6 BPTF Maintains Open Chromatin Structure at Upstream, Introns and 
Downstream of Genes 
NURF is an ATP-dependent chromatin-remodeling complex that promotes 
accessibility to underling DNA sequence (Tsukiyama and Carl 1995) (Barak, Lazzaro 
and Lane, et al. 2003). To investigate whether the observed pattern of BPTF localization 
in genes is accompanied by remodeling activity of NURF, we decided to map NURF 
dependent changes in chromatin structure in the genome. To this end, we investigated 
open chromatin structure in control and BPTF KO mESCs (Landry , et al. 2008) using 
the technique of formaldehyde assistance isolation of regulatory elements followed by 
high throughput sequencing (FAIRE-Seq). In FAIRE-Seq, the chromatin is fixed by 
formaldehyde, sheared with sonication and subjected to phenol-chloroform extraction. 
DNA fragments that are not bound by nucleosomes are enriched in the aqueous phase, 
which is subsequently purified and subjected to high throughput sequencing (Simon, et 
al. 2012) (Figure 3.5.A). 
Two biological replicates from control and BPTF KO mESCs were sequenced 
along with total genomic DNA as an input control. Mapping the FAIRE-Seq profile to 
mouse genome with masked repetitive elements revealed 24-33% of reads were 
uniquely mapped (Figure 3.5.B). High Pearson Correlation Coefficient calculated using 
deeptools package (Ramírez, et al. 2014) between the two control replicates and BPTF 
KO replicates indicates good reproducibility (Figure 3.5.C). We also compared our 
FAIRE-Seq profile from control cells to a recently published FAIRE-Seq profile from 
mESCs (Murtha, et al. 2014) and found high correlation, which suggest that our data is 
of high quality (Figure 3.5.C). 
	  
	   115	  
Screening through the FAIRE-Seq profiles using IGV identified regions that are 
enriched in control but not BPTF KO FAIRE-Seq indicating that NURF is required to 
maintain open chromatin regions at these sites and our approach can be used to 
identify those regions (Figure 3.5.D, red highlights). Next, we used Diffreps software 
(Shen, et al. 2013) to identify those differently enriched regions between the control and 
BPTF KO mESC replicates with pValue< 0.001. Differeps identified 56,800 differentially 
enriched regions with 27,864 regions enriched in control cells that require NURF to 
maintain open chromatin structure in control cells (we called those open regions) and 
28,936 regions enriched in Bptf KO cells that require NURF to maintain closed 
chromatin structure in control cells (we called those closed regions) (Figure 3.5.E). 
Validation of a representative number of FAIRE sites was performed by FAIRE-qPCR 
(Figure 3.5.F). Next, we did correlation analysis between BPTF dependent changes in 
chromatin structure identified by FAIRE-Seq (here after BPTF-dependent FAIRE sites) 
and BPTF-dependent genes in mESC, similar to figure 3.3.A. This analysis shows 
significant co-localization of BPTF-dependent FAIRE sites within BPTF dependent 
genes (pValue=4.43E-5) (Figure 3.5.G, right). Similar analysis was performed for BPTF-
dependent FAIRE over enhancer in mESC. This analysis shows a significant overlap 
over enhancer (pValue=1.0E-28) suggesting that BPTF and by extension NURF is 
required for regulating chromatin structure at distal regulatory elements (Figure 3.5.G, 
left) in mESC. 
To investigate whether BPTF-dependent FAIRE sites are enriched over genes, 
we mapped the identified open and closed regions over genomic annotations using 
CEAS software (Shin, et al. 2009). In contrast to closed FAIRE sites, open FAIRE sites 
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showed significant enrichment in 1kb upstream, 5’UTR, introns, 3’UTR and 1kb 
downstream of genes (Figure 3.5.H). This suggests that within genes, BPTF and NURF 
complex maintain open chromatin structure. To investigate whether BPTF is localized 
over BPTF-dependent FAIRE, we measured BPTF ChIP-Seq signal over TSSs, TTSs of 
genes and enhancers that have BPTF-dependent FAIRE sites. These analyses show 
BPTF enrichment at TTS of genes and enhancers that have BPTF-dependent FAIRE 
sites (Figure 3.5.I, J). Together, these results show broad localization of BPTF-
dependent changes in chromatin structure, and within genes it mostly maintain open 
chromatin regions at upstream, introns and downstream regions of genes.  
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3.7 BPTF Localization and Remodeling Activity Overlap with Factors Localize in 
Promoters, Gene Bodies and Downstream of Genes 
Recruitment of BPTF at promoter regions can be explained by interaction with 
H3K4me3 and H4K16ac. However, our finding from ChIP-Seq and FAIRE-Seq analyses 
showed that BPTF localizes at gene bodies and 3’end of genes suggesting novel 
recruiting mechanisms for BPTF at these regions. In attempt to identify such 
mechanisms, we screened for overlap between BPTF ChIP-Seq peaks and BPTF-
dependent FAIRE sites (chromatin remodeling activity) over a panel of histone 
modifications and DBPs using previously published ChIP-Seq data from mESCs (Table 
2.3). Toward this end, we collaborated with Dr. Mikhail Dozmorove (Department of 
Biostatistics, VCU) to use Genome Runner (GR), a previously published tool that can be 
used to measures significant overlaps between ChIP-Seq data set (Dozmorov, et al. 
2011). As expected, we observed significant overlap between BPTF peaks (All BPTF 
peaks from ChIP-Seq) and H3K4me4, H4K16ac, CTCF and cohesin (Smc1) peaks 
(Figure 3.6.A) (Table 3.1). We also detect overlap with factors known to localize at 
promoter regions such as H3K9ac, H3K27ac, NelfA, a negative elongating factor, 
Mediators (Med1 Med12), RNA-pol 2 p-Ser5 and DPY30, a H3K4me3 associated 
protein (Figure 3.6.A). In addition we detected overlap with factors associated with gene 
bodies such as H3K36me3, CDK9, a subunit of the positive elongation factor P-TEFb, 
the H3K36me3 interacting protein MRG15 (Xie, et al. 2011), and the PAF1 subunit 
CTR9. Also, we detected overlap with histone variants H2A.Z, H2A.Zac, H3.3 and the 
H3K4me1 (Figure 3.6.A). The H3.3 and H2A.Z are histone variants, and nucleosomes 
with these variants are less stable compered to canonical histone. H2A.Z is enriched in 
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promoters, enhancer regions and CTCF binding sites (Hu, et al. 2013) (Fu, et al. 2008), 
and maintain low nucleosome occupancy at these regions (Hu, et al. 2013). Also, its 
level at promoters is correlated with gene expression (Barski, et al. 2007). H3.3 is also 
found in TSS, gene bodies and distal regulatory elements, and its incorporation into 
nucleosomes decreases nucleosome stability (Jin and Felsenfeld 2007) and prevents 
incorporation of linker histone. Thus, the observed overlap of BPTF peaks with these 
variants indicates that BPTF localizes over regions with less stable nucleosomes such 
as regulatory element, TSSs and CTCF binding sites. The overlap with H2A.Z agrees 
with a previous finding that H2A.Z interact with BPTF in vivo (Kim, et al. 2013). 
We repeated the GR analysis for BPTF-dependent FAIRE sites. We found that 
BPTF-dependent FAIRE sites overlapped with known BPTF recruiters (H3K4me3, 
H4K16ac, CTCF and cohesin (Smc1 and Smc3), the promoter-associated factors 
H3K9ac, H3K27ac and DPY30, and the elongation factors H3K36me3 and CDK9. Also, 
overlap with H2A.Z, H2A.Zac, H3.3 turnover and H3K4me1 was detected (Figure 3.6.B) 
(Table 3.2). 
 The observed overlap between BPTF peaks and BPTF-dependent FAIRE with 
DPY30 was interesting because previous work suggest the DPY30 is a potential subunit 
of NURF. However, we found that the majority (93%) of DPY30 peaks that overlap with 
BPTF are overlap with H3K4me3. This suggests that DPY30 is associated with BPTF 
through H3K4me3 (Figure 3.6.C).  
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Factor Observed Expected Diff p3val Obs/Tot
NelfA 1575 53 OVER 0.00E+00 0.03
H4K16ac 9824 584 OVER 0.00E+00 0.18
Lsd1 2044 143 OVER 0.00E+00 0.04
Tet1 2781 134 OVER 0.00E+00 0.05
H3K4me1 6288 538 OVER 0.00E+00 0.12
H3K4me3 2669 180 OVER 0.00E+00 0.05
H3K9ac 2798 171 OVER 0.00E+00 0.05
H3K27ac 2231 183 OVER 0.00E+00 0.04
H3K36me3 7841 172 OVER 0.00E+00 0.14
Cdk9 2745 274 OVER 0.00E+00 0.05
H2A.Z 4931 327 OVER 0.00E+00 0.09
H2A.Zac 2006 141 OVER 0.00E+00 0.04
H3.3CTurnCOverCSites 8863 389 OVER 0.00E+00 0.16
RNAJPolCIICChIAJPETCLoopCEnds 1894 64 OVER 0.00E+00 0.03
Smc1CChIAJPETCLoopCEnds 1883 191 OVER 5.56EJ308 0.03
Rbbp5 1511 56 OVER 4.64EJ300 0.03
Dpy30 1605 108 OVER 5.04EJ291 0.03
Ctcf 2051 327 OVER 7.28EJ280 0.04
p300 1410 61 OVER 1.06EJ274 0.03
RNAJPolCIICSer5p 1244 33 OVER 1.06EJ254 0.02
Med1 1336 75 OVER 2.72EJ250 0.02
Ctr9 1128 17 OVER 6.30EJ239 0.02
Tbp 1170 34 OVER 1.06EJ237 0.02
Ringb1 1345 104 OVER 2.91EJ236 0.02
Med12 1329 98 OVER 5.24EJ236 0.02
Smc1 1628 239 OVER 1.16EJ230 0.03
Merg15 1060 10 OVER 2.64EJ228 0.02
Yy1 1379 135 OVER 1.97EJ227 0.03
Spt5 944 18 OVER 1.38EJ197 0.02
RNAJPolCII 1042 76 OVER 2.02EJ185 0.02
E2f1 940 43 OVER 1.20EJ181 0.02
Wdr5 890 25 OVER 2.32EJ181 0.02
Capd3 837 29 OVER 2.75EJ167 0.02
Esrrb 851 53 OVER 1.68EJ156 0.02
Klf4 762 28 OVER 2.04EJ151 0.01
Nipbl 805 49 OVER 1.02EJ148 0.01
Zfx 715 19 OVER 1.60EJ146 0.01
Smc3 1197 241 OVER 4.29EJ142 0.02
Hdac1 765 47 OVER 3.94EJ141 0.01
Tcfcp2l1 929 123 OVER 1.25EJ137 0.02
RNAJPolCIICSer2p 629 13 OVER 2.54EJ131 0.01
Cbp 787 83 OVER 6.59EJ127 0.01
nJMyc 585 16 OVER 8.03EJ120 0.01
Rest 671 49 OVER 1.18EJ119 0.01
Hdac2 670 64 OVER 1.47EJ111 0.01
H3K27me3 786 171 OVER 1.04EJ88 0.01
EnhancerJPromoterCSmc1CChIAJPETCCLoopCEnds 430 15 OVER 1.66EJ86 0.01
MBD3 461 48 OVER 3.36EJ75 0.01
Setdb1 356 12 OVER 3.82EJ72 0.01
Ell2 328 18 OVER 1.49EJ62 0.01
CtcfCChIAJPETCCLoopCEnds 370 35 OVER 1.91EJ62 0.01
cJMyc 282 5 OVER 3.01EJ60 0.01
Aff4 322 20 OVER 3.94EJ60 0.01
Suz12 298 28 OVER 1.05EJ50 0.01
Caph2 206 20 OVER 3.13EJ35 0
COct4 417 144 OVER 6.89EJ31 0.01
H3K9me3 1275 837 OVER 6.28EJ22 0.02
Stat3 90 9 OVER 3.81EJ16 0
Ell3 134 34 OVER 1.15EJ14 0
Kap1 267 119 OVER 4.47EJ14 0
Utx 112 25 OVER 1.03EJ13 0
Atrx 68 5 OVER 1.63EJ13 0
Nanog 336 198 OVER 2.14EJ09 0.01
Brdm4 57 9 OVER 3.42EJ09 0
CoRest 88 26 OVER 6.25EJ09 0
Sox2 312 188 OVER 2.72EJ08 0.01
Tbx3 40 13 OVER 2.08EJ04 0
Nr5a2 103 66 OVER 4.39EJ03 0
Smad1 12 5 no 8.95EJ02 0
BPTF9ChIP3Seq9all9peaks99
Table 3.1: Results from co-localization analysis for BPTF ChIP-Seq 
peaks 
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Factor Observed Expected Diff p3val Obs/Tot
Smc1 1532 42.66667 OVER 0.00E+00 0.03
H4K16ac 5712 377.3333 OVER 0.00E+00 0.1
Tet1 1772 52.33333 OVER 0.00E+00 0.03
Ctcf 2047 195.3333 OVER 0.00E+00 0.04
H3K4me1 5684 325.6667 OVER 0.00E+00 0.1
H3K4me3 2546 95.66667 OVER 0.00E+00 0.04
H3K9ac 2741 81 OVER 0.00E+00 0.05
H3K27ac 2626 105 OVER 0.00E+00 0.05
H3K36me3 3444 107.3333 OVER 0.00E+00 0.06
Cdk9 2682 80 OVER 0.00E+00 0.05
H2A.Z 3422 215.6667 OVER 0.00E+00 0.06
H2A.Zac 2152 93 OVER 0.00E+00 0.04
Smc1@ChIACPET@Loop@Ends 2608 140.3333 OVER 0.00E+00 0.05
RNACPol@II@ChIACPET@Loop@Ends 1890 50 OVER 0.00E+00 0.03
Smc3 1426 43 OVER 8.02EC289 0.03
Dpy30 1271 38 OVER 1.69EC257 0.02
H3.3@Turn@Over@Sites 1295 118.6667 OVER 2.21EC217 0.02
p300 1049 23.66667 OVER 5.72EC217 0.02
Lsd1 921 29.33333 OVER 1.08EC185 0.02
Yy1 1049 82 OVER 1.26EC183 0.02
Med12 712 14.33333 OVER 6.70EC149 0.01
NelfA 685 14.66667 OVER 2.40EC142 0.01
Med1 668 11.66667 OVER 1.78EC140 0.01
EnhancerCPromoter@Smc1@ChIACPET@@Loop@Ends 612 9 OVER 4.71EC130 0.01
Capd3 562 9 OVER 4.48EC119 0.01
Aff4 520 9.666667 OVER 3.08EC109 0.01
Sox2 613 51.66667 OVER 1.55EC105 0.01
RNACPol@II@Ser5p 480 7.333333 OVER 2.41EC102 0.01
RNACPol@II 554 47.33333 OVER 1.64EC95 0.01
@Oct4 515 34 OVER 4.29EC94 0.01
Cbp 422 20 OVER 8.22EC82 0.01
Tbp 359 6 OVER 1.83EC76 0.01
Nanog 477 53.66667 OVER 1.32EC75 0.01
Ell2 355 9.666667 OVER 4.02EC73 0.01
Ctcf@ChIACPET@@Loop@Ends 368 22 OVER 5.89EC69 0.01
Rbbp5 369 25 OVER 1.64EC67 0.01
Nipbl 314 8 OVER 2.20EC65 0.01
Spt5 270 4.666667 OVER 1.29EC57 0
Ringb1 341 33 OVER 2.73EC57 0.01
Caph2 270 6 OVER 5.38EC57 0
Ell3 281 13.33333 OVER 3.30EC55 0
Utx 261 13 OVER 7.31EC51 0
Hdac2 252 11.66667 OVER 1.75EC49 0
Ctr9 234 6.666667 OVER 1.61EC48 0
Merg15 221 5.333333 OVER 6.67EC47 0
Mbd3 214 14 OVER 4.02EC40 0
Brdm4 150 3 OVER 1.30EC32 0
Suz12 163 8.333333 OVER 1.86EC32 0
E2f1 124 4.666667 OVER 1.03EC25 0
Hdac1 132 11 OVER 4.28EC24 0
RNACPol@II@Ser2p 108 2 OVER 4.91EC24 0
Klf4 107 2 OVER 8.13EC24 0
Tcfcp2l1 140 17.33333 OVER 8.94EC23 0
H3K27me3 219 64.33333 OVER 2.83EC20 0
CoRest 96 5.333333 OVER 1.32EC19 0
Wdr5 107 12.66667 OVER 9.04EC18 0
Setdb1 83 4.333333 OVER 2.39EC17 0
Rest 106 13.66667 OVER 4.36EC17 0
H3K9me3 325 573.6667 UNDER 7.58EC17 0.01
Esrrb 75 6.666667 OVER 5.82EC14 0
nCMyc 46 2.666667 OVER 8.04EC10 0
Zfx 39 1.333333 OVER 1.86EC09 0
cCMyc 31 0.333333 OVER 2.57EC08 0
Kap1 117 46 OVER 2.62EC08 0
Tbx3 27 3 OVER 1.17EC05 0
Stat3 23 2.333333 OVER 2.66EC05 0
Nr5a2 18 50.33333 UNDER 1.04EC04 0
Smad1 17 1.333333 OVER 1.62EC04 0
Atrx 26 4.666667 OVER 1.62EC04 0
BPTF9dependent9FAIRE3Seq9all9regions
Table 3.2: Results from co-localization analysis for BPTF 
dependent FAIRE sites 
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3.8 Novel Sites of BPTF Enrichment and Remodeling Activity Co-localizes with 
H3K36me3 and H3K4me1 and Significantly Associated with BPTF-Dependent 
Genes 
 Next, we set out to identify novel recruiting mechanisms of BPTF to the 
chromatin. BPTF is known to physically interact with H3K4me3, H4K16ac, CTCF and 
cohesin. To discover new NURF recruitment factors we filter out BPTF peaks that 
overlap with these factors. To this end we divided BPTF peaks into two groups. Group 
A, contains BPTF peaks that overlap with sites of H3K4me3, H4K16ac, CTCF or 
cohesin. Group B, contains all other BPTF peaks (Figure 3.7.A). Similar strategy was 
performed for BPTF-dependent FAIRE sites (Figure 3.7.B).  
 First, we investigated which group is more correlated with BPTF dependent 
genes in mESCs. For BPTF ChIP-Seq peaks, localization analysis showed that Group B 
is significantly correlated with BPTF dependent genes (pValue=1.54E-17) (Figure 3.7.A, 
Group B), but Group A is not (pValue=0.5) (Figure 3.7.A, Group A). For BPTF-
dependent FAIRE sites, similar analysis showed that Group B is significantly overlapped 
with BPTF dependent genes (pValue=5.6E-5) (Figure 3.7.B, Group B) but Group A is 
not (pValue=0.9) (Figure 3.7.B, Group A). These analyses suggest that BPTF 
recruitment by factors other than H3K4me3, H4K16ac, CTCF and cohesin are more 
correlated with BPTF-dependent genes.  
 To identify factors that could function with NURF to regulate gene expression, we 
repeated GR analysis using Group A and Group B for BPTF ChIP-Seq peaks and 
BPTF-dependent FAIRE sites. While Group A for both BPTF peaks and BPTF-
dependent sites overlapped with many factors similar to the entire data set, the Group B 
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peaks overlap with limited number of factors (Figure 3.7.C, D) (Table 3.3) (Table 3.5). 
The Group B for BPTF ChIP-Seq peaks enriched with H3K36me3, H3K4me1, H2A.Z, 
and H3.3 turnover (Figure 3.7.C) (Table 3.4). The group B for BPTF-dependent FAIRE 
sites also enriched with H3K36me3 and H3K4me1 (Figure 3.7.D) (Table 3.6). These 
results demonstrate that the sites more significantly correlated with BPTF-dependent 
genes are occupied by H3K36me3 and H3K4me1. These results suggest that these 
factors either directly or indirectly can recruit BPTF/NURF to the genome. 
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Table 3.3: Results from co-localization analysis for BPTF ChIP-Seq 
peaks Group A 
 Factor Observed Expected Diff p3val Obs/Tot
Smc1 1628 69 OVER 0.00E+00 0.14
H4K16ac 9824 134 OVER 0.00E+00 0.82
Dpy30 1539 23 OVER 0.00E+00 0.13
Lsd1 1823 34 OVER 0.00E+00 0.15
NelfA 1556 14 OVER 0.00E+00 0.13
p300 1390 12 OVER 0.00E+00 0.12
Rbbp5 1420 13 OVER 0.00E+00 0.12
Tet1 2536 29 OVER 0.00E+00 0.21
Ctcf 1606 75 OVER 0.00E+00 0.13
H3K27ac 1809 44 OVER 0.00E+00 0.15
H3K36me3 4902 44 OVER 0.00E+00 0.41
H3K4me1 3528 125 OVER 0.00E+00 0.3
H3K4me3 2669 40 OVER 0.00E+00 0.22
H3K9ac 2633 35 OVER 0.00E+00 0.22
Cdk9 2213 75 OVER 0.00E+00 0.19
H2A.Z 3253 73 OVER 0.00E+00 0.27
H2A.Zac 1914 34 OVER 0.00E+00 0.16
H3.3HTurnHOverHSites 4326 100 OVER 0.00E+00 0.36
RNANPolHIIHChIANPETHLoopHEnds 1560 17 OVER 0.00E+00 0.13
Smc1HChIANPETHLoopHEnds 1359 49 OVER 1.31EN283 0.11
RNANPolHIIHSer5p 1240 9 OVER 2.33EN280 0.1
Med1 1265 20 OVER 3.43EN279 0.11
Med12 1259 23 OVER 8.39EN276 0.11
Tbp 1164 11 OVER 9.55EN261 0.1
Yy1 1201 38 OVER 2.30EN252 0.1
Smc3 1193 59 OVER 1.05EN237 0.1
Ringb1 1078 25 OVER 3.46EN231 0.09
RNANPolHII 974 14 OVER 1.32EN213 0.08
E2f1 927 9 OVER 8.72EN206 0.08
Ctr9 910 5 OVER 2.04EN204 0.08
Spt5 890 4 OVER 2.20EN200 0.07
Wdr5 823 7 OVER 9.37EN183 0.07
Capd3 831 12 OVER 2.22EN181 0.07
Nipbl 784 13 OVER 8.18EN170 0.07
Klf4 723 8 OVER 6.60EN159 0.06
Zfx 698 4 OVER 9.69EN156 0.06
Hdac1 712 11 OVER 1.94EN154 0.06
Merg15 687 3 OVER 7.34EN154 0.06
nNMyc 582 2 OVER 2.00EN130 0.05
Tcfcp2l1 645 27 OVER 3.42EN129 0.05
Hdac2 610 15 OVER 1.64EN128 0.05
Esrrb 596 16 OVER 1.07EN124 0.05
Cbp 527 19 OVER 3.36EN107 0.04
RNANPolHIIHSer2p 476 1 OVER 5.69EN107 0.04
EnhancerNPromoterHSmc1HChIANPETHHLoopHEnds 372 3 OVER 3.28EN82 0.03
Ell2 320 5 OVER 2.78EN69 0.03
Aff4 311 3 OVER 1.52EN68 0.03
Rest 316 10 OVER 2.73EN65 0.03
cNMyc 278 1 OVER 1.80EN62 0.02
Suz12 270 8 OVER 2.83EN56 0.02
Mbd3 266 9 OVER 8.84EN55 0.02
Setdb1 235 5 OVER 2.39EN50 0.02
HOct4 309 36 OVER 1.36EN49 0.03
CtcfHChIANPETHHLoopHEnds 210 7 OVER 1.39EN43 0.02
H3K27me3 269 33 OVER 1.60EN42 0.02
Caph2 186 7 OVER 2.78EN38 0.02
Ell3 113 11 OVER 4.16EN20 0.01
Sox2 171 39 OVER 5.74EN20 0.01
Stat3 75 2 OVER 7.91EN17 0.01
Utx 78 8 OVER 3.97EN14 0.01
Nanog 135 42 OVER 2.28EN12 0.01
Brdm4 51 1 OVER 3.88EN12 0
CoRest 67 9 OVER 2.67EN11 0.01
Kap1 108 30 OVER 2.76EN11 0.01
H3K9me3 314 187 OVER 9.79EN09 0.03
Atrx 34 1 OVER 2.38EN08 0
Tbx3 19 2 OVER 2.06EN04 0
Smad1 10 1 OVER 6.64EN03 0
Nr5a2 33 19 no 5.19EN02 0
BPTF9ChIP3Seq9peaks9group9A
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  Table 3.4: Results from co-localization analysis for BPTF ChIP-Seq peaks Group B 
 Factor Observed Expected Diff p3val Obs/Tot
H3K36me3 2939 133 OVER 0.00E+00 0
H3K4me1 2760 407 OVER 0.00E+00 0.02
H3.33Turn3Over3Sites 4537 321 OVER 0.00E+00 0.11
H2A.Z 1678 270 OVER 1.57EA228 0.04
H4K16ac 0 456 UNDER 1.03EA101 0
Merg15 373 6 OVER 1.28EA79 0.01
Rest 355 33 OVER 2.46EA60 0
H3K27me3 517 127 OVER 1.08EA53 0
RNAAPol3II3ChIAAPET3Loop3Ends 334 50 OVER 8.31EA48 0.01
Smc1 0 192 UNDER 9.34EA44 0
Ctr9 218 13 OVER 1.43EA41 0.01
Smc13ChIAAPET3Loop3Ends 524 180 OVER 9.51EA39 0.01
Smc3 4 178 UNDER 3.87EA38 0
Esrrb 255 42 OVER 3.30EA35 0.01
H3K27ac 422 137 OVER 1.13EA33 0.07
Cdk9 532 217 OVER 6.48EA31 0
Cbp 260 61 OVER 9.14EA29 0.01
RNAAPol3II3Ser2p 153 11 OVER 1.27EA28 0
H3K4me3 0 120 UNDER 5.81EA28 0
Mbd3 195 32 OVER 2.40EA27 0
Tcfcp2l1 284 87 OVER 1.18EA24 0.01
Ctcf3ChIAAPET33Loop3Ends 160 22 OVER 1.31EA24 0
Setdb1 121 10 OVER 2.85EA22 0
Ringb1 267 86 OVER 4.74EA22 0
Tet1 245 87 OVER 3.67EA18 0.01
H3K9me3 961 638 OVER 3.49EA16 0.01
Ctcf 445 258 OVER 1.42EA12 0.07
Lsd1 221 114 OVER 4.69EA09 0.01
EnhancerAPromoter3Smc13ChIAAPET33Loop3Ends 58 12 OVER 3.79EA08 0
Kap1 159 82 OVER 6.80EA07 0
Atrx 34 4 OVER 1.13EA06 0
Yy1 178 99 OVER 1.99EA06 0
Spt5 54 15 OVER 2.64EA06 0
RNAAPol3II3Ser5p 4 29 UNDER 1.34EA05 0
p300 20 58 UNDER 1.67EA05 0
Rbbp5 91 42 OVER 2.12EA05 0
Wdr5 67 31 OVER 2.74EA04 0.03
NelfA 19 46 UNDER 8.07EA04 0
Nanog 201 142 OVER 1.41EA03 0
Tbp 6 22 UNDER 2.49EA03 0
H3K9ac 165 117 OVER 4.19EA03 0.01
Capd3 6 19 UNDER 9.31EA03 0
E2f1 13 30 UNDER 9.51EA03 0
Nipbl 21 41 no 1.11EA02 0
nAMyc 3 13 no 1.24EA02 0
Tbx3 21 8 no 1.58EA02 0
Hdac2 60 38 no 2.62EA02 0
Hdac1 53 33 no 3.09EA02 0
H2A.Zac 92 120 no 5.42EA02 0
Med1 71 51 no 7.00EA02 0
Suz12 28 16 no 7.04EA02 0
Utx 34 21 no 7.95EA02 0.01
Stat3 15 7 no 8.80EA02 0
Klf4 39 26 no 1.07EA01 0
Nr5a2 70 54 no 1.50EA01 0
RNAAPol3II 68 53 no 1.72EA01 0
Ell2 8 14 no 2.01EA01 0
Dpy30 66 79 no 2.80EA01 0
CoRest 21 25 no 5.55EA01 0
Zfx 17 14 no 5.90EA01 0
Brdm4 6 8 no 5.93EA01 0
Caph2 20 17 no 6.22EA01 0
3Oct4 108 115 no 6.39EA01 0
Smad1 2 3 no 6.55EA01 0
Ell3 21 24 no 6.55EA01 0
cAMyc 4 5 no 7.39EA01 0
Aff4 11 12 no 8.35EA01 0
Med12 70 72 no 8.67EA01 0
Sox2 141 143 no 9.05EA01 0
BPTF9ChIP3Seq9peaks9group9B
	  
	   135	  
  Table 3.5: Results from co-localization analysis for BPTF 
dependent FAIRE-Sites Group A 
 Factor Observed Expected Diff p3val Obs/Tot
Smc1 1532 7.666667 OVER 0.00E+00 0.19
Smc3 1417 5.333333 OVER 0.00E+00 0.17
H4K16ac 5707 52.66667 OVER 0.00E+00 0.7
Tet1 1629 6 OVER 0.00E+00 0.2
Ctcf 1617 32.33333 OVER 0.00E+00 0.2
H3K4me1 2845 48.66667 OVER 0.00E+00 0.35
H3K4me3 2544 8.666667 OVER 0.00E+00 0.31
H3K9ac 2506 13.66667 OVER 0.00E+00 0.31
H3K27ac 2108 12 OVER 0.00E+00 0.26
H3K36me3 1433 16 OVER 0.00E+00 0.18
H2A.Z 2355 26.33333 OVER 0.00E+00 0.29
H2A.Zac 1801 16 OVER 0.00E+00 0.22
Smc1>ChIAAPET>Loop>Ends 1998 18 OVER 0.00E+00 0.25
RNAAPol>II>ChIAAPET>Loop>Ends 1473 8.333333 OVER 0.00E+00 0.18
Cdk9 2343 14.33333 OVER 0.00E+00 0.29
Dpy30 1200 6.333333 OVER 1.04EA279 0.15
p300 1011 2.666667 OVER 1.88EA234 0.12
Yy1 904 9.666667 OVER 1.54EA203 0.11
Lsd1 761 3.333333 OVER 1.17EA173 0.09
NelfA 666 1.333333 OVER 2.15EA152 0.08
Med12 618 1 OVER 4.45EA141 0.08
Med1 602 0.666667 OVER 2.54EA137 0.07
H3.3>Turn>Over>Sites 628 18.33333 OVER 1.74EA132 0.08
Capd3 541 0.666667 OVER 4.56EA123 0.07
EnhancerAPromoter>Smc1>ChIAAPET>>Loop>Ends 514 2.666667 OVER 1.79EA115 0.06
RNAAPol>II>Ser5p 474 1.333333 OVER 1.55EA107 0.06
RNAAPol>II 489 7 OVER 4.34EA107 0.06
Aff4 477 3 OVER 6.54EA107 0.06
Sox2 405 9 OVER 1.58EA86 0.05
Tbp 352 0.333333 OVER 3.09EA80 0.04
Rbbp5 354 3 OVER 1.00EA78 0.04
>Oct4 354 6 OVER 8.40EA77 0.04
CBP 340 3.666667 OVER 6.73EA75 0.04
Ell2 321 1.333333 OVER 1.55EA72 0.04
Ringb1 300 5 OVER 3.33EA65 0.04
Nipbl 277 1 OVER 1.37EA62 0.03
Spt5 245 0.666667 OVER 2.20EA55 0.03
Nanog 263 9.666667 OVER 8.43EA54 0.03
Ctcf>ChIAAPET>>Loop>Ends 240 1.666667 OVER 1.30EA53 0.03
Caph2 230 0 OVER 1.13EA52 0.03
Ell3 217 0.666667 OVER 4.21EA49 0.03
Hdac2 193 2 OVER 4.38EA43 0.02
Ctr9 188 1.333333 OVER 1.30EA42 0.02
Utx 184 1 OVER 1.01EA41 0.02
Mbd3 168 1.333333 OVER 3.77EA38 0.02
E2f1 120 0.666667 OVER 1.81EA27 0.01
Suz12 116 1 OVER 1.40EA26 0.01
Brdm4 112 0.666667 OVER 1.08EA25 0.01
Merg15 108 1.333333 OVER 8.37EA25 0.01
Hdac1 104 1.333333 OVER 6.47EA24 0.01
Wdr5 100 0.333333 OVER 1.11EA23 0.01
Tcfcp2l1 97 1 OVER 2.31EA22 0.01
Klf4 84 0 OVER 3.97EA20 0.01
CoREST 84 0.666667 OVER 1.78EA19 0.01
RNAAPol>II>Ser2p 76 0.333333 OVER 2.37EA18 0.01
Setdb1 65 0.333333 OVER 6.56EA16 0.01
H3K27me3 90 10 OVER 1.02EA15 0.01
Rest 56 1.666667 OVER 1.22EA12 0.01
nAMyc 45 0.333333 OVER 1.85EA11 0.01
Esrrb 43 1.333333 OVER 2.29EA10 0.01
Zfx 37 0.333333 OVER 1.13EA09 0
cAMyc 31 0 OVER 2.50EA08 0
Kap1 46 6.333333 OVER 2.76EA08 0.01
STAT3 20 0 OVER 7.64EA06 0
Tbx3 16 0.333333 OVER 6.28EA05 0
Atrx 15 0.333333 OVER 1.07EA04 0
Smad1 14 0.333333 OVER 1.82EA04 0
H3K9me3 57 87.66667 UNDER 9.71EA03 0.01
Nr5a2 4 7 no 3.66EA01 0
BPTF9dependent9FAIRE3Seq9all9group9A9regions9
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Table 3.6: Results from co-localization analysis for BPTF 
dependent FAIRE-Sites Group B 
Factor Observed Expected Diff p3val Obs/Tot
H3K4me1 2839 276 OVER 0.00E+00 0.06
H3K36me3 2011 100.6667 OVER 0.00E+00 0.04
H2A.Z 1067 180.6667 OVER 1.38E6140 0.02
H3.37Turn7Over7Sites 667 98 OVER 9.08E695 0.01
H4K16ac 5 339 UNDER 9.46E673 0
Smc17ChIA6PET7Loop7Ends 610 126.6667 OVER 2.45E671 0.01
H3K27ac 518 87.33333 OVER 3.68E669 0.01
RNA6Pol7II7ChIA6PET7Loop7Ends 417 45.66667 OVER 6.32E667 0.01
H2A.Zac 351 68.66667 OVER 2.93E643 0.01
Cdk9 339 66.33333 OVER 4.36E642 0.01
Sox2 208 34.33333 OVER 4.12E629 0
Nanog 214 40.66667 OVER 2.04E627 0
Ctcf 430 172.6667 OVER 8.79E626 0.01
Lsd1 160 20 OVER 1.55E625 0
H3K9ac 235 65.33333 OVER 8.35E623 0
Merg15 113 5.666667 OVER 9.74E623 0
7Oct4 161 30 OVER 2.35E621 0
Ctcf7ChIA6PET77Loop7Ends 128 20.66667 OVER 1.75E618 0
Enhancer6Promoter7Smc17ChIA6PET77Loop7Ends 98 8.333333 OVER 2.20E618 0
H3K4me3 2 80.66667 UNDER 4.13E618 0
H3K9me3 268 497 UNDER 9.39E617 0.01
Med12 94 12.33333 OVER 1.60E615 0
Tet1 143 39.66667 OVER 2.51E614 0
Utx 77 10 OVER 6.65E613 0
Smc1 0 39.66667 UNDER 2.52E610 0
Ell3 64 9.666667 OVER 3.39E610 0
Med1 66 12.33333 OVER 9.55E610 0
Hdac2 59 8.666667 OVER 1.32E609 0
Cbp 82 21 OVER 1.81E609 0
Ctr9 46 4.666667 OVER 9.32E609 0
Yy1 145 63.33333 OVER 1.26E608 0
H3K27me3 129 53.33333 OVER 1.71E608 0
Suz12 47 7 OVER 5.19E608 0
Aff4 43 6.333333 OVER 1.24E607 0
Brdm4 38 4 OVER 1.54E607 0
Caph2 40 5.333333 OVER 1.80E607 0
Pol7II7Ser2p 32 2.666667 OVER 9.45E607 0
Mbd3 46 9.666667 OVER 1.49E606 0
Smc3 9 43.33333 UNDER 2.40E606 0
Ell2 34 4.666667 OVER 3.41E606 0
Klf4 23 1.333333 OVER 7.08E606 0
Nipbl 37 7.666667 OVER 1.53E605 0
Esrrb 32 6.333333 OVER 2.46E605 0
Rest 50 16.66667 OVER 5.51E605 0
Tcfcp2l1 43 14.33333 OVER 1.22E604 0
Spt5 25 5 OVER 2.60E604 0
Setdb1 18 2 OVER 3.46E604 0
Dpy30 71 38.33333 OVER 1.56E603 0
Hdac1 28 10.33333 OVER 3.49E603 0
Atrx 11 1.333333 OVER 3.89E603 0
Nr5a2 14 33.33333 UNDER 5.57E603 0
Kap1 71 42.66667 OVER 8.69E603 0
p300 38 19 no 1.18E602 0
Ringb1 41 22.66667 no 2.44E602 0
RNA6Pol7II 65 44.33333 no 4.42E602 0
Capd3 21 10 no 4.82E602 0
Tbx3 11 4 no 7.07E602 0
CoRest 12 5.333333 no 8.95E602 0
NelfA 19 10.33333 no 9.46E602 0
Smad1 3 0.666667 no 3.17E601 0
Stat3 3 1 no 3.17E601 0
Zfx 2 1 no 5.64E601 0
Tbp 7 5.333333 no 5.64E601 0
RNA6Pol7II7Ser5p 6 8 no 5.93E601 0
Wdr5 7 9 no 6.17E601 0
Rbbp5 15 15.66667 no 8.57E601 0
c6Myc 0 0.333333 no 1.00E+00 0
E2f1 4 3.666667 no 1.00E+00 0
n6Myc 1 0.666667 no 1.00E+00 0
BPTF9dependent9FAIRE3Seq9all9froup9B9regions9
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3.9 BPTF Directly Interacts with the RNA-pol 2 Associated Protein THOC4 
 Our findings from the genome wide studies showed that overlap with H3K36me3 
and H3K4me1, which suggest that these modifications could potential recruit BPTF to 
chromatin. BPTF has multiple functional domains that could interact with H3K4me1 and 
H3K36me3 (Alkhatib and Landry 2011). One of these domains is the PHD domain, 
which is known to interact with histones, modified histones and non-histone proteins 
(Musselman and Kutateladze 2011). BPTF has two conserved PHD domains (Figure 
3.8.A). Although the C-PHD domain specifically interacts with the H3K4me3 (Wysocka, 
Swigut, et al. 2006), it is possible that interaction with H3K4me1 or H3K36me3 can be 
mediated through an uncharacterized N-PHD domain. 
 In order to discover possible interactions between BPTF and these histone 
modifications, we performed in vitro co-immunoprecipitation using synthetic peptides for 
H3K36me3 and H3K4me1 to pull-down endogenous BPTF from P19 cells, an 
embryonic cancer cell line (McBurney 1993). As a positive control we used synthetic 
peptides for H3K4me3, and synthetic peptides for H3 N-terminal tail and H3 amino acid 
27-45 to guard for binding to unmodified H3. As expected we detected strong interaction 
with the positive control H3K4me3, but did not detect an interaction between BPTF and 
the K3K36me3 and K3K4me1 histone modifications (Figure 3.8.B). We concluded that 
under these conditions, BPTF dose not interacts with H3K36me3 or H3K4me1. As the 
N-PHD domain of BPTF has not been characterized, we speculate that it might interact 
with novel recruiter for BPTF. 
 A project conducted by Marissa Mack in Dr. Landry’s lab showed that the N-PHD 
does not interact with histone, DNA or RNA. However, unbiased screening using mass-
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spectrometry to identify novel factors associated with the N-PHD from total nuclear 
extract discovered an interaction with the THOC4 (also known as REF/Aly). THOC4 is a 
highly conserved protein that interacts with phosphorylated CTD of RNA-pol 2 
(MacKellar and Greenleaf 2011), interacts with mRNA through RNA-binding domain and 
localizes at gene bodies (Yoh, Lucas and Jones 2008) (Swinburne, et al. 2006). THOC4 
can play multiple roles in transcription (Stubbs and Conrad 2015) including mRNA 
processing (Yoh, Lucas and Jones 2008) mRNA export (Dufu, et al. 2010) (Stutz, et al. 
2000) (Cheng, et al. 2006) and transcription activation (Bruhn, Munnerlyn and 
Grosschedl 1997) (Suganuma, et al. 2005).  
In order to confirm this interaction, we did co-immunoprecipitation (Co-IP) 
analysis using mESCs nuclear extract. Co-IP using BPTF antibody detects 
immunoprecipitation of THOC4, and reciprocal Co-IP with THOC4 antibody detects 
immunoprecipitation of BPTF further supporting the in vivo interaction (Figure 3.8.C). To 
investigate whether the THOC4 directly interacts with BPTF we performed in vitro pull-
down using recombinant MBP-tagged THOC4 and recombinant NURF complex. This 
analysis showed pull-down of BPTF with the MBP-THOC4 (Figure 3.8.D). To further 
confirm that the interaction is mediated through the N-PHD domain, we performed in 
vitro pull-down using GST-N-PHD and MBP-THOC4 (Figure 3.8.E). This analysis 
showed that the N-PHD domain is sufficient in interacting with THOC4. Together these 
results suggest a direct interaction between NURF complex and THOC4, likely through 
the N-PHD domain of BPTF. 
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3.10 BPTF Localizes to Gene Body and Regulates the Chromatin Structure and 
mRNA Processing of Ccnd1 Gene 
Our results show localization of BPTF in gene bodies and downstream regions of 
genes, and interaction with THOC4, a mRNA processing factor. Next, we wants to 
investigate whether recruiting BPTF to these regions could impact gene expression. To 
this end, we selected the Cyclin D1 (Ccnd1) gene. We focused on Ccnd1 because (i) It 
is a BPTF-dependent gene in mESCs (Landry, Sharov, et al. 2008), (ii) our ChIP-Seq 
data show localization of BPTF at the gene body and 3’UTR, but not at the promoter 
region (Figure 3.9.A), (iii) our FAIRE-Seq show a NURF-dependent change in chromatin 
structure at 3’UTR (Figure 3.9.A).  
          In a separate project in our lab, we first confirmed that Ccnd1 is a BPTF 
dependent genes using Northern blot, and its expression is down regulated in BPTF KO 
mESCs. From this analysis no truncated transcripts were observed following BPTF KO. 
In addition, we investigated whether BPTF regulate the promoter of Ccnd1 gene using 
integrating reporter assay. In this assay, the Ccnd1 promoter is cloned upstream of 
Neomycin resistant gene (Neo), and a linearized vector then stably transfected into 
control and BPTF KO mESC. The active promoter will drive the expression of the Neo 
gene which allows the cells to grow in Neomycin containing media. Thus, testing 
whether the promoter is a BPTF dependent or independent is determined by monitoring 
the ability of the control cells and BPTF KO mESCs to grow in media with Neomycin. 
This analysis shows that the Ccnd1 promoter is BPTF independent in mESC, as no 
difference was observed in the promoter activity in BPTF KO cells (Figure 3.9.B). These 
results suggest that Ccnd1 is not regulated by NURF functions at the promoter.  
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Further, our ChIP-seq data show no localization of BPTF at Ccnd1 promoter (Figure 
3.9.A). Together, these finding suggest that BPTF regulate Ccnd1 gene expression 
independent from transcription initiation. 
 Following transcription initiation, RNA-pol 2 engages in active elongation stage to 
generate a pre-mRNA. Processing of the pre-mRNA including 5’ capping and splicing 
occur co-transcriptionally as elongation proceeds through the DNA template. Successful 
completion of this process results a mature mRNA that can be exported from the 
nucleus and translated in the cytoplasm (Bentley 2014). However, defects in this 
process result in unprocessed pre-mRNAs that are degraded by RNA degradation 
pathways (Houseley and Tollervey 2009). 
Our preliminary data suggest that BPTF does not regulate Ccnd1 transcription 
initiation. As our genome wide data show that BPTF localizes in gene bodies and 
results from our co-IP shows interaction with the mRNA processing factors THOC4, we 
hypothesized that BPTF might regulate the pre-mRNA processing of Ccnd1. To test this 
hypothesis, we used qRT-PCR to measure the presence of processed (spliced) and 
unprocessed (unspliced) Ccnd1 transcripts. To adjust for the amount of the Ccnd1 
transcript between the control and BPTF KO mESC we normalized to exon 1. While no 
difference is observed in the processed transcripts, we observe an increase in the 
unprocessed transcripts near the 3’end of the gene with BPTF KO (Figure 3.9.C). The 
increase in the unprocessed transcripts is not due to amplification of genomic DNA, as 
minus RT controls failed to show amplification for all the tested primers (Figure 3.9.C). 
These analyses show that BPTF KO promotes intron retention in the Ccnd1 transcripts.  
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The observed defects in intron retention correlate with our FAIRE-Seq data which 
shows a defect at the 3’UTR of Ccnd1. To confirm this correlation we performed FAIRE-
qPCR across the gene and confirmed the observed alteration in the chromatin structure. 
The results show changes in the chromatin structure at the last coding exons and 
3’UTR (Figure 3.9.D). Together these results suggest that BPTF regulates Ccnd1 
mRNA processing, and open chromatin structure at the 3’end of the gene. 
Next, we investigated whether the observed defects in mRNA processing are 
associated with defects in THOC4 recruitment following BPTF KO. To this end we 
perform ChIP assays. From these analyses we confirmed BPTF enrichment at the 
Ccnd1 gene body and 3’UTR (Figure 3.9.E). Because the recruitment of many factors is 
co-dependent we next performed ChIP for THOC4. This analysis found a reduction in 
THOC4 localization at Ccnd1 promoter and gene body following BPTF KO (Figure 
3.9.E), and this reduction in part overlaps with BPTF localization (Figure 3.9.E amplicon 
# 3). To show that the observed reduction in THOC4 recruitment the Ccnd1 is not due 
to a reduction in the protein level following BPTF KO in mESC, we measured THOC4 
protein levels in BPTF KO ESC by Western blotting. This analysis showed no difference 
in THOC4 level demonstrating that BPTF does not regulate THOC4 protein expression 
(Figure 3.9.F). Together, these results suggest a correlation between THOC4 
recruitment and BPTF recruitment. 
The above results show defects in mRNA splicing at Ccnd1 and intron retention. 
Pre-mRNA processing occurs co-transcriptionally and it can be influenced by RNA-pol 2 
elongation rate and chromatin structure (Braunschweig , Gueroussov , et al. 2013). 
Genome wide investigation showed an association between RNA-pol 2 pausing and 
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intron retention in the transcript (Braunschweig, Barbosa-Morais , et al. 2014). RNA-pol 
2 pausing can be in part due to defects in recruiting splicing factors (Fong and Zhou 
2001) (Alexander , et al. 2010). In addition, H3K36me3 occupancy in genes increases 
following inhibition of intron exclusion from transcripts (Kim, et al. 2011). Our ChIP 
results show increase in RNA-pol 2 occupancy at the gene body and the 3’UTR as well 
as an increase in H3K36me3 level throughout the gene in BPTF KO mESC (Figure 
3.9.E). This suggests defects in normal elongation rate of RNA-pol 2 and occupancy of 
the elongation mark H3K36me3 following BPTF KO. Thus, in agreement with previous 
reports, our analyses show that the defects in intron retention within Ccnd1 transcripts 
are accompanied with increase RNA-pol 2 and H3K36me3 occupancy within Ccnd1 
gene.  
Next, we wanted to test whether THOC4 has a role in BPTF recruitment at 
Ccnd1 gene. To this end, we created THOC4 stable KD mESC line using retrovirus 
system (Figure 3.9.G). To test whether THOC4 KD affects BPTF expression, we 
examined BPTF protein level using Western blotting. This analysis shows an increase in 
BPTF expression following THOC4 KD (Figure 3.9.G). To test if BPTF localization at 
Ccnd1 gene body and 3’UTR is dependent on THOC4, we investigated BPTF 
localization at Ccnd1 gene in THOC4 KD and control cells. This analysis shows 
reduction in BPTF localization following THOC4 KD, after normalizing for differences in 
BPTF expression with THOC4 KD (Figure 3.9.H). These results suggest that BPTF 
recruitment to Ccnd1 is dependent on THOC4 localization. Along with the results from 
THOC4 recruitment in BPTF KO cells, it is likely that BPTF recruitment and THOC4 
recruitment are interdependent on each other.  
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Our findings at Ccnd1 gene show that BPTF is localized at the gene and is 
required for regulating the chromatin structure at 3’UTR. Loss of BPTF results in 
alteration of chromatin structure, defects in elongation rate and promote intron retention. 
Together, our results suggest that BPTF is required for normal Ccnd1 mRNA 
processing. 
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3.11 BPTF Regulates mRNA Processing at Multiple BPTF-Dependent Genes 
The observed defects in mRNA processing at Ccnd1 gene suggest a role for the 
NURF complex in regulating mRNA processing. In order to test whether this occurs 
broadly, we used qRT-PCR to measure processed and unprocessed transcripts for four 
different BPTF-dependent genes Gldc, Cnot1, Scd2, Soat1 genes. Our genome wide 
data sets indicate that these genes have BPTF peaks, BPTF-dependent FAIRE sites 
and are down regulated in expression following BPTF KO (Landry , Sharov , et al. 
2008). Similar to the analysis for Ccnd1 Figure 3.9.C we used qRT-PCR to measure the 
presence of processed (splices) and unprocessed (unspliced) transcripts of these 
genes, after normalizing for the transcript level in the control and BPTF KO mESC. 
Similar to the defects in Ccnd1 mRNA processing, we detect significant increases in the 
unprocessed transcripts (unspliced) with no difference in the processed transcripts 
(spliced) following BPTF KO (Figure 3.10.A). We did not detect amplification using 
these primers in the minus RT control (Figure 3.10.B). This suggests that BPTF, and by 
extension NURF, regulates mRNA processing at multiple genes.  
Collectively, our results suggest a novel model for NURF complex in regulating 
gene expression additional to its classical role in transcription initiation. In this model, 
NURF is recruited to gene bodies and 3’ end of genes through physical interactions 
between its BPTF subunit and THOC4. NURF localization to gene bodies recruits 
mRNA processing factors to mediate normal pre-mRNA processing to generate mature 
mRNAs. We propose that defects in chromatin structure with NURF depletion result in 
RNA-pol 2 pausing and an increase in H3K36me3 levels. These defects in chromatin 
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structure resulting in RNA-pol 2 pausing result in intron retention that promotes the 
transcription degradation  (Figure 3.11). 
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Figure 3.11: Proposed model for the role of NURF in regulating mRNA processing 
In control cells, THOC4 recrui s NURF to gene bodies (1). Once recruited NURF 
regulates the chromatin structure (2). This allows normal elongation of RNA-pol 2 
(3), and leads to normal mRNA processing (4). Eventually, this generates mature 
processed mRNA (5). In BPTF KO, hence no NURF complex, lacking BPTF 
reduces THOC4 localization (1) and lead to defects in chromatin structure (2). 
This alters RNA-pol2 rate and induce pausing within the gene (3). This causes 
defects in the mRNA processing and intron retention within the transcripts (4). 
Eventually, this generates immature mRNA (5). 
Figure 3.11 
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CHAPTER FOUR 
 
Discussion and Future Directions 
 
   
 
 
4.1 Discussion  
One level of controlling gene expression is through regulation of chromatin 
structure, which acts as a barrier, to provide accessibility for DBPs. Major regulator of 
chromatin structure are ATP-dependent chromatin remodeling complexes (Clapier and 
Cairns 2009). In common, these complexes utilize ATP to mediate their remodeling 
activity. However, they have different function in vivo, which in part is due to their 
subunits compositions and their interacting partners. Thus, studying how these 
complexes are targeted to certain region in the genome and where they regulate the 
chromatin structure will help to understand their roles in vivo.  
One ATP-dependent chromatin-remodeling complex is NURF. In mESC, NURF 
complex is not essential for the pluripotency state or cell viability, but it is required for 
normal ESC differentiation. This is likely due to the observed defects in genes required 
for differentiation. Works from animal models and human cell lines show that the major 
role of NURF is to act as a regulator of RNA-pol 2 transcriptions (Alkhatib and Landry 
2011). It is known that NURF is localized at promoters to regulate accessibility of TFs at 
promoter regions (Badenhorst, Voas, et al. 2002) (Alkhatib and Landry 2011). This 
recruitment achieved through interaction with H3K4me3 and/or sequence specific TFs. 
However, how prevalent this role of NURF in regulating gene expression is unknown. It 
is known that the role of chromatin remodeling complexes in transcription is not limited 
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to transcription initiation. Genome wide studies uncovered roles of chromatin 
remodeling complexes within genes and at distal regulatory elements (Schnetz, et al. 
2010) (Smolle, et al. 2012). Thus, it is likely that NURF has as of yet uncharacterized 
roles in regulating gene expression. The goal of this project is to discover novel ways 
NURF regulates transcription of the genome by completing three specific aims… 
 
Aim1: Identifying NURF Localization Genome Wide in Mouse Genome  
In this aim we mapped NURF’s specific subunit BPTF in the mouse 
genome using ChIP-Seq approach. In order to use this technique we generated 
and characterized a BPTF ChIP grade antibody.  
 
Aim2: Identifying NURF Dependent Changes in Chromatin Structure Using 
FAIRE-Seq 
 In this aim we mapped NURF dependent changes in chromatin structure 
using FAIRE-Seq approach. FAIRE-Seq profile from control and BPTF KO 
mESCs were compared to identify NURF dependent changes in chromatin 
structure.  
 
Aim3: Characterize a Mechanism of NURF Recruitment to Chromatin and 
Role in Regulation of Gene Expression 
 In this aim we characterized the role of a previously uncharacterized 
domain in BPTF using in vivo and in vitro pull-downs.  
	  
	   155	  
Also, we used qRT-PCR and ChIP analyses to characterize role of NURF 
function within five BPTF-dependent genes.  
 
As a result of completing these aims we show that BPTF localizes to and 
remodels chromatin within gene bodies and 3’UTR of genes. This is an important 
finding as it suggests new roles for NURF complex within gene bodies and 3’UTR. In 
addition we discovered a new role for a previously uncharacterized domain the N-
terminal PHD domain of BPTF. We show using in vivo and in vitro pull downs that this 
domain mediate direct interaction with the RNA-pol 2 associated protein THOC4. This 
interaction recruits BPTF and likely NURF to gene bodies as BPTF recruitment at 
Ccnd1 gene is abolished following THOC4 KD. Moreover, we show using Ccnd1 as an 
example that recruiting NURF to gene bodies has functional consequences as it is 
required for normal mRNA processing, and BPTF KO is associated with defects in pre-
mRNA intron retention in the transcripts of BPTF dependent genes. We further show 
that the defects in pre-mRNA intron retention found in four BPTF dependent genes.  
 
 
 
4.1.1 Mapping NURF Localization in the Genome Using ChIP-Seq  
 
NURF is a chromatin associated complex, the lack of ChIP-grade specific 
antibody to study its localization limited investigating its role in vivo. In this work we 
generated and characterized a ChIP-grade specific antibody for NURF specific subunit 
BPTF. This antibody is specific as evident by the Western blotting (Figure 3.1 B), and 
efficient in immunoprecipitation of BPTF bound chromatin as shown by ChIP-qPCR 
(Figure 3.1.C). Moreover, our preliminary high seq experiments that compared amount 
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of mapped reads from BPTF-1, BPTF-2 and IgG further confirmed the efficiency of 
BPTF-2 antibody and that it can be used in genome wide experiments. Thus, the 
availability of this tool will help in studying BPTF localization and by extension NURF 
complex in vivo.  
In this work we used BPTF-2 antibody to map BPTF localization in the mouse 
genome. The results from our ChIP-Seq analysis uncovered new insights for BPTF and 
by extension NURF complex localization. We found that BPTF is broadly localized to 
the genome as opposed to pointed enrichment at certain sites. This localization pattern 
of NURF, an ISWI complex, is in agreement with a previously suggested model for 
localization of ISWI containing complexes to chromatin (Erdel, Schubert, et al. 2010). In 
this model ISWI complexes continuously sample the chromatin with low residence time 
in an ATP-independent manner. These low residence sampling functions are 
interspersed with times of high residence presumably because they anchored at regions 
where there is a localization signal. The signal can be histone modifications, histone 
variants or DNA binding proteins. In case of NURF, the signals can be H3K4m3, 
H4K16ac, CTCF or cohesin, as they physically interact with NURF subunits (Alkhatib 
and Landry 2011) (Qiu, et al. 2015). Indeed, the identified BPTF peaks significantly 
overlap with the sites of these factors (Figure 3.6.A) and BPTF signal are enriched over 
these sites (Figure 3.2.G). In order to test this model, measuring residence time for 
NURF with mutants that abolish interaction to these signals would be useful. Previously 
reported mutations in the C-PHD domain (Wysocka, Swigut, et al. 2006) and the 
bromodomain (Ruthenburg, et al. 2011) can be used in this regard as they specifically 
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abrogate BPTF interaction to H3K4me3 and H4K16ac respectively, without affecting the 
complex integrity.  
 
Our results show BPTF localization at promoters, 5’UTR, within genes and 3’end 
of genes (Figure 3.4.A, C). The enrichment at promoter regions is in agreement with the 
known interaction between the C-PHD domain of BPTF and H3K4m3, a marker at 
promoters (Shen , et al. 2012), and it also agrees with the many works that show the 
role of NURF in regulating accessibility at promoter regions (Barak, Lazzaro and Cooch, 
et al. 2004) (Vicent, et al. 2011). In addition, the obtained signal from our BPTF ChIP-
Seq at promoter regions (Figure 3.4.A) is similar to a signal from a previous ChIP-Seq 
experiment performed using tagged construct for the C-terminal region of BPTF that has 
the C-PHD and the bromodomain (Ruthenburg, et al. 2011). This further supports the 
validity of our data. 
 In contrast to these known functions for NURF at promoter regions, we 
uncovered new localization of BPTF at gene bodies, 3’UTR and downstream of genes. 
This localization pattern for BPTF is novel to mammalian NURF, and resembles the 
ISWI complexes in yeast in which there are three ISWI containing complexes Isw1a, 
Isw1b and Isw2. Genome wide localization studies show that Isw1a and Isw2 localize at 
TSSs and TTSs, while the Isw1b is physically recruited at gene bodies and 3’end of 
genes (Smolle, et al. 2012) (Yen, et al. 2012). Isw1b is recruited to these gene features 
through direct interactions between H3K36me3 and the PWWP domain of its IOC4 
subunit (Smolle, et al. 2012). Although we see strong correlation between BPTF-ChIP-
Seq peaks and H3K36me3, our pull down analysis did not detect interactions with this 
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modification in mESC. This might be due to lack of a subunit in NURF that has PWWP 
domain, which interacts with H3K36me. This suggests that although the recruiting 
mechanism is not conserved in mammals, the need for the ISWI complexes in gene 
bodies and the 3’UTR is conserved.   
A previous study performed BPTF ChIP-Seq in T47D human cell lines (Vicent, et 
al. 2011). However, this study has low sequence depth and used a low quality antibody 
that shows unspecific binding. The finding from this study showed that 41% of identified 
BPTF peaks were localized to intragenic regions (Vicent, et al. 2011). This is in general 
agrees with our finding that BPTF enriched within gene features.  
Our genome wide data show that a significant portion of BPTF peaks localize at 
gene bodies and 3’end of genes regions which do not localize known NURF recruiters. 
How NURF is recruited to these regions? We envision that additional recruiters can 
interact with NURF subunits and mediate the localization to these regions. Recruiting 
factors to gene bodies can be through direct association with the elongating RNA-pol 2. 
An example for this mechanism is recruiting the histone chaperone Spt6 to gene bodies, 
which is mediated through direct interaction with phosphorylated p-Ser 2 at the CTD 
domain of RNA pol-2 (Yoh, Cho, et al. 2007). In addition, interaction with factors 
associated with RNA-pol 2 can recruit additional factors to gene bodies. Example of 
such recruitment is the Chd1 chromatin remodeling factor that interacts with Paf1 
complex and FACT complex, which are associated with RNA-pol 2 (Simic, et al. 2003). 
Furthermore, histone modifications within genes bodies such as H3K36me3 can serve 
as a recognition signal to recruit factors to gene bodies through direct interactions as 
the case with the chromatin remodeling complex Isw1b (Smolle, et al. 2012) and factors 
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involved in recruiting splicing regulators such as MRG15 (Zhang, et al. 2006). It is 
possible that NURF can be recruited to gene bodies thorough one on these 
mechanisms. The specific subunit of NURF, BPTF has functional domains such as N-
terminal PHD, DDT, C-terminal PHD and bromodomain (Alkhatib and Landry 2011). 
While the DDT, C-PHD and bromodomain mediate the interaction with ISWI, H3K4me3 
and H4K16ac, respectively, the N-terminal PHD has not been characterized. Due to the 
potential role of PHD domain in mediating protein-protein interaction with histone and 
non-histone proteins (Musselman and Kutateladze 2011) we focused on characterizing 
the role of BPTF N-terminal PHD domain. 
 
4.1.2 Mapping BPTF/NURF Dependent Changes in the Genome Using FAIRE-Seq  
Our results from the FAIRE-Seq analysis shows that BPTF-dependent changes 
in chromatin structure reside within intragenic and intergenic regions, and within genes 
more sites are at promoter regions (Figure 3.5.H). We also observed that NURF 
maintain open chromatin structure and closed chromatin structure at almost equal 
number of sites (27,864 open sites and 28,936 closed sites) suggesting that NURF 
functions to reduce and promote accessibility to chromatin equivalently with no baized 
toward one outcome. Although, we don’t see direct overlap between BPTF-ChIP Seq 
peaks and BPTF-dependent FAIRE sites, we see more BPTF occupancy at TTS of 
genes that have FAIRE-dependent sites and enhancer regions that overlap with BPTF-
dependent FAIRE sites versus the one that don’t, which suggests direct activity of 
NURF at some of these sites.  
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The distribution of open and closed NURF dependent changes in chromatin 
structure in the genome is distinct. Within genes NURF mainly maintain open chromatin 
structure at 1kb upstream, 5’UTR, 3’UTR and 1kb downstream, while it maintains 
closed chromatin structure at intergenic (Figure 3.5.H). This pattern is also observed for 
the yeast ISWI complexes Isw1a, Isw1b and Isw2 complexes (Whitehouse, et al. 2007) 
(Yen, et al. 2012). Changes in chromatin structure following deletion of Isw2 were 
localized 5’ end and 3’end of genes as well as intergenic regions (Whitehouse, et al. 
2007), and similar pattern was observed for Isw1a (Yen, et al. 2012). However, Isw1b 
mostly function within genes and 3’end of genes (Gkikopoulos, et al. 2011) (Yen, et al. 
2012). This further suggests a conserved role of ISWI complexes in gene expression at 
upstream within and downstream of genes. 
 
4.1.3 Correlation Between BPTF Localization and BPTF-Dependent FAIRE Sites 
and BPTF Dependent Genes in mESC 
In mESCs there are 1,679 BPTF-dependent genes (Landry , Sharov , et al. 
2008). Our ChIP-Seq and FAIRE-Seq data show that 871 out of 1,679 have BPTF 
ChIP-Seq peaks (Figure 3.4.A) and 732 out of 1,679 have BPTF-dependent FAIRE 
sites (changes in chromatin structure) (Figure 3.6.G) within the TSS and TTS. Although 
we detect a correlation between BPTF dependent genes and BPTF localization and this 
correlation equivalent to the INO80 complex, the correlation is not as strong as the 
BRG1 and CHD7 chromatin remodeling factors we tested (Figure 3.4.A). The observed 
correlation between NURF binding and function and gene expression agrees with the 
observed correlation of ISWI proteins. Weak correlations were detected between ISWI 
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proteins binding and gene expression in yeast and Drosophila (Gelbart, et al. 2005) 
(Gkikopoulos, et al. 2011) (Sanchez and Zhou 2011). However, it seems that this 
observation is not limited to ISWI complexes, but also extended to other chromatin 
associated proteins. In a comprehensive analysis in yeast for correlation between 
localization of 70 chromatin associated proteins and their dependent genes, it has been 
shown that only 24% genes occupied by a factor are sensitive to its deletion (Lenstra 
and Holstege 2012). Thus, it has been suggested that in general there is a weak 
correlations between localization of chromatin-associated proteins and gene expression 
(Lenstra and Holstege 2012). This likely indicates that while a chromatin-associated 
factor can bind many genes, only genes with specific properties are sensitive to its lost. 
It is also possible that other factors can compensate for its lost on some genes, which 
indicates functional overlap and redundancy. In agreement with this, studies showed KD 
of one chromatin remodeler have slight defect in chromatin structure, which is 
significantly synergized by double mutant as for example the case for Chd1 and Isw1 
double mutant in yeast (Gkikopoulos, et al. 2011).  
 
4.1.4 BPTF Localization and BPTF Dependent Changes Over H3K36me3 and 
H3K4me1 are More Correlated with BPTF Dependent Genes 
Our overlapping analysis using genome runner with a panel of histone 
modifications and DBPs show significant overlap between BPTF peaks as well as 
BPTF-dependent changes in chromatin structures and factors localized at promoter 
regions and within genes such as RNA-pol 2, H3K36me3, H3K4me1 and Cdk9 
(Figure3.6.A, B). These agree with the pattern of BPTF signal from the ChIP-Seq over a 
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meta-gene that resamples a signal of elongation factors (Figure 3.5.B). Along with the 
observed distribution of BPTF peaks and BPTF dependent FAIRE sites over genes, 
these indicate that NURF localization over genes is correlated with factors associated 
with these regions. 
As only 22% of BPTF peaks and 14% of BPTF-dependent FAIRE sites can be 
explained by H3K4me3, H4K16ac, CTCF and cohesin, the majority of the remaining 
sites are likely recruited to chromatin with novel recruiters. We found that BPTF ChIP-
Seq peaks and BPTF dependent FAIRE-sites that don’t overlap with H3K4me3, 
H4K16ac, CTCF or cohesin (Group B sites) are more associated with BPTF dependent 
genes (Figure 3.7.A, B). A work in Drosophila shows that the BPTF isoform that lacks 
the C-terminal region (can’t recognize H3K4me3 and H4K16ac) is not required for the 
majority of NURF dependent genes and the developmental defects associated with 
losing NURF (Kwon, Xiao, et al. 2009). This suggests that recognition of H3K4me3 is 
not required for the majority of BPTF genes. In agreement with BPTF signal from ChIP-
Seq, the overlap between group B peaks with the H3K36me3 and H3K4me1 suggest a 
novel recruiting mechanism of BPTF to intragenic regions. This is further supported by 
the overlap of group B FAIRE-sites with the elongation mark H3K36me3, which mainly 
localizes at active genes. 
 
4.1.5 BPTF Directly Interacts with THOC4 
The results from our genome wide data suggest a novel recruiting mechanism of 
BPTF in gene bodies. Although significant overlap was detected for H3K36me3, our 
pull-down did not detect interaction with this modification (Figure 3.8.B). Thus, we 
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thought that unknown factor is recruiting NURF through protein-protein interaction with 
one of NURF subunit (BPTF, SNF2L or RbAp46/48 proteins). As BPTF is specific to 
NURF and it has uncharacterized PHD domain, domain that is known to mediate 
interactions with histone and non-histone proteins (Musselman and Kutateladze 2011), 
it was subjected to investigation by a different project in our lab using unbiased 
screening by mass-spectrometry. These analyses revealed an interesting interaction 
with THOC4. THOC4 is a highly conserved mRNA binding protein that directly interacts 
with the phosphorylated RNA-pol 2 in yeast (MacKellar and Greenleaf 2011). In 
mammals, it also interacts with Iws1 a protein associated with RNA-pol 2 (Yoh, Cho, et 
al. 2007). THOC4 also binds to mRNA and involves in mRNA processing and exporting 
(Stubbs and Conrad 2015). These roles of THOC4 and our BPTF localization pattern 
form the genome wide data suggest that THOC4 can recruit NURF to gene bodies. Our 
in vivo pull down confirmed the interaction with THOC4 (Figure 3.8.C). However, a 
previous work showed that THOC4 is identified as a protein associated with H3K4me4 
using mass spectrometry (Vermeulen, et al. 2010). This study also showed enrichment 
of all NURF subunits with H3K4me3 along with THOC4. Although this might support our 
finding that THOC4 interacts with NURF complex, it does not rule out that this 
interaction is indirect. As BPTF directly interact with H3K4me3, similarly THOC4 could 
interact with H3K4me3 or any factors that interact with H3K4me3. In this case observing 
NURF subunits and THOC4 in H3K4me3 pull down is due to indirect interaction through 
H3K4me3. However, our in vitro pull-down using recombinant THOC4 protein and 
recombinant NURF and the in vitro pull-down using the N-PHD domain arguing against 
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this and indicate that the interaction between THOC4 and BPTF is direct (Figure 3.8.E, 
D).  
 
4.1.6 BPTF Regulates Messenger RNA Processing 
The role of BPTF in regulating mRNA processing is suggested by BPTF 
localization, BPTF dependent changes in chromatin structure and the interaction with 
the mRNA processing factor THOC4. Our data at Ccnd1 support this hypothesis. The 
observed defect in splicing at Ccnd1 transcripts at the last intron following BPTF KO is 
associated with BPTF localization as well as BPTF-dependent changes in chromatin 
structure. Also, a reduction in THOC4 localization was observed in the middle of Ccnd1. 
In agreement with our results, a previous work showed that defects in THOC4 
recruitment at c-myc gene is associated with increase in unspliced transcript (Yoh, Cho, 
et al. 2007). In addition, depletion of THOC4, also affect recruitment of BPTF to Ccnd1 
gene. Thus, our ChIP experiments suggest that THOC4 recruits BPTF, and once 
recruited BPTF stabilizes THOC4 localization. Our results also show that BPTF KO is 
associated with increase in H3K36me3 accumulation throughout the gene body and 
increase RNA-pol 2 occupancy at the middle and the end of Ccnd1. These two features 
are associated with intron retention in transcripts (Braunschweig, Barbosa-Morais , et al. 
2014) (Kim, et al. 2011). Intron retention regulates the abundance of mRNA transcript 
through generating immature transcripts that is subjected to degradation. Our results 
from four genes support that the observed defects in Ccnd1 is likely occur at many 
BPTF-dependent genes and not specific to one gene. 
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How does NURF depletion result in intron retention? One possible mechanism is 
that BPTF KO directly or indirectly enhances recruitment of factors that inhibit pre-
mRNA intron exclusion from the transcript by the splicing machinery. NURF remodeling 
activity could remodel chromatin in front of RNA-pol 2 promoting its elongation. When 
NURF is depleted, alterations in chromatin structure could occur which form barriers in 
front of elongating RNA-pol 2, which in turn could result in a pausing of RNA-pol 2. This 
pausing indicates a delay of RNA-pol 2 elongation, which provides more time for 
splicing inhibitor to be recruited such as the splicing regulator PTBP1 (Yap , et al. 2012). 
It has been shown that binding of PTBP1 protein at introns induces intron retention and 
down regulation of genes (Yap , et al. 2012). PTBP1 directly interacts with MRG15 a 
protein that localizes within genes through direct interaction with H3K36me3 (Zhang, et 
al. 2006). Recruiting PTBP1 by H3K36me3/MRG15 has been shown to effect 
alternative splicing (Luco, et al. 2010). As BPTF KO abnormally increases H3K36me3 
within genes, it is possible that this facilitates recruitment of PTBP1, which in turn 
inhibits exclusion of intron sequences from the transcript. In addition, H3.3K36me3 is 
recognized by BS69 proteins, which is known to induce intron retention through 
interfering with component of U5 snRNP spliceosome assembly (Gao, et al. 2009). 
Thus, an increase in H3K36me3 occupancy might involve in recruiting factors known to 
induce intron retention.  
 
Our model from this work is that NURF is recruited to gene bodies through direct 
interaction between BPTF and the mRNA processing factor THOC4 (Figure 3.11). Once 
recruited, NURF stabilizes the mRNA processing factors and help in regulating the 
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chromatin structure to facilitate elongation (Figure 3.11). BPTF KO alters the chromatin 
structure, destabilizes the binding of mRNA processing factor, induces pausing of the 
RNA-pol 2 within genes and increases H3K36me3. This lead to defects in pre-mRNA 
splicing resulting in inclusion of an intron that affects the transcript stability (Figure3.11).   
 
 
 
 
4.2 Future directions 
 
 
This work investigates the role of NURF complex in regulating gene expression 
in mESCs. However, recent work from our lab established that NURF functions as a cell 
type specific regulator of gene expression (Qiu, et al. 2015). It would be of a great 
interest to investigate if the roles for NURF discovered here as a regulator of intron 
retention explain its functions as a cell type specific regulator of gene expression. To 
facilitate these studies in addition to mESC, our lab has successfully generated BPTF 
KO moues embryonic fibroblast (MEF) and DP thymocyte (Landry, et al. 2011) (Qiu, et 
al. 2015). In addition, BPTF-dependent genes at these cell types have been identified 
(Landry , Sharov , et al. 2008) (Landry, et al. 2011) (Qiu, et al. 2015). As the current 
work generated and characterized a ChIP-grade antibody for BPTF, this will allow 
mapping BPTF localization at these cell types. Employing BPTF-dependent genes 
along with BPTF localization at these cell types and comparing BPTF localization 
between these cells will be of great values to understand how NURF can function as a 
regulator of gene expression in different cell types. In addition, investigating the 
changes in chromatin structure by comparing FAIRE-Seq profile from control and BPTF 
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KO cells will further help in determining what sites are common and specific between 
different cell types. 
The results from the current work show defects in mRNA processing as a 
consequence of BPTF KO. In order to investigate whether this is a general effect 
following BPTF KO, RNA-Seq approach would be required. In this experiment, RNA-
Seq profile will be generated from control cells and BPTF KO cells, and mapped reads 
to introns will be evaluated in these two conditions. In addition, RNA-Seq profile from 
THOC4 KD cells would be useful to include in the comparison to assess to what extent 
NURF and THOC4 work in regulating intron retention. 
Although our work uncovered a new mechanism for BPTF recruitment to 
chromatin through THOC4 localization within genes, recruiting mechanisms for large 
number of BPTF sites at regions distal from genes still need to be uncovered. First, it 
would be interesting to investigate how much of BPTF peaks could be explained by 
interaction with THOC4. To this end, ChIP-Seq analysis would be required to identify 
THOC4 localization in the mESC. The availability of ChIP-grade antibody for THOC4 
suggests that genome wide profiling of THOC4 is possible. Alternatively, genome wide 
mapping of BPTF using our ChIP-grade antibody in THOC4 KD background can be 
used. Such analysis will be informative, as it will determine what fraction of BPTF peaks 
requires THOC4.  
Additionally, it would be interesting to investigate using unbiased screening what 
proteins can interact with BPTF. To this end, generating a BPTF tagged construct that 
would be stably transfected into the cell is needed. Following affinity purification of 
BPTF bound partners; eluted fraction will be used for mass-spectrometry analysis. This 
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approach will likely uncovered new partners of BPTF that can have an impact on its 
function, and might explain part of its localization in the genome.  
Finally, our work expands our understanding of how the mammalian NURF can 
function as a regulator of gene expression. In oppose to its known role as a regulator at 
promoter regions, we propose that NURF can also function within gene bodies to 
regulate normal mRNA processing. 
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